美國證券交易委員會
華盛頓特區20549
形式
根據1934年《證券交易所法》第13或15(d)條提交的年度報告 |
日終了的財政年度
或
根據1934年《證券交易所法》第13或15(d)條提交的過渡報告 |
從 到
委員會檔案編號
(註冊人章程中規定的確切名稱)
(州或其他司法管轄區 成立或組織) |
(國稅局僱主 識別號) |
|
|
|
|
(主要行政辦公室地址) |
(Zip代碼) |
註冊人的電話號碼,包括地區代碼:(
根據1934年證券交易法第12(b)條登記的證券:
每個班級的標題 |
交易符號 |
註冊的每個交易所的名稱 |
根據1934年證券交易法第12(g)條登記的證券:無。
如果註冊人是《證券法》第405條所定義的知名經驗豐富的發行人,則通過複選標記進行驗證。
如果註冊人無需根據該法案第13條或第15(d)條提交報告,則通過勾選標記進行驗證。
是的 ☐
通過勾選標記標明登記人是否(1)在過去12個月內(或在登記人被要求提交此類報告的較短期限內)提交了1934年證券交易法第13或15(d)條要求提交的所有報告,以及(2)在過去90天內一直遵守此類提交要求。
通過勾選標記檢查註冊人是否已在過去12個月內(或在註冊人被要求提交此類文件的較短期限內)以電子方式提交了根據S-t法規第405條(本章第232.405條)要求提交的所有交互數據文件。
通過勾選標記來確定註冊人是大型加速歸檔者、加速歸檔者、非加速歸檔者、小型報告公司還是新興成長型公司。請參閱《交易法》第120條第2條中「大型加速申報人」、「加速申報人」、「小型報告公司」和「新興成長型公司」的定義。
☒ |
加速編報公司 |
☐ |
|
|
|
|
|
非加速歸檔 |
☐ |
小型上市公司 |
|
|
|
新興成長型公司 |
☐ |
如果是新興成長型公司,請通過勾選標記表明註冊人是否選擇不利用延長的過渡期來遵守根據《交易法》第13(a)條規定的任何新的或修訂的財務會計準則。
通過勾選標記檢查註冊人是否已提交報告並證明其管理層根據《薩班斯-奧克斯利法案》(15 U.S.C.)第404(b)條對其財務報告內部控制有效性的評估7262(b))由編制或發布審計報告的特許會計師事務所執行。
如果證券是根據該法案第12(b)條登記的,請通過勾選標記表明文件中包含的登記人的財務報表是否反映了對先前發布的財務報表錯誤的更正。
通過勾選標記來驗證這些錯誤更正是否是需要根據§240.10D-1(b)對註冊人的任何高管在相關恢復期內收到的基於激勵的補償進行恢復分析的重述。☐
通過勾選標記檢查註冊人是否是空殼公司(定義見《交易法》第120條第2款)。
是的
截至上一個工作日 在註冊人最近完成的第二財年(2024年3月31日)中,非附屬公司持有的註冊人普通股的總市值為美金
註冊人2025年年度股東大會最終委託聲明的部分內容通過引用納入本報告第三部分。
目錄
|
|
|
項目1. |
5 |
|
|
|
|
項目1A. |
15 |
|
|
|
|
ITEm 10。 |
24 |
|
|
|
|
ITEm 1C。 |
網絡安全............................................................................................................................................................... |
24 |
|
|
|
項目2. |
26 |
|
|
|
|
項目3. |
27 |
|
|
|
|
項目4. |
27 |
|
|
||
|
|
|
項目5. |
28 |
|
|
|
|
項目7. |
30 |
|
|
|
|
項目7A。 |
40 |
|
|
|
|
項目8. |
42 |
|
|
|
|
項目9. |
87 |
|
|
|
|
ITEm 9A。 |
87 |
|
|
|
|
ITEm 90。 |
87 |
|
|
|
|
ITEm 9C。 |
87 |
|
|
||
|
|
|
項目10. |
88 |
|
|
|
|
項目11. |
88 |
|
|
|
|
項目12. |
88 |
|
|
|
|
項目13. |
88 |
|
|
|
|
項目14. |
88 |
|
|
||
|
|
|
項目15. |
88 |
|
|
|
|
項目16. |
92 |
|
|
|
|
93 |
3
與前瞻性陳述相關的信息
這份Form 10-k年度報告包含聯盟證券法規定的“前瞻性陳述”。這些前瞻性陳述涉及對未來的預期或預測,包括我們對未來業務表現和總體前景的預期;部門和產品線增長以及支持我們增長預期的假設;對我們產品的需求和客戶謹慎購買行為的短期性質,特別是在我們的高性能化學品部門;研發活動;我們在印度尼西亞Cilegon的工廠擴建用於增強碳的可用性;我們在路易西安那州維爾普拉特的工廠安裝技術控制的合規日期的延長;我們在安大略省薩尼亞的工廠安裝技術控制的合規日期的延長;我們的2025年可持續發展目標;我們的2025財年展望;我們對Event®可持續解決方案技術平臺的雄心;我們手頭的現金、運營提供的現金以及我們信貸和商業票據設施下可用現金為我們的現金需求提供資金的充分性;預期的資本支出,包括與環境相關的和技術控制資本支出;監管發展;我們管理工作場所安全的能力;現金需求和可用現金的使用,包括與長期合同義務相關的未來現金支出、對員工福利計劃的貢獻、環境補救成本和未來呼吸器負債以及此類支出的時機;面臨利率和外匯風險的風險;我們預計將支付的未來福利計劃付款;未來攤銷費用;我們收回遞延稅項資產的能力;我們的營業稅率;以及法律和環境訴訟的可能結果。我們還不時在我們向公眾發佈的其他材料中以及授權人員的口頭聲明中提供前瞻性聲明。
前瞻性陳述並不能保證未來業績,並且受到風險、不確定性、潛在不準確的假設和其他因素的影響,其中一些因素超出了我們的控制或難以預測。如果已知或未知的風險成為現實,我們的實際結果可能與過去的結果以及前瞻性陳述中表達的結果存在重大差異。本報告第1A項描述了可能導致我們的實際結果與前瞻性陳述中表達的結果存在重大差異的重要因素。
我們沒有義務公開更新前瞻性陳述,無論是由於新信息、未來事件還是其他原因,除非法律要求。然而,建議投資者參考我們在向美國證券交易委員會(「SEC」)提交的10-Q和8-k報告中就相關主題所做的任何進一步披露。
4
部分 I
項目1. B無用
一般
Cabot是一家全球特種化學品和性能材料公司,總部位於麻薩諸塞州波士頓。我們的主要產品是增強碳和特種碳、特種化合物、導電添加劑、碳納米管、煙狀金屬氧化物、噴射著色劑和氣凝膠。Cabot及其附屬公司在美國(「美國」)設有製造設施和業務以及其他20多個國家。Cabot的企業成立於1882年,並於1960年在德拉瓦州成立。本報告中使用的術語「Cabot」、「公司」、「我們」和「我們的」是指Cabot Corporation及其合併子公司。
在2022財年初,我們推出了「為明天創造」的增長戰略。該戰略的重點是投資可持續增長、開發創造更美好未來的創新產品和流程,並推動我們所有工作的持續改進。我們的產品通常基於我們四項核心競爭力中一項或多項的技術專業知識和創新:製造和處理極細顆粒;修飾極細顆粒的表面以改變其功能;設計顆粒以賦予配方特定性能;並將顆粒與其他成分結合以提供配方性能中間體或複合材料。我們專注於製造顆粒和這些顆粒的配方,其成分、形態和表面功能可提供必要的性能,以支持客戶現有和新興應用。
我們的業務目前分為兩個可報告部門:增強材料和高性能化學品。本節稍後將更詳細地討論我們的業務部門。
我們的網際網路地址是www.cabotcorp.com。我們在以電子方式向SEC提交或提供此類材料後,在合理可行的範圍內儘快在我們的網站上或通過我們的網站免費提供我們的10-k表格年度報告、10-Q表格季度報告、8-k表格當前報告,以及根據1934年證券交易法第13(a)或15(d)條提交或提供的報告的修訂。我們網站上出現的信息不是本10-k表格年度報告的一部分,也不包含在其中。
增強材料
產品
木炭是元素碳的一種形式,由副產品原料流在高度受控的工藝中生產,以生產各種尺寸、結構和表面化學的顆粒和聚集體,從而為各種應用帶來許多不同的性能特徵。增強碳(Cabot生產的一類黑)用於增強其所加入的系統和應用的物理性能。
我們的增強碳產品用於輪胎和工業產品。增強碳傳統上被用於輪胎行業作為橡膠增強劑,以提高胎面耐久性,也被用作性能添加劑,以降低滾動阻力和提高牽引力。在軟管、皮帶、擠出異材和模製品等工業產品中,增強碳用於提高產品的物理性能,包括產品的物理強度、流體阻力、導電性和電阻率。
除了我們的增強碳之外,我們還製造工程彈性體複合材料(“E2C®”)解決方案,這是由增強碳和橡膠組成的複合材料,使用我們的專利彈性體複合材料製造工藝製造。與完全由傳統橡膠混合方法制成的增強碳/橡膠化合物相比,這些複合材料提高了耐磨性/耐磨性,減少了橡膠部件的疲勞,並降低了滾動阻力,使橡膠產品製造商減少了對性能進行權衡的需要。E2C®解決方案的使用使我們的客戶能夠生產性能更好的輪胎,包括巨型越野輪胎和公路商用輪胎,以及用於採礦等高耐磨應用的其他橡膠產品。此外,由於E2C®解決方案可以集成到當前的產品方法中,無需額外的大量資本投資,並且與傳統產品相比,需要更少的混合階段、更低的混合溫度和更短的混合週期,因此可能會降低運營和生產成本。E2C®是我們增長的重點領域之一。
2023財年,我們推出了新技術平台EVOLVE® Sustainable Solutions。我們在該平台下的目標是與客戶和技術合作夥伴合作,開發具有可靠性能並在三個可持續發展類別中以工業規模生產的產品:可再生、可再生和可再生,這意味著使用可再生材料或從報廢輪胎中回收的材料製成的產品和/或使用可減少溫室氣體排放的工藝。
需求、銷售和客戶的驅動因素
對我們的增強材料產品的需求在很大程度上受到輪胎和汽車行業的增長和發展的推動。除了全球總體經濟狀況外,輪胎中增強碳的需求主要受到所生產的替換和原始設備輪胎數量的影響,而這些輪胎反過來又受到(i)車輛和駕駛的驅動
5
趨勢,包括行駛里程數以及生產和註冊的車輛數量,(ii)供應鏈庫存水平的變化以適應終端市場需求,(iii)對高性能輪胎的需求,(iv)對更大輪胎和更大車輛的需求,例如卡車、公共汽車、用於農業、採礦和類似車輛的越野車輛,(v)對電動和混合動力汽車的需求,(vi)消費者和工業在新車上的支出以及(vi)影響車輛燃油效率和輪胎法規的監管要求的變化。工業產品增強碳的需求主要受車輛生產和設計趨勢、建築活動和一般工業生產的影響。
西歐、日本和北美發達地區的需求主要受到人口變化、客戶的高質量要求、嚴格的輪胎監管標準、消費者偏好的變化(例如,不同的輪胎尺寸、型號和動力總成類型),輪胎更換需求相對穩定。中國、東南亞、南美和東歐等發展中市場的需求主要受到中產階級不斷壯大、快速工業化、基礎設施支出和汽車擁有趨勢以及對這些地區出口到西方市場的產品的需求的推動。汽車產量和出口的增長反過來又推動了發展中地區對原始設備輪胎和替代輪胎的需求。
增強碳和E2 C ®解決方案的銷售主要由Cabot員工進行,其次通過分銷商和銷售代表進行。我們通常在區域內「製造和銷售」,這除了其他優勢外,還為我們的客戶提供了區域供應鏈,並且通常可以降低運輸成本。對五個主要輪胎客戶的銷售額占Reinhabilitation Matters總淨銷售額和營運收入的重要組成部分。任何這些客戶的損失,或向他們銷售的銷量大幅減少,可能會對該部門產生重大不利影響,直到該業務被取代。
在適當情況下,我們已與某些客戶達成供應安排,通常持續時間為一年。這些安排通常規定銷售價格調整,以考慮包括天然氣在內的相關原料成本的變化,以及在許多情況下其他相關成本(例如一氧化碳成本)的變化2 歐洲的信貸、供應商融資和產品交付)。2024財年,我們大約三分之二的增強碳產量是在這些供應安排下銷售的。根據這些安排銷售的大部分銷量銷往美洲和歐洲的客戶。
我們銷售的大部分增強碳用於輪胎和汽車產品,因此,我們的財務業績可能會受到汽車行業周期性的影響。然而,我們產品的大部分市場都是替換輪胎,而從歷史上看,替換輪胎的周期性較小,因為替換輪胎的需求與行駛里程相關。
競爭
我們是世界上領先的木炭製造商之一。我們在增強碳的銷售方面與四家在全球運營的公司和許多其他在區域運營的公司競爭,其中一些公司將產品出口到生產地區以外。我們還與替代產品競爭,特別是沉澱二氧化矽,以及營銷上以使用更可持續材料製成的產品,特別是再生碳(有時稱為回收木炭)。 我們加固材料產品的競爭基於產品性能、質量、可靠性、價格、服務、技術創新、可持續發展性能和物流。我們相信,我們的產品差異化、技術領先地位、全球製造業務、卓越的運營和物流、可持續發展績效以及客戶服務為我們提供了競爭優勢。
原材料
我們用於生產增強碳的主要原材料由來自世界各地石油精煉作業、焦油蒸餾和乙烯生產的副產品殘餘重油組成。這種「原料」不是專為目的而生產的,而是其他工業過程的副產品流,否則通常會作為燃料油消耗並燃燒以獲取熱量或電力。天然氣也被用作我們生產增強碳的原料。我們的製造過程還需要水和電。一般來說,原材料是現成的且供應充足的。原材料成本通常受到各種類型原料的可用性、該等原材料的供需以及相關運輸成本的影響。
操作
我們在阿根廷、巴西、加拿大、中國、哥倫比亞、捷克共和國、法國、印度尼西亞、義大利、日本、墨西哥、荷蘭和美國擁有或擁有控股權並運營增強碳生產工廠。一家股權附屬公司在委內瑞拉經營一家增強碳工廠。此外,我們還擁有馬來西亞迪克森港一家生產我們E2 C ®產品的實體98%的所有權權益。
6
下表顯示了截至2024年9月30日我們在我們持股不足100%的業務中的所有權權益:
位置 |
|
百分比權益 |
中國上海 |
|
70%(合併子公司) |
中國天津 |
|
70%(合併子公司) |
中國·五台市 |
|
60%(合併子公司) |
瓦拉斯克·梅拉里奇(Valmez),捷克共和國 |
|
52%(合併子公司) |
印度尼西亞西勒貢 |
|
98%(合併子公司) |
馬來西亞狄臣港之 |
|
98%(合併子公司) |
委內瑞拉瓦倫西亞 |
|
49%(股權附屬公司) |
2024年,我們在印度尼西亞西萊貢工廠開始了一個擴建項目,以增加約80,000噸的增強碳產能,我們預計該產能將於2025財年投入使用。
除了木炭外,我們的製造過程還以尾氣形式產生可用能源作為副產品。我們的九個增強碳生產基地和四個增強碳/特種碳生產基地都設有能源中心,我們目前正在路易斯安那州維爾普拉特的增強碳工廠安裝一個能源中心。這些能源中心使我們能夠通過某種形式的能源聯合發電(例如蒸汽或電力)來利用尾氣。我們可以在內部使用這種聯合發電能源來降低我們的製造運營成本,或者出售它並從這些能源中心運營中產生收入。
Performance Chemicals
在Performance Chemical領域,我們設計、製造和銷售可在汽車、建築、基礎設施、打印、電子和消費品領域以及與能源產生、傳輸和儲存相關的廣泛客戶應用中提供性能的材料。在此報告部門,我們結合了特種碳、特種化合物、電池材料、煙狀金屬氧化物、氣凝膠和噴射產品線。我們的重點增長領域包括用於電池應用的導電添加劑和其他材料,以及用於印刷後瓦楞包裝應用的墨水分散液。我們最近爲該部門的增長而進行的投資,包括這些特定重點領域的投資,在「運營」標題下進行了描述。
產品
木炭是元素碳的一種形式,在高度受控的過程中製造,以生產各種結構和表面化學的顆粒和聚集體,從而爲各種應用帶來許多不同的性能特徵。
我們的特種碳用於賦予顏色、提供流動性控制、增強導電性和靜電荷控制、提供紫外線防護、增強機械性能並通過表面處理提供配方靈活性。這些特種碳產品用於多種應用,例如塑料,這些應用代表了我們產品、墨水、塗層、粘合劑、調色劑、電池和顯示器的最大用途。
我們的色母和導電化合物產品(我們稱之爲「特種化合物」)是由特種碳與聚合物和其他添加劑混合而成的配方。這些產品通常被塑料樹脂生產商和轉換商用於汽車、工業、包裝、基礎設施、農業、消費品和電子行業。作爲直接混合特種木炭的替代方案,這些配方更易於處理,並幫助客戶實現所需的分散度和顏色水平,並管理小劑量添加劑的添加。此外,我們的導電化合物產品通常用於幫助確保均勻的導電性能並降低塑料應用中與靜電放電相關的風險。
我們的電池材料產品包括我們的導電添加劑和熱塑性氧化鋁,主要用於電動汽車中使用的先進鉛和鋰離子電池。我們的導電添加劑由導電碳、碳納米管和碳納米結構以及這些材料的混合物組成,每種材料都爲電池製造商提供不同水平的導電性和配方靈活性,以解決性能(能量密度、快速充電)、成本和安全性問題。在鋰離子電池中,我們的導電添加劑用於陰極和陽極應用,通過在活性材料之間提供導電網絡來提高能量密度。熱處理氧化鋁用於減少正極材料和電解質分解並提高容量保持力,從而延長電池循環壽命。
熱處理二氧化硅是一種超細、高純度顆粒,用作汽車、建築、微電子、電池和消費品等各種產品的增強劑、增稠劑、研磨劑、觸變劑、懸浮劑或防結塊劑
7
行業這些產品包括粘合劑、密封劑、化妝品、電池、墨水、調色劑、有機硅彈性體、塗料、拋光漿和藥品。除了上面討論的電池應用外,熱塑性氧化鋁也是一種超細、高純度顆粒,還被用作各種產品中的研磨劑、吸收劑或阻擋劑,例如噴射媒體、照明、塗料、化妝品和拋光漿。
氣凝膠是一種具有高表面積的疏水性二氧化硅基顆粒,用於各種隔熱和特種化學應用。在建築和建築行業,該產品用於絕緣可噴石膏和複合建築產品,以及用於絕緣生態日光照明應用的半透明天窗、窗戶、牆壁和屋頂系統。在特種化學品行業,該產品用於提供啞光飾面、絕緣和增稠性能,用於各種應用,包括鋰離子電池的熱失控管理。
我們的噴射着色劑是高品質的顏料基黑色和彩色分散體和墨水。我們的乳液基於我們專利的顏料表面改性技術和聚合物包封技術。該分散體用於含水噴墨中,以賦予色彩、清晰的印刷特性和耐久性,同時保持打印頭的高可靠性。這些產品用於各種噴印應用,包括傳統的在家工作和企業辦公環境,並且越來越多地用於商業和瓦楞包裝,所有這些都需要高水平的衛生棉條和膠體穩定性。我們的噴墨使用我們的顏料基着色劑分散體,用於圖形藝術的商業印刷領域。
需求、銷售和客戶的驅動因素
我們的特種碳產品具有廣泛的最終用途,需求在很大程度上受到建築和基礎設施、汽車、電子和消費品行業的增長和發展的推動。對我們用於電池的導電添加劑的需求在很大程度上是由車輛電氣化趨勢推動的。對熱塑性二氧化硅的需求主要受到有機硅、粘合劑和塗料應用關鍵市場趨勢的影響,特別是用於汽車輕質結構粘合劑、用於風力渦輪機的環氧粘合膏、用於建築的高性能塗層和混合密封劑以及用於醫療設備的有機硅和電子產品的激增。對特種化合物的需求主要受到汽車、基礎設施、消費品和電子設備、包裝和農業行業的增長和發展的影響。
對我們的噴射着色劑的需求主要受到印刷媒體、辦公室和在家工作環境中印刷的頁面的發展以及印刷機銷售和利用水平的影響,因爲數字含水顏料基墨水滲透到歷史上由模擬印刷方法提供的商業和包裝應用中。
這些產品的銷售由Cabot員工以及分銷商和銷售代表進行。在我們的特種碳和特種化合物產品線中,銷售通常面向廣泛的客戶。在我們的熱塑性金屬氧化物產品線中,與五個客戶的合同銷售約佔收入的三分之一。在我們的電池材料產品線中,對三個客戶的銷售額約佔收入的50%。
競爭
我們是我們在這一細分市場銷售的產品的領先生產商。我們在碳黑銷售方面與三家在全球運營的公司和許多其他在地區運營的公司展開競爭,其中許多公司將產品出口到其製造地區以外。在電池應用方面,我們主要與兩家生產導電碳的全球公司以及一些地區性製造商競爭。對於碳納米管,我們主要與一家總部位於中國的公司以及許多地區性製造商競爭。我們主要與一家在全球運營的氣相氧化鋁製造商競爭。對於氣相二氧化硅,我們與兩家在全球開展業務的公司和其他幾家在地區開展業務的公司展開競爭。對於氣凝膠,我們主要在全球範圍內與另一家生產氣凝膠產品的公司競爭。我們還與世界各地的地區性公司生產的非氣凝膠絕緣產品競爭。對於特種化合物,我們與許多地區性公司和少數全球性公司競爭。我們的噴墨着色劑和油墨旨在取代噴墨打印應用中使用的傳統顏料分散體和染料。噴墨着色劑的競爭產品是由大型化學公司和小型獨立生產商製造和銷售的有機染料和其他分散顏料。
我們的Performance Chemical產品的競爭基於產品性能、質量、可靠性、服務、技術創新和價格。我們相信,我們的產品差異化、技術領先地位、卓越的運營和客戶服務爲我們提供了競爭優勢。
8
原材料
一般來說,我們產品的原材料是現成的且供應充足的。用於生產特種碳和導電添加劑的主要原材料由來自世界各地石油精煉作業、焦油蒸餾和乙烯生產的殘餘重油組成。天然氣也用於生產我們的特種碳。由於產品純度是導電碳最關鍵的要求之一,我們從精選的主要供應商處獲取這些產品的原材料。我們的原材料成本通常受到各種類型原料和天然氣的可用性、該等原材料的供需以及相關運輸成本的影響。我們的製造過程還需要水和電。
碳納米管的主要原材料是我們合成的催化劑和聚丙烯。生產熱塑性二氧化硅的原材料是各種氯硅烷基原料。我們購買原料,並對某些客戶收取費用將其原料轉化爲產品(即所謂的「通行費轉化」)。我們還購買氧化鋁作爲生產熱塑性氧化鋁的原料。我們簽訂了主要從圍欄線合作伙伴購買熱塑性二氧化硅原料的長期採購合同或安排,我們相信這將使我們能夠滿足可預見的未來的原材料需求。此外,我們還在現貨市場購買一些原材料,以幫助確保靈活性並最大限度地降低成本。生產氣凝膠的主要原材料是硅溶膠和/或硅酸鈉。
我們特種化合物使用的主要原材料包括主要來自我們的木炭工廠的木炭、優質和再生熱塑性樹脂以及來自各種來源的礦物填充劑。噴射着色劑的原材料包括來自我們的黑工廠的黑、有機顏料和來自各種來源的其他處理劑。噴墨的原材料包括顏料分散體、溶劑和其他添加劑。
運營
我們擁有或擁有控股權並運營主要在中國、荷蘭和美國生產特種碳的工廠。我們在中國以及在美國和荷蘭的特種碳工廠生產導電添加劑。我們還在中國、德國、英國(「英國」)、以及美國以及德國法蘭克福的一家生產氣凝膠的製造工廠,該工廠目前處於閒置狀態。一家股權附屬公司在印度經營着一家煙狀金屬氧化物工廠。我們的特種化合物主要是在我們擁有或擁有控股權的位於比利時、加拿大、中國和阿拉伯聯合酋長國的工廠中生產的。我們的噴射着色劑和墨水是在我們位於美國的工廠生產的
下表顯示了截至2024年9月30日我們在我們持股不足100%的業務中的所有權權益:
位置 |
|
百分比權益 |
中國天津(特種碳和化合物業務) |
|
90%(合併子公司) |
中國江西省(熱塑性金屬氧化物業務) |
|
90%(合併子公司) |
中國烏海(熱塑性金屬氧化物業務) |
|
80%(合併子公司) |
Mectur Dam,印度(煙燻金屬氧化物業務) |
|
50%(股權附屬公司) |
目前,我們的四個增強碳/特種碳生產基地都設有能源中心。這些內容在上面對加固材料部門的討論中進行了描述。
在過去的幾年裏,我們一直在投資通過多個產能擴張項目和其他交易來實現增長,特別是爲了提高我們特種碳和電池材料產品的製造能力。 這些投資包括我們於2022年從Tokai Carbon Group購買其位於中國天津的木炭製造工廠,我們預計未來將對某些製造單元進行技術升級,以使我們能夠生產導電添加劑。我們打算加快對額外電池材料製造能力的投資,以滿足需求。
9
全球運營
我們的兩個部門都在全球運營,我們的收入和運營利潤的很大一部分來自美國以外的業務。特別是,中國的製造商仍然是汽車輪胎和產品(包括最近的電動汽車電池)的重要生產商,自1988年我們對中國進行初始投資以來,我們擴大了在中國的業務,以支持中國對我們產品日益增長的需求。我們在中國的業務聘請了當地的管理團隊,我們在中國的業務模式主要是在國內製造和銷售產品,並向在中國有業務的知名本地和跨國客戶銷售產品。截至2024年9月30日,中國在我們所有部門的銷售額約佔我們收入的25%,位於中國的物業、廠房和設備約佔2024年9月30日我們的物業、廠房和設備總數的25%,這在我們的合併財務報表附註V中披露。在中國有大量業務涉及法律、業務和其他風險,這些風險在項目1A的「風險因素」標題下有更全面的描述。如果我們在中國的運營能力受到法律、監管和運營風險的限制,可能會對我們的整體運營和我們證券的價值產生實質性的負面影響。
專利和商標
我們擁有並是多項專利的被許可人,這些專利在不同時間到期,涵蓋我們的許多產品以及流程和產品用途。儘管根據這些專利和許可製造和銷售的產品對Cabot來說很重要,但任何特定專利或許可的損失不會對我們的整體業務產生重大影響。我們使用我們擁有的各種商標銷售我們的產品,並採取合理措施來保護它們。雖然我們的商標對Cabot很重要,但我們任何一個商標的損失都不會對我們的整體業務產生重大影響。
研究與開發
我們的產品用途廣泛,可滿足許多行業的特定性能要求,爲創新創造機會。2024財年,我們在技術開發上花費了約6300萬美元。我們的研發活動包括專注於導電添加劑、墨水分散液和工程彈性體複合材料領域的研發活動。我們還專注於整個產品線的流程創新。我們正在投資進一步推進各個領域的可持續發展努力,以減少浪費、減少排放並在生產過程中利用更可持續的材料。
季節性
我們的業務通常不具有季節性,儘管我們在假期期間可能會經歷一些地區性季節性下降。
人力資本資源
我們的成功是通過員工的參與和承諾實現的。我們相信,我們分佈在全球的員工隊伍使我們能夠很好地爲我們運營所在地區和地區的廣泛客戶群提供服務。截至2024年9月30日,我們的全球辦公室和製造地點網絡約有4,200名員工,其中41%的員工位於美洲(其中61%在美國),32%位於亞太地區(其中75%在中國),27%位於歐洲、中東和非洲(「EMEA」)。在全球員工中,42%從事製造業。
我們的管理執行委員會(「執行委員會」)由我們的首席執行官和他的九名直接下屬組成,他們共同對我們的業務和區域運營、財務、法律、安全、健康、環境和可持續發展、人力資源、研發、全球商業服務和數字職能負有管理責任。
我們的主要人力資本目標是吸引、留住和培養最高素質的人才,並確保他們感到安全、支持和有能力做好最好的工作。因此,我們的管理團隊非常關注與Cabot員工隊伍有關的問題,特別是在員工健康與安全、人才、敬業度、多樣性、保留和發展以及總回報領域。我們的董事會對我們的人力資本管理工作進行監督,重點關注員工敬業度和發展、高管繼任和薪酬、多元化、公平和包容性(DE & I)以及員工健康和安全。這些重點領域也體現在我們的2025年可持續發展目標中,其中包括:
我們的核心價值觀和文化
10
我們根深蒂固的誠信、尊重、卓越和責任價值觀是我們公司的基礎和我們的運營方式。它們是我們與客戶、利益相關者以及彼此互動的標準,營造積極的工作環境,激發協作和創新,並支持我們專注於創造股東價值。
我們的文化體現了我們的價值觀,我們的工作方式是提供一個安全的環境,讓每個團隊成員都能做出貢獻併產生影響。我們的文化基於五個支柱:
2024財年,我們在全球範圍內推出了新的價值觀和文化研討會,以促進共同理解並強化我們的價值觀和文化如何積極影響我們的日常工作行爲和績效。我們的高級領導和人力資源團隊與各地區20多個地點的員工共同主持了這些互動會議。
多元化、公平和包容性(DE & I)
爲了支持我們培育多元化和包容性環境的承諾,在2024財年,我們繼續將DE & I目標作爲確定短期激勵獎勵資金水平時考慮的因素。 這些目標是:
作爲上財年包容性領導力培訓的後續行動,我們繼續注重營造包容性環境,開發並部署了包容性自我評估清單,供領導者檢查和加強自己的當地實踐。超過100名領導者完成了評估並審查了結果,與他們的領導團隊合作,確定進一步促進工作場所包容性的機會和行動。
截至2024年9月30日,有關所有Cabot員工性別代表性以及位於美國的Cabot員工種族和民族代表性的人口信息如下表所示:
性別多樣性
|
男性 |
|
佔總數的% |
|
|
女性 |
|
佔總數的% |
|
|
總 |
|
|||||
執行委員會 |
|
7 |
|
|
70 |
% |
|
|
3 |
|
|
30 |
% |
|
|
10 |
|
管理 * |
|
579 |
|
|
72 |
% |
|
|
227 |
|
|
28 |
% |
|
|
806 |
|
專業貢獻者 |
|
824 |
|
|
70 |
% |
|
|
351 |
|
|
30 |
% |
|
|
1,175 |
|
小時和助理員工 |
|
1,719 |
|
|
80 |
% |
|
|
441 |
|
|
20 |
% |
|
|
2,160 |
|
總人口 |
|
3,129 |
|
|
75 |
% |
|
|
1,022 |
|
|
25 |
% |
|
|
4,151 |
|
種族和民族多樣性
|
非少數 |
|
佔總數的% |
|
|
有色人種 ** |
|
佔總數的% |
|
|
總 |
|
|||||
執行委員會 |
|
8 |
|
|
100 |
% |
|
|
- |
|
|
0 |
% |
|
|
8 |
|
管理 * |
|
232 |
|
|
77 |
% |
|
|
71 |
|
|
23 |
% |
|
|
303 |
|
專業貢獻者 |
|
192 |
|
|
80 |
% |
|
|
48 |
|
|
20 |
% |
|
|
240 |
|
小時和助理員工 |
|
348 |
|
|
73 |
% |
|
|
132 |
|
|
28 |
% |
|
|
480 |
|
總人口 |
|
780 |
|
|
76 |
% |
|
|
251 |
|
|
24 |
% |
|
|
1,031 |
|
11
* 管理層包括人員經理(不包括執行委員會成員)和高級個人貢獻者角色。
** People of Color由美國員工組成,他們認爲自己是白人以外的種族或民族。
人才吸引、發展和保留
我們有許多計劃和計劃來吸引、培養和留住我們爲特定員工群體和地區量身定做的人才,包括領導力和高管發展計劃、技術培訓和其他基於技能的培訓。在2024財年,我們在亞太地區部署了一項新的製造業領導力發展計劃,重點是培養我們未來工廠領導者的能力和準備。這一舉措包括評估和360度反饋,以幫助提高認識,併爲個人發展計劃提供信息,高級領導人提供指導和支持,通過學習平台進行自學,同行學習和小組討論,以幫助教育他們並使他們爲未來的角色做好準備。我們還進一步擴大了我們在線學習平台的內部推廣和使用,並將其提供給全球所有員工,以支持我們的領導力發展計劃、DE&I知識和技能建設,以及通過我們面向員工的職業發展門戶網站進行自我導向學習。我們繼續看到該平台的強勁採用和使用,我們的平台提供商共享的指標超過了同行基準。
員工敬業度
我們相信,我們對員工敬業度和發展的持續關注和投資將繼續受到員工的歡迎,在2024財年,我們引入了使用員工敬業度「脈搏」調查來監控全年的結果,基於去年的兩年期全球調查所採取的見解和行動。
我們擁有完善的績效管理和人才發展流程,經理定期提供反饋和指導以發展員工。全年,經理和員工都會參與年度目標設定、目標進展季度審查、績效反饋、職業發展討論和年終績效評估。此外,我們定期審查每個職能和業務部門的人才發展和繼任計劃,以識別和發展人才管道。
我們在美國和海外的一些員工受到集體談判或類似協議的保護。我們與全球員工、工會和勞資委員會建立了總體上積極且富有成效的員工關係。
Cabot 2024財年的全球自願流動率約爲6.0%,這表明該公司的流失率相對於2023財年的7.3%有所下降。
整體薪酬
我們努力提供全面的獎勵計劃,使我們能夠吸引、保留和激勵最優秀的人才來支持我們的業務。我們的薪酬計劃信奉按績效付費的理念,旨在在我們爭奪人才的市場中具有競爭力。我們的薪酬實踐獎勵個人和公司的績效,並根據角色、經驗、貢獻和績效公平區分。我們重視員工的努力,並通過我們的認可和激勵計劃獎勵這些貢獻。我們定期評估這些做法,以確保我們在每個地理位置都具有市場競爭力,從而提供我們認爲具有吸引力且有吸引力的工作場所。
Cabot致力於確保員工獲得公平且不受歧視的薪酬,同時考慮與工作相關的因素,例如責任、地點、工作經驗、教育、績效和貢獻。我們每年都會進行審查,以監控我們的薪酬實踐,並在適當的情況下制定薪酬行動。我們本財年的總體調查結果繼續表明,對於從事同一工作和地點的人,全球女性和男性之間以及美國代表性不足的群體,在所有薪酬組成部分(年基本工資、短期激勵和長期激勵)方面,我們的薪酬都很強。
我們還致力於在所有運營地點提供極具競爭力的福利計劃,包括滿足或超過當地法規,並專注於健康和福利、員工福祉、員工援助計劃(NAP)和退休儲蓄。我們在美國提供的福利計劃的例子包括在僱主匹配水平方面超過市場標準的穩健的401(k)計劃、廣泛的健康福利(包括醫療、牙科和/或視力)、人壽和意外保險、殘疾保險、帶薪休假、學費報銷和其他自願福利。我們相信,員工的健康和福祉對於Cabot的成功至關重要,因此,在2024財年,我們:
12
員工健康與安全
我們認爲,作爲僱主,我們的主要責任之一是提供安全的工作環境,促進全體員工的健康。我們的目標是讓所有員工、承包商和訪客在回家時保持當天上班時的狀態。作爲我們「邁向零」計劃的一部分,我們制定了一個長期目標,即在我們的全球設施中實現零傷害。我們打算通過採取一系列措施來實現這一雄心勃勃的目標,包括培訓員工識別危險,確保建立降低風險的程序,併爲監督人員配備安全執行我們工作所需的工具和技能。作爲這項工作的一部分,我們的領導團隊成員參與根本原因確定,並在我們的運營設施網絡中共享結果。認識到我們可能需要許多年才能實現我們的零目標,我們已經建立了個人安全的持續改善目標,以實現到2025年,我們的可記錄和嚴重傷害率比我們2019年的基線測量降低50%。在2024財年,我們基於員工和承包商每200,000個工作小時的受傷人數的總可記錄事故率(TRIR)爲0.22,我們的損失時間事故率(LTIR)爲0.16。相比之下,美國勞工統計局報告稱,2023年化學制造業的平均TRIR爲1.8,LTIR爲0.6。
我們繼續被公認爲美國化學顧問Responsible Care®公司,作爲我們對Responsible Care承諾的一部分,我們仍然專注於持續改善我們流程和產品的健康和安全。根據該認證,我們每年報告我們的安全績效指標,並定期接受外部審計,以評估我們的計劃、找出差距並根據需要採取糾正措施。
通過經執行委員會批准並經董事會通過的全球SHE和可持續發展承諾,我們有責任證明我們的公司價值觀並不斷改進我們的運營方式。SHE和可持續發展承諾定義了我們持續改進安全的幾個重要目標,包括:
安全、健康、環境和可持續發展
認識到安全、健康、環境和可持續發展對卡博特的重要性,我們的董事會設立了安全、健康、環境和可持續發展委員會。該委員會由獨立董事組成,定期召開會議並監督我們的安全、健康和環境績效、過程安全、安保、產品管理、社區參與和政府事務。特別是,委員會審查與我們的安全、健康、環境和可持續發展計劃相關的指標、審計結果、新興趨勢、總體績效、風險和機會評估以及管理流程。
我們正在進行的業務受到廣泛的聯邦、州、地方和外國法律、法規、規則和與安全、健康和環境事項有關的法令(「SH&E要求」)的約束。我們的運營所受的SH&E要求包括要求獲得並遵守各種與環境有關的許可,以建造任何新設施和運營我們所有現有設施,以及進行產品註冊。我們已經並將繼續花費大量資源來建造、維護、運營和改善我們在世界各地的安全、健康和環境保護設施,並遵守SH&E要求。我們在2024財年在與環境相關的資本支出上花費了5,800美元萬。我們預計2025財年在此類問題上的支出約爲7,800美元萬。這些成本包括與遵守2013年11月我們與美國環境保護局(EPA)和路易斯安那州環境質量部(「LDEQ」)就Cabot在美國的三個碳黑製造設施達成的同意法令相關的成本,以及我們2025財年預期資本支出的很大一部分將繼續用於在路易斯安那州維爾普拉特的第三家也是最後一家工廠安裝空氣污染控制設備。這項和解涉及環保局針對美國碳黑製造行業的國家執法倡議,指控其違反了《清潔空氣法》下的某些監管和許可要求,包括新來源審查(「NSR」)建築許可要求。
13
根據這項和解協議,Cabot已在其位於德克薩斯州潘帕和路易斯安那州富蘭克林的碳黑工廠安裝了二氧化硫和/或氮氧化物的技術控制,並正在其位於Ville Platte的工廠安裝此類技術控制。我們目前正在與環保局和LDEQ討論,根據主要與新冠肺炎大流行相關的不可抗力事件,將我們在維爾普拉特工廠的合規日期延長至2025年。我們預計,安裝這些技術控制的總資本成本將約爲25000美元萬,並將在2025年年中發生。截至2024年9月30日,我們在美國安裝這些控制裝置已經花費了20100美元的萬。運行這些控制裝置增加了我們工廠的運營成本。美國所有的碳黑製造商都已與美國環保局達成和解,並安裝了類似的控制措施。此外,根據安大略省環境、自然保育及園林部(「MECP」)第419條的規定,我們位於安大略省薩尼亞的增強碳廠的二氧化硫(「SO2」)排放新規定已於2023年7月1日生效。我們不符合這一新的空氣標準,正在與MECP討論一項關於這一要求的減排計劃,我們預計,按照目前的形式,將要求工廠在2028年7月1日之前安裝空氣污染控制措施。到目前爲止,這並沒有限制我們在薩尼亞運營增強碳工廠的能力,因爲我們正在與MECP合作解決方案。我們預計,我們將需要爲安裝這些新的二氧化硫排放控制而產生大量的資本成本,特別是在安裝日期之前的24個月期間。此外,在歐盟,大量無機化學品BREF目前正在修訂中,我們預計最早可能從2028年開始要求在公司在歐盟的四個碳黑工廠安裝二氧化硫和/或氮氧化物的技術控制。
如上所述,世界各地的環境機構正在越來越多地執行法規和其他要求,導致全球範圍內的空氣排放限制更加嚴格,特別是在與氮氧化物、二氧化硫和顆粒物排放有關的限制方面。此外,對氣候變化的日益關注促使全球努力減少溫室氣體(「GHG」)排放,目標是在未來實現溫室氣體淨零排放,這將影響碳黑行業和我們的業務,因爲這些製造過程會排放二氧化碳。目前,在歐洲,我們的四個碳黑設施受歐盟排放交易計劃(「EU ETS」)的約束。歐盟ETS第四階段於2021年1月開始,我們的碳黑設施更新了產品基準。由於歐盟ETS計劃在2023年5月通過的ETS指令改革後進行了修訂,從而增強了歐盟ETS的雄心,該計劃下的免費津貼將隨着時間的推移逐步取消,這可能會導致公司因購買排放信用的需求增加而增加成本。此外,爲了讓我們位於荷蘭波特勒克的碳黑工廠從2025年開始保留分配給該工廠的最大免費配額,我們於2024年6月向荷蘭排放當局提交了我們在2050年實現該工廠碳中和的計劃。我們的計劃假設在2050年前爲這些業務安裝並運行的工廠的碳捕獲、利用和儲存技術方面的潛在投資。我們將繼續關注歐盟ETS計劃和相關報告的修訂和更新,包括將於2026年年初適用的碳黑產品基準的更新,以及可能降低分配給我們的碳黑工廠的免費配額上限並增加我們的合規成本的其他措施。此外,我們正在評估新的碳邊界調整機制(CBAM)計劃未來在歐盟的潛在適用性,作爲歐盟ETS下免費配額的替代方案,以及作爲歐盟ETS的補充制度。我們在荷蘭的碳黑工廠還需要繳納荷蘭二氧化碳稅,這是歐盟ETS計劃的一項附加稅。在中國,電力行業目前正在實施全國排污權交易計劃,預計將擴大到水泥、鋼鐵和電解鋁行業。我們繼續監督該計劃的進一步實施,並預計該計劃未來可能適用於碳黑行業,現有的地區性試點計劃預計將繼續運作,直到國家計劃生效。我們在加拿大安大略省的碳黑工廠受安大略省排放性能標準交易系統的約束,該系統是從聯邦碳稅計劃過渡而來的,根據該制度,具體的過渡要求於2022年1月1日生效。在墨西哥,我們的碳黑工廠正在參與國家ETS計劃,這是對我們工廠2023年生效的試點計劃的過渡。在我們運營的其他地區,我們的一些設施被要求報告其溫室氣體排放量,但目前不受要求交易或排放控制的計劃的限制,但可能受到影響我們購買的燃料的有限碳稅計劃的影響。我們通常希望根據需要支付任何已發生的稅款或購買排放抵免,以應對任何分配缺口,並將這些成本轉嫁給我們的客戶。此外,未來我們運營的地區和國家可能會通過進一步的空氣排放法規,這可能會對我們的運營產生影響。越來越多的與排放相關的監管計劃以及對氣候變化的擔憂預計將增加我們未來的資本和運營成本。
CABOT已被指定爲1980年《全面環境響應、補償和責任法案》(「超級基金法」)和類似的州法規中與我們剝離的業務主要相關的幾個地點的潛在責任方。(見下文第3項「法律訴訟」和下文第8項「或有」標題下的注T。)在接下來的幾年裏,隨着各種環境場地的修復,我們預計將從我們的環境儲備中支出與此類修復相關的費用。截至2024年9月30日,我們的環境儲備約爲500美元萬。根據我們對我們在每個地點可能發生的費用份額的持續分析,對準備金進行了調整。由於不同地點的未知情況、關於責任的政府法規和法律標準的變化以及處理現場調查和管理的技術的變化,這些估計存在固有的不確定性。
14
補救。雖然該儲備代表了我們對預期發生的成本的最佳估計,但調查和補救這些地點的實際成本可能超過環境儲備中應計的金額。雖然特定地點可能發生異常事件,並對我們特定時期的運營業績產生重大不利影響,但我們認爲與這些地點相關的總成本不可能對我們的綜合財務狀況產生重大不利影響。此外,我們還可能產生與我們目前尚不清楚或目前無法做出估計的環境負債相關的未來成本。
國際癌症研究機構(「IARC」)將木炭歸類爲20億族物質(已知的動物致癌物,可能是人類致癌物)。我們已向客戶和員工傳達了IARC對木炭的分類,並酌情將該信息包含在我們的安全數據表和其他地方。我們仍然相信,從整體來看,現有證據表明,木炭對人類沒有致癌性,並且按照我們的安全數據表中描述的良好內務管理和安全工作場所實踐處理時不會對健康構成危害。
我們的產品受制造或進口和商業分銷所在國家的化學控制法和法規要求的約束。這些法律包括美國的《有毒物質控制法》(TSCA)和歐盟的《化學品註冊、評估和授權》(REACH)對化學物質和庫存的監管。這些化學物質的製造商或進口商必須提交關於這些物質的具體健康、安全、環境、風險和用途信息。根據REACH框架的「評估」部分,歐洲化學品管理局(ECHA)和歐洲聯盟成員國評估公司在登記檔案和測試提案中提交的信息,以確定相關物質是否可以安全使用。2021年完成了對二氧化硅物質的評估,隨後,荷蘭提出了未經處理的二氧化硅的Stot RE 1分類,但尚未最後敲定。炭黑計劃在2026年進行物質審查。類似的制度也存在於世界其他地區,包括英國、土耳其、中國、韓國和臺灣。其中許多化學品管制條例正在產品/物質登記或通知的多年實施期內實施。
對納米材料的額外要求適用於我們的許多現有產品,包括碳黑、氣相二氧化硅、噴墨顏料、氣相氧化鋁以及先進的碳,如碳納米結構和碳納米管。一些國家已經實施了針對特定國家的納米材料報告方案,另一些國家正在制定該方案。在歐盟,針對納米材料的特定應用的安全性評估正在進行中。此外,2022年通過了一項意見,將包括我們目前生產的碳納米管等級的多壁碳納米管的子集歸類爲致癌物質10類億和根據歐盟法規反覆暴露後的特定靶器官毒物(肺)1類。該意見尚未發表在《適應技術進步》(ATP)中,這將使該分類具有法律約束力。我們的碳納米管結合在基質中或包含在電池、注塑件、塑料、塗料、粘合劑和密封劑的導電材料中,我們認爲在正常使用條件下,它們不會對最終用戶構成健康風險。接觸碳納米管的情況可能發生在工作場所。然而,我們相信,通過我們製造設施的工程控制和我們現場所需的個人防護裝備的使用,工作場所的暴露可以得到適當的管理。
許多組織和監管機構越來越關注缺水、節水和水質問題,特別是在某些地理區域。我們從事各種活動以促進節水和廢水回收,特別是考慮到我們的一些製造工藝是水密集型的。與這些活動相關的成本預計不會對我們的運營產生重大不利影響。
美國各機構和國際機構已採用適用於某些製造和工業設施以及海港地點的安全要求。這些與安全相關的要求在某些情況下涉及準備安全評估和安全計劃,在其他情況下涉及向特定政府當局登記某些設施。我們密切監控所有與安全相關的監管動態,並相信我們符合所有現有要求。預計遵守此類要求不會對我們的運營產生重大不利影響。
項目1A. RIsk因素
除了本報告其他地方描述的因素外,以下是可能對我們業務產生不利影響的重要因素。以下描述的風險並不是我們面臨的唯一風險。我們目前尚不清楚或我們目前認爲不重大的其他風險也可能損害我們的業務運營和財務業績。
行業風險
15
行業產能利用率和來自其他特種化學品公司的競爭可能會對我們的業務產生不利影響。
我們的業務對行業產能利用率很敏感,當產能利用率發生變化時,定價往往會波動,這可能會影響我們的財務業績。此外,我們在競爭激烈的市場中運營。我們成功競爭的能力部分取決於我們保持卓越技術能力以及繼續爲現有和未來客戶識別、開發和商業化新的、創新的、高附加值產品的能力。我們的競爭對手或產品提供與我們的產品類似功能的公司提供的現有或新開發的產品的競爭加劇,特別是那些環境足跡有所改善、可以替代我們的產品,可能會對我們產品的需求產生負面影響。此外,我們競爭對手的行爲可能會損害我們維持或提高價格、成功進入新市場或維持或擴大我們市場地位的能力。
環境法律及 影響我們行業的法規對我們的運營施加了限制,可能威脅我們的競爭地位並增加我們的運營成本,這可能會對我們的業務和運營業績產生不利影響。
我們正在進行的製造業務受到與環境問題有關的廣泛的聯邦、州、地方和外國法律、法規、規則和法令的約束,其中許多規定了巨額罰款、民事和刑事制裁,以及可能對違規行爲的禁令救濟。這些要求包括要求獲得和遵守各種與環境有關的許可證和其他許可證,以建造新設施和運營現有設施,以及與各機構就環境事項和環境要求達成和解。這些環境監管要求對我們的運營施加了限制,並可能威脅到我們的競爭地位。我們已經並將繼續花費大量資金來建設、維護、運營和改善我們在世界各地的環境保護設施。此外,在環境法律、法規和政策的制定、實施和執行方面,對環境正義的日益重視可能會導致合規要求和成本的增加。環境正義是我們開展業務的所有個人和社區的公平待遇和有意義的參與,無論種族、膚色、國籍或收入如何。此外,我們實際或認爲未能遵守這些原則可能會損害我們的聲譽。
此外,世界各地的環境機構正在越來越多地執行法規和其他要求,導致全球範圍內對空氣排放限制更加嚴格,特別是在與氮氧化物、二氧化硫和顆粒物排放有關的限制方面。我們預計,在我們運營的地區遵守現有法規和其他監管和稅收變化的提議,如果獲得批准,將要求我們在合規、資本改善或可能限制我們當前或計劃的運營方面產生大量額外成本。我們可能無法通過漲價來抵消這些合規義務的成本。我們實施提價的能力在很大程度上受到競爭和經濟條件的影響,並可能因所服務的細分市場而顯着不同。這樣的漲幅可能不被我們的客戶接受,可能不足以補償增加的監管成本,或者可能會減少對我們產品的需求和我們的銷售量。此外,爲符合環境要求所需的基本建設改善往往涉及在現有工廠運營中開發和安裝新技術,這些新技術有可能無法如我們預期的那樣運行。這些基礎設施改善的啓動和我們及時遵守這些要求的能力可能會出現延誤。特別是,鑑於我們預計將在薩尼亞工廠安裝的新技術的複雜性,我們可能會在該工廠遇到這些問題。
對這些事項的描述包含在上文第1項「安全、健康、環境和可持續發展」標題下的討論中以及下文第8項「意外情況」標題下的註釋T中。
我們可能面臨與氣候變化發展以及對碳中和和淨零排放的日益關注相關的某些監管和財務風險,這可能會對我們的業務和運營業績產生不利影響,並且我們或我們行業中其他公司對氣候變化的潛在影響的壓力和不利宣傳可能會損害我們的聲譽。
二氧化碳是一種溫室氣體,在碳黑製造過程中排放。對溫室氣體和全球氣候變化之間關係的擔憂,以及對碳中性和淨零的更多關注,可能會導致在國家和超國家層面上出臺額外的法規,以監測、管制、控制二氧化碳和其他溫室氣體的排放,並對其徵稅。氣候變化包括極端天氣影響,如降雨和風暴模式和強度的變化、水資源短缺、海平面顯著變化以及大氣和水溫上升。一些政府機構已經或正在考慮爲應對氣候變化而進行監管改革,包括監管溫室氣體排放。具體地說,在某些地理區域,我們的碳黑設施正在或可能受到溫室氣體排放交易計劃或碳稅計劃的約束,根據這些計劃,如果我們的排放水平超過我們的自由分配,我們可能被要求支付任何已發生的稅款或購買排放抵免。美國和我們運營所在的其他司法管轄區的新立法或法規的結果可能會導致對某些活動提出新的或額外的要求和費用或限制。遵守溫室氣體和氣候變化倡議可能會給我們帶來額外成本,除其他外,包括增加生產成本、增加原料成本、額外徵稅、減少排放限額。
16
或對生產或經營的額外限制。此外,我們某些用於特殊應用的碳黑產品的溫室氣體排放量高於我們的其他產品,這可能會增加我們的合規成本,並使我們在沒有技術開發的情況下實現排放目標更具挑戰性。我們可能無法通過漲價來抵消這些新的或更嚴格的法律法規和合規成本的影響,這可能會對我們的業務產生不利影響,並對我們的增長產生負面影響。我們實施提價的能力在很大程度上受到競爭和經濟條件的影響,並可能因所服務的細分市場而顯着不同。這樣的漲幅可能不被我們的客戶接受,可能不足以補償增加的監管成本,或者可能會減少對我們產品的需求和我們的銷售量。未來通過的任何氣候變化法規也可能對我們與位於不受此類限制地區的公司競爭的能力產生負面影響。
此外,氣候變化和相關監管對我們的原料供應商和客戶的潛在影響高度不確定,並且無法保證隨着時間的推移,它不會對我們傳統木炭原料的可用性、我們客戶的業務和採購安排以及我們的財務狀況和運營業績產生不利影響。例如,對煉油產品的需求下降可能會減少我們使用的某些關鍵原材料的可用性並增加其成本。此外,我們的許多輪胎客戶都設定了2030年至2050年期間的可持續發展目標,以購買更可持續的原材料,包括減少化石來源材料的使用,這可能會減少對我們傳統木炭產品的需求。
此外,即使沒有加強監管,公衆對我們或我們所在行業對氣候變化或環境損害的潛在影響的認識和負面宣傳也可能損害我們的聲譽或以其他方式對公司造成不利影響。近年來,投資者也開始對可持續性和氣候變化表現出越來越大的興趣,因爲這與他們的投資決策有關。我們未能及時執行我們的可持續發展戰略,充分回應這些環境問題,可能會損害我們的聲譽,並對我們證券的感知價值產生負面影響。此外,與溫室氣體排放和氣候變化相關的新信息披露要求,包括歐洲可持續發展報告標準、美國證券交易委員會批准並得到法院支持的任何最終規則,以及要求氣候信息披露的州法律,可能會轉移資源、增加我們的合規成本並損害我們的聲譽,從而對我們的業務產生負面影響。此外,天氣對我們的運營和工廠地點的影響越來越大,可能會影響保險的成本或可用性。
我們無法預測針對氣候變化以及其他可持續發展和環境問題的法律、監管和社會反應將如何影響我們的業務。
原材料和能源的價格和可用性的波動可能會影響我們的利潤率和運營資本以及能源中心運營的收入。
我們的製造過程消耗大量的能源和原材料,其成本取決於全球供需以及我們無法控制的其他因素。我們的木炭業務使用多種原料作爲原材料,包括高硫燃料油、低硫燃料油、焦油蒸餾物和乙烯分解殘渣,其成本和可用性在一定程度上取決於地理位置。我們的木炭原料成本的重大變動或波動可能會對我們的營運資金和運營業績產生不利影響。此外,監管變化或地緣政治衝突可能會影響我們原材料的可用性和價格。例如,俄羅斯入侵烏克蘭以及由此引發的持續戰爭過去曾擾亂並可能在未來繼續擾亂歐洲天然氣的價格和供應。
我們的某些碳黑供應安排包含調整價格以適應相關原料變化的條款 和天然氣價格指數。我們還試圖通過非合同銷售的價格上漲、生產率的提高和降低成本的努力來抵消原材料和能源成本上漲的影響。能否成功地用價格上漲抵消原材料和能源成本的上漲,主要受競爭和經濟狀況的影響,並可能因所服務的細分市場而顯着不同。這樣的提價可能不被我們的客戶接受,可能不足以彌補原材料和能源成本的增加,或者可能會減少對我們產品的需求和我們的銷售量。如果我們不能完全抵消原材料或能源成本增加的影響,可能會對我們的財務業績產生重大影響。能源價格和原材料成本的快速下降也會對我們的財務業績產生負面影響,因爲這種變化可能會對我們從能源中心獲得的收入和產量提高投資產生負面影響,並可能對我們的合同價格調整產生負面影響。此外,我們在我們的供應安排中使用各種原料指數來調整我們的價格,以適應原材料成本的變化。根據原料市場和我們對原料的選擇,我們在供應安排中使用的指數可能無法準確跟蹤我們的實際成本。這可能會導致我們的定價調整與我們實際原料成本的變化之間的不協調,這可能會影響我們的淨營運資本和我們的利潤率。此外,任何這些價格調整的實施時間可能無法準確跟蹤我們在財務報表中反映的實際成本。
我們從選定的主要供應商和某些合資夥伴處獲取某些原材料。如果任何原材料供應商停止向我們供應原材料或無法及時或以可接受的價格履行與我們簽訂的供應協議下的義務,甚至根本無法履行其義務,我們可能會被迫承擔更高的成本以在其他地方獲得必要的原材料。
17
此外,我們的製造過程在操作中需要水。如果氣候變化、製造業以及數字化和電力需求的趨勢造成水供應和需求之間的不匹配,導致我們運營的水資源減少,那麼我們的運營就有可能被削減,特別是在人類用水需要優先於其他用途的情況下,例如製造業運營。如果未來出現水資源短缺,這些成本可能會增加。
客戶或合資企業關係發生重大不利變化,或者客戶或合資企業合作伙伴未能履行與我們協議下的義務,可能會損害我們的業務或現金流。
我們成功地加強了與最大客戶的關係和業務增長,並在較長時間內保留了他們的業務,這對我們未來的業績非常重要。我們的業務中有一組關鍵客戶,這些客戶加在一起,佔我們總淨銷售額和運營收入的很大一部分。失去我們的任何重要客戶,或銷售給他們的數量大幅減少,都可能對我們的運營結果產生不利影響,直到此類業務被取代或任何臨時中斷結束。此外,在我們的增強材料部門,我們與許多主要客戶簽訂了供應安排,這些客戶的供應期限通常爲一年,約佔我們增強碳總量的三分之二。我們在談判這些安排下的價格和數量條款方面的成功可能會對我們的結果產生實質性影響。此外,我們的許多業務是通過根據長期合同運營的合資安排進行的,包括爲合資業務供應原材料和提供其他服務。任何有關這些合同安排條款的爭議或我們與合資夥伴之間關係的惡化都可能擾亂合資企業的運營,這可能會影響我們的財務業績並損害我們的聲譽。此外,任何客戶的財務狀況惡化,損害客戶向我們付款的能力,也可能增加我們的應收賬款,並可能影響我們未來的業績和財務狀況。
我們面臨在包括中國在內的一些國家開展業務所固有的政治或國家風險。
美國以外的銷售額佔我們2024財年收入的大部分。我們在包括中國在內的幾個國家開展業務,這些國家的法律體系和金融市場不太穩定,而且可能比美國更腐敗或更難預測的商業環境。正如我們的合併財務報表附註五所述,在中國的銷售額約佔我們2024財年收入的25%,位於中國的物業、廠房和設備佔我們截至2024年9月30日的物業、廠房和設備總額的約25%。我們在美國以外的業務,包括在中國的業務,使我們面臨與外國政府執法不確定相關的風險,以及外國政府實體在最少提前通知的情況下更改適用規則和法規的風險。這些風險可能會導致我們的業務發生實質性變化,這可能會對我們的證券價值產生負面影響。此外,我們在包括中國在內的一些國家的業務面臨以下風險:經濟增長率的變化;政治或經濟狀況的不穩定;經營許可證或執照的不續期;可能的徵用或其他政府行動;政府官員和其他第三方的腐敗;社會動亂、戰爭、恐怖活動或其他武裝衝突;沒收稅收或其他不利的稅收政策;剝奪合同權;影響產品生產、定價和營銷的貿易法規;知識產權保護減少;與匯回現金相關的限制或額外成本;外匯管制;通貨膨脹;貨幣波動和貶值;政治緊張,可能導致我們的客戶或供應商在過去沒有實施制裁的國家受到制裁;全球健康、安全和環境問題對經濟條件和市場機會的影響;以及金融政策和信貸供應的變化。
例如,出於對空氣質量的擔憂,中國政府不時在很少或根本不通知的情況下限制工業區的製造業運營。這些削減的時間和長度很難預測,有時會應用於製造業務,而不考慮被削減的業務是否符合該地區的環境法規。因此,我們在中國的製造業務過去一直受到這些限制,未來可能也會受到這些限制。這些事件可能會對我們的運營造成影響的政府實施的任何削減期間和之後的運營業績和現金流產生負面影響。此外,對客戶設施運營的任何此類限制都可能會減少對我們產品和產量的需求。
18
經營風險
作爲一家化學制造公司,我們的運營面臨運營風險,有可能造成環境或其他損害以及人身傷害,或擾亂我們向客戶供貨的能力,其中任何一種情況都可能對我們的業務、運營業績和現金流產生不利影響。
的 化學品製造業務的運營以及化學產品的銷售和分銷面臨運營以及安全、健康和環境風險。例如,木炭、特種化合物、煙狀金屬氧化物、氣凝膠、碳納米管和其他化學品的生產和/或加工涉及某些可能被認爲危險、有毒或有害的物質或成分的處理、交通、製造或使用。雖然我們採取預防措施以安全的方式處理和交通這些材料,但如果處理不當或釋放到環境中,它們可能會造成財產損失或導致我們提出人身傷害索賠。
我們的製造過程以及我們的化學產品和/或用於製造我們產品的原材料的交通都會受到化學制造固有風險的影響,包括泄漏、火災、爆炸、有毒物質釋放、惡劣天氣、機械故障或計劃外停機。此外,我們的工廠發生重大運營問題,特別是在我們製造的特定產品的唯一來源的工廠,或者我們供應鏈或分銷操作的中斷可能會導致生產損失,這反過來可能使我們難以滿足客戶需求。例如,近年來,我們在路易斯安那州富蘭克林和墨西哥阿爾塔米拉的工廠發生了計劃外停電,導致一段時間的產量和收益減少,並增加了我們的固定成本。供應鏈和分銷渠道的其他中斷,包括由全球或地區物流延誤和限制造成的中斷,如鐵路或其他交通中斷,可能會擾亂我們的業務運營。這些事件及其後果可能會在經營困難期間和之後對我們的經營業績和現金流產生負面影響,並可能損害我們的聲譽。
由於圍欄安排或合資夥伴的行爲而導致我們的運營中斷可能會擾亂我們的製造運營並對我們的財務業績產生不利影響。
在我們的某些氣相金屬氧化物工廠,我們與鄰近的第三方製造工廠(「圍欄合作伙伴」)有圍欄安排(其中許多是閉環的),他們爲我們的製造業務提供原材料和/或獲取我們的運營產生的副產品。因此,圍欄合作伙伴生產設施的任何中斷或削減,如果影響他們向我們供應原材料或獲取我們的製造副產品的能力,都可能擾亂我們的製造運營,或導致我們爲緩解此類干擾而招致更高的運營成本。近年來,我們經歷了來自某些圍欄合作伙伴的原材料供應中斷,這導致我們削減了業務或產生了更高的運營成本。此外,我們通過合資安排運營我們的某些碳黑設施,根據合資安排,我們的合資夥伴提供原料和/或獲取我們的運營產生的副產品。與合資夥伴就這些安排的條款發生糾紛可能會影響我們的合資企業運營,並可能減少我們從此類運營中獲得的收入。例如,在與我們在捷克共和國的合資夥伴的持續爭端之後,我們目前正在進行仲裁,這已經並將繼續對這些業務產生負面影響,並減少我們從這些合資業務中獲得的收入。此外,鄰近工業設施發生的重大事件,如環境排放,也可能擾亂我們的運營,導致對我們的負面宣傳,損害我們的聲譽。
我們的產品受到廣泛的安全、健康和環境要求的約束,這可能會損害我們製造和銷售某些產品的能力。
爲了確保和維護生產或銷售我們產品的權利,我們必須滿足不同司法管轄區的產品相關注冊和其他監管要求。獲得和維護這些批准需要大量的產品測試和數據,並且不確定是否會獲得這些批准。
19
某些國家和國際衛生組織已將碳黑歸類爲可能或疑似人類致癌物質。在未來,如果(I)這些組織將碳黑重新歸類爲已知或確認的致癌物,(Ii)其他司法管轄區的其他組織或政府當局將碳黑或我們的任何其他成品、原材料或中間體歸類爲可疑或已知的致癌物或其他危險物質,或(Iii)發現生產或使用碳黑或我們的任何其他成品、原材料或中間體對健康造成不利影響,我們可能會被要求大幅提高成本,以遵守環境、健康和安全法律,或遵守對我們產品的銷售限制,這可能會受到法律索賠的影響,我們的聲譽和業務可能會受到不利影響。此外,根據歐盟法規,包括我們目前生產的碳納米管等級的多壁碳納米管的子集已被歸類爲致癌物質10類億和特定目標器官毒物(肺),在反覆暴露後被歸類爲1類。儘管我們的碳納米管結合在基質中或包含在導電材料中,但在工作場所可能會接觸到碳納米管。我們可能會被要求承擔額外的成本,以符合安全製造和處理這些材料的要求,並且我們可能會受到與我們的產品相關的法律索賠。此外,目前被歸類爲非危險的化學品可能在未來被重新歸類爲危險化學品,我們的產品可能具有今天沒有被認識到的特徵,但在未來可能會被發現損害人類健康或致癌。
信息技術系統故障、數據安全漏洞、網絡安全攻擊或網絡中斷過去曾傷害過我們,並可能會損害我們的信息、擾亂我們的運營並使我們承擔責任,這可能會對我們的運營產生不利影響。
我們依賴信息技術(其中一些由第三方管理)來管理我們業務的日常運營和活動、運營我們的製造設施的要素、管理我們的客戶和供應商交易以及維護我們的財務、會計和業務記錄。此外,我們收集和存儲某些數據,包括專有業務信息,並可能訪問受隱私和安全法律法規約束的機密或個人信息。
這些數據的安全處理、維護和傳輸對我們的運營和業務戰略至關重要。信息技術系統故障,包括與我們的託管服務提供商相關的故障,或與維護或升級我們的系統相關的故障,或與我們收購的業務整合相關的信息技術和其他系統的集成,或者網絡中斷可能會阻礙我們的交易處理和我們的財務報告,以及我們的運營,包括導致過程安全事件,任何這些故障都可能對我們的業務或運營結果產生重大不利影響。在過去,我們的網絡一直受到攻擊,可能是來自可疑的外國民族國家攻擊者,他們進行偵察並部署惡意軟體。雖然我們的系統能夠在造成物質傷害之前隔離並驅逐攻擊者,但罪犯、流氓內部人士、民族國家和其他攻擊者可能會繼續攻擊我們的網絡,我們的防禦系統可能無法成功檢測他們的行爲或阻止他們造成潛在的物質傷害,包括盜竊、破壞、誤用或損壞我們的數據或系統或其系統可能與我們互連的其他實體的數據或系統。
此外,我們的信息技術系統可能會受到旨在提取信息、破壞信息或擾亂業務流程的外部各方的危害。儘管我們的安全設計和控制以及我們的第三方提供商的安全設計和控制,我們可能容易受到網絡攻擊、計算機病毒、安全漏洞、疏忽或故意的員工操作、系統故障和其他風險,這些風險可能會導致敏感、機密或個人數據的泄露,不當使用我們或我們的第三方提供商的系統、解決方案或網絡,未經授權訪問、使用、披露、修改或破壞信息,或運營中斷。由於我們越來越依賴遠程工作,我們面臨着更多的信息技術安全和欺詐風險,這可能會造成更多的信息安全漏洞和/或放大信息技術系統任何中斷的影響。此外,隨着我們在運營中更多地使用人工智能工具,未經授權訪問我們的數據以及基於我們對人工智能工具的依賴而犯下合規錯誤或錯誤決定的風險將會增加。我們過去曾通過我們或我們的服務提供商的信息系統或軟體中未檢測到的漏洞,在未經授權的情況下訪問我們的信息技術系統。隨着網絡安全威脅的演變,任何信息安全事件的範圍和影響都是無法預測的。此外,美國十多個州也通過了全面的數據保護立法,全球有關信息安全和隱私的監管環境日益苛刻,新的和不斷變化的要求,如歐盟的一般數據保護條例,人民的Republic of China個人信息保護法,巴西的Lei Geral de Protecao de Dados。遵守這些法律法規的成本可能比我們預期的更高,或者花費的時間比我們預期的更長,任何不遵守的行爲都可能導致罰款或處罰。
違反我們的安全措施、網絡事件和中斷、盜竊或意外丟失、無意披露或未經批准傳播有關公司、我們的員工、我們的供應商或我們的客戶的專有信息或敏感或機密信息,或未能遵守與信息安全或隱私相關的法律和法規,可能會損害我們的競爭地位,減少我們對研發和其他戰略舉措的投資價值,或導致
20
政府實體或個人針對我們的法律索賠或訴訟、巨額罰款、處罰和判決、擾亂我們的運營、補救要求、改變我們的業務行爲以及損害我們的聲譽,否則可能會損害我們的業務和運營業績。 未來爲信息技術系統的安全投入額外資源可能會顯着增加開展業務的成本或對我們的財務業績產生不利影響。
自然災害和惡劣天氣事件可能會影響我們的運營和財務業績。
我們在世界上面臨自然災害的地區運營設施,如洪水、風暴、颶風、乾旱和地震。極端天氣事件和不斷變化的天氣模式給現有基礎設施帶來了物理風險,由於與氣候變化有關的因素,這些風險可能會變得更加頻繁或更加嚴重,包括在歷史上沒有受到自然災害影響的地區。此類事件可能會擾亂我們的原材料供應,或以其他方式影響我們產品的生產、交通和交付,或影響對我們產品的需求,並以其他方式損害我們的業務和我們的經營結果,可能會以超過特定情況下可用保險覆蓋範圍的實質性方式。此外,我們的某些設施位於近年來經歷了極端高溫條件的地區。如果極端炎熱的條件造成不安全的工作環境或受到額外的安全工作場所要求的影響,我們在這些設施的運營可能會中斷,這可能會增加他們的運營成本。
我們最近經歷了上述類型的中斷。例如,2021年7月西歐發生的嚴重洪水對我們位於比利時佩平斯特的特種化合物工廠造成了嚴重破壞。這種中斷導致近期收益因銷量下降和運營成本的某些增加而減少。 2024財年,我們還經歷了惡劣的天氣事件,對加固材料部門的業績產生了負面影響。具體來說,墨西哥的乾旱影響了我們的運營,巴西的洪水影響了我們的客戶。
金融風險和其他風險
全球或地區經濟狀況或貿易關係負面或不確定可能會對我們的業務產生不利影響。
我們的運營和業績受到全球和地區經濟狀況的影響。影響我們銷售產品的企業或地理區域的經濟狀況的不確定性或惡化可能會減少對我們產品的需求,而通脹壓力可能會增加我們的成本。我們還可能面臨產品和服務的定價壓力,或者無法成功地將原材料成本或能源價格的上漲轉嫁給客戶,這可能會減少我們的收入並對我們的財務狀況和現金流產生不利影響。此外,在經濟不確定時期,我們的客戶可能會暫時採取超過實際基本需求下降幅度的庫存削減(「去庫存」)措施。鑑於我們在主要產品價值鏈中的地位,在經濟衰退週期早期,我們的運營業績通常會受到更大的去庫存影響。
我們在歐盟的業務對我們的業務至關重要,對我們的客戶也很重要。如果歐盟化學制造業的競爭力因環境合規成本增加、經濟政策不一致和僵化的勞工實踐等因素而繼續惡化,我們的客戶可能難以維持其在該地區業務的競爭力,或者因從其他地區(特別是亞洲)的低成本進口而失去可觀的市場份額。例如,輪胎生產從成本較高的地區(例如歐盟)轉向成本較低的地區(例如亞洲)可能會增加亞洲製造的輪胎的出口並銷往歐洲,並可能導致歐盟輪胎產量減少並降低我們的盈利能力。
此外,美國與我們開展業務的國家之間貿易關係的變化或與之相關的緊張局勢可能會對我們的業務產生不利影響。例如,美國與中國貿易關係的緊張增加了對我們在中國的供應商和客戶實施制裁的風險,如果實施制裁,可能會限制我們與此類公司做生意的能力。此外,我們可能會遇到中國意想不到的經營困難,中國的投資機會受到更多限制,資金轉移難度更大,進出中國的旅行受到更多限制,或者貨幣負面影響。此外,美國對從中國進口的商品徵收的貿易關稅可能會增加我們資本項目的成本,或者對我們的客戶產生負面影響,減少對我們產品的需求。此外,美國和中國貿易關係中不斷升級的緊張局勢和/或任何一個國家實際或潛在的額外限制性政策都可能要求我們在中國以外的地區複製我們在中國擁有的技術或其他資源和能力,從而增加我們的成本。
訴訟或法律程序可能會讓我們承擔重大責任,從而對我們的財務業績產生負面影響。
正如下文「意外情況」標題下第8項註釋T中更全面地描述的那樣,我們是訴訟、索賠和訴訟的一方或主體,包括但不限於涉及環境、健康和安全問題以及與石棉肺症、硅肺病和煤炭工人肺病相關的產品責任和人身傷害索賠。我們也是各種環境訴訟和補救事宜的潛在責任方,其中涉及大量問題。未決或未來訴訟(包括與呼吸器索賠相關的責任)或與環境修復活動有關的不利裁決、判決或和解可能會對我們的財務業績產生不利影響,或導致我們的業績與任何前瞻性陳述中表達或預測的業績存在重大差異。
21
我們的稅率和其他納稅義務取決於多種因素,其中任何一個因素的變化都可能影響我們未來的稅率和財務業績。
我們的未來稅率可能會受到多種因素的不利影響,包括:我們確定利潤賺取和徵稅的司法管轄區的變化;我們淨遞延稅資產估計實現的變化;我們之前未應計非美國預扣稅的非美國盈利的匯回本國;在確定各種納稅申報表後對估計稅款進行調整;無法扣稅的費用增加;可用稅收抵免的變化;解決各稅務機關稅務審計中出現的問題;以及稅法的變化,包括作爲經合組織包容性框架一部分通過的第二支柱立法,該框架爲某些跨國企業規定了15%的全球最低企業稅率,或此類稅法的解釋。此外,無法記錄稅收優惠的損失可能會嚴重影響我們的稅率及其季度波動性。
外幣匯率和利率波動影響我們的財務業績。
我們在使用美元以外的貨幣的國家賺取收入、支付費用、擁有資產和產生債務。在2024財年,我們的大部分收入來自美國以外的銷售。由於我們的合併財務報表是以美元呈現的,因此我們必須在每個報告期內或結束時按有效匯率將收入和支出以及資產和負債轉換爲美元。因此,在我們經營業務的國家,美元對其他貨幣價值的增減將影響我們的經營業績和以外幣計價的資產負債表項目的價值。例如,在2023財年和2024財年,由於阿根廷官方匯率全年相對於美元走弱,我們記錄了與重新計量以阿根廷披索計價的淨貨幣資產有關的匯兌損失。此外,我們可能會因政府控制的貨幣貶值而蒙受外幣損失,例如我們在2023財年和2024財年都記錄了與阿根廷央行引導的阿根廷披索大幅貶值的影響有關的外幣損失。由於我們業務的地域多樣性,隨着時間的推移,一些貨幣的疲軟可能會被其他貨幣的強勢所抵消。此外,我們還面臨着利率不利變化的風險。我們使用商業票據和信貸協議下的借款相結合的方式來滿足我們的短期現金需求,季度內的借款可能高於季度末。由於這筆債務的利率是可變的,利率的變化可能會影響我們的借貸成本。我們通過正常的經營和融資活動以及在被認爲適當時通過使用衍生工具以及外幣債務來管理這兩種風險。然而,我們不能肯定,我們將成功地降低外匯和利率波動敞口所固有的風險。
未來爆發的任何大範圍健康流行病都可能對我們未來的業務產生重大不利影響。
我們的全球業務使我們面臨與公共衛生危機相關的風險,流行病、流行病或傳染病的爆發可能會對經濟以及我們的業務、運營業績和現金流產生嚴重的不利影響。具體來說,大流行或未來的全球衛生危機可能會擾亂我們客戶的運營並減少對我們產品的需求,要求或導致我們停止運營或工廠的生產線閒置,可能會嚴重影響我們充足配備人員和維持運營的能力,並可能擾亂我們的供應鏈並對我們確保設施供應的能力產生重大不利影響。大流行還可能導致成本增加以及建築項目的勞動力和材料可用性減少,這可能會增加我們資本改進項目的成本並推遲此類項目的完成。
我們已與金融對手方簽訂了多份衍生品合同。這些合同的有效性取決於這些金融對手方履行義務的能力,他們的不履行可能會損害我們的財務狀況。
作爲我們金融風險管理戰略的一部分,我們簽訂了遠期外幣合同和交叉貨幣掉期。我們使用這些工具的風險管理計劃的有效性部分取決於這些合同的交易對手方履行其財務義務。如果我們的任何交易對手未來無法履行其義務,我們可能會因工具未能對沖或充分解決財務風險而面臨收益和現金流波動性增加的風險。
22
技術風險
我們可能無法通過新產品、新應用和技術開發成功實現增長預期,而且我們花在這些努力上的錢也可能無法帶來與我們投資相稱的收入或利潤增長。
通過開發新產品或產品應用,我們可能無法成功實現增長預期。此外,我們不能確定我們在新產品和技術開發上的投資成本是否會帶來與我們的投資相稱的收入或利潤增長,或在我們預期的時間內增長。例如,我們對進一步開發我們的E2C®解決方案、噴墨分散劑和油墨以及電池材料應用的投資可能不會導致這些投資的收益增長預期。此外,我們試圖調整我們的戰略投資的步伐,包括我們正在進行的那些爲發展我們在歐洲和美國的電池材料業務而進行的投資,以滿足市場對電動汽車需求增長的預期,但就像向電動汽車過渡一樣,市場對新產品的需求和接受度可能不會像我們預期的那樣發展,我們可能無法實現與我們進行此類投資時的預期一致的增長。同樣,我們不能確定我們在Evolve®可持續解決方案技術平台上進行的投資是否會成功,包括在我們客戶預期的時間內,爲我們的客戶開發產品,使用來自可再生或可回收材料的可持續增強碳,或使用導致更低溫室氣體排放的工藝。此外,我們正在開發的產品的適時商業化可能會因爲製造或其他技術困難、市場接受度或市場規模不足以支持新產品、競爭對手先於我們推出的新產品,以及從試驗階段進入生產階段的困難而中斷或延遲。這些中斷或延遲可能會影響我們未來的業務結果。
持續保護我們的專利、商業祕密和其他專有知識產權對於我們的成功至關重要。
我們的專利、商業祕密和其他知識產權對我們的成功和競爭地位至關重要。我們在美國和其他國家擁有各種專利和其他知識產權,涵蓋我們的許多產品,以及工藝和產品用途。在我們認爲不適合或不能獲得專利保護的情況下,我們依靠商業祕密法律和實踐來保護我們的專有技術和流程,例如與我們的員工、客戶、顧問、業務合作伙伴、潛在被許可人和其他人簽訂的保密協議,以保護我們的商業祕密和其他專有信息。然而,商業祕密可能很難保護,我們已經實施的保護措施可能無法阻止披露或未經授權使用我們的專有信息,也無法在發生挪用或其他侵犯我們專有權利的情況下提供足夠的補救措施。此外,我們是屬於美國和其他國家的其他公司的各種專利和知識產權的許可人。由於一些國家的法律和執法機制可能不允許我們像在美國那樣保護我們的專有權利,因此我們的知識產權實力將因國家而異。
無論我們的專有知識產權如何,我們可能會受到有關我們的產品、流程或產品使用侵犯他人知識產權的指控的影響。這些索賠,即使沒有根據,辯護也可能昂貴且耗時,如果我們敗訴,我們可能會被禁止銷售我們的產品或使用我們的流程和/或受到損害賠償,或者被要求籤訂要求支付版稅和/或使用限制的許可協議。我們可能無法獲得許可協議,或者如果有,可能無法以可接受的條款獲得許可協議。
投資組合管理、產能擴張和整合風險
任何未能從收購、聯盟或合資企業中實現利益或實現我們的投資組合管理目標的行爲都可能會對未來的財務業績產生不利影響。
爲了實現我們的戰略計劃目標,我們可能會尋求收購、聯盟或合資企業,以補充或擴大我們在全球的現有業務,或增加產品技術,或兩者兼而有之。收購業務、新技術和產品或與第三方達成安排的成功與否並不總是可預測的,我們可能無法成功實現預期的目標。我們可能無法將任何被收購的業務成功整合到我們的現有業務中,使該等業務盈利,或從這些收購中實現預期的成本節約或協同效應(如果有的話),這可能會對我們的業務業績產生不利影響。除了戰略收購,我們還根據我們的目標和與我們的增長戰略的一致性來評估我們的投資組合。在實施這一戰略時,我們可能不會成功地分離非戰略性資產。剝離此類資產的收益或虧損,或因此而損失的營業收入,可能會影響我們的收益。此外,我們過去有,將來也可能再次產生與減少收益的收購或資產剝離相關的資產減值費用。
23
工廠產能擴張和現場開發項目可能會影響現有工廠運營、被推遲和/或無法實現預期效益。
我們按計劃完成產能擴展和場地開發項目的能力可能會因爲需要獲得環境和其他監管批准、意外的成本增加、勞動力和材料的可用性、天氣條件等不可預見的危險以及其他通常與建設項目相關的風險而被推遲或中斷。這些風險包括現有工廠運營被中斷的風險,以及與使用新技術的運營延遲啓動相關的風險,這些中斷可能會使我們難以滿足客戶需求。此外,在產能擴大的情況下,這些活動的成本可能會對相關企業的財務業績產生負面影響,直到特定設施的產能利用率足以吸收與擴張相關的增量成本。此外,我們在新興地區擴大產能的能力在一定程度上取決於這些地區的經濟和政治條件,在某些情況下,還取決於我們建立業務、建設額外製造能力或形成戰略商業聯盟的能力。
第10項億。未解析d員工評論
沒有。
項目1C.網絡安全
風險管理和策略
正如第一部分IA項風險因素所指出的,Cabot認識到網絡安全漏洞的威脅可能會給公司帶來重大風險。因此,我們已採取措施保護公司數據以及我們信息技術和通信系統的持續運營。我們的網絡安全計劃包括信息技術(「IT」)政策和標準以及IT風險管理計劃。我們的網絡安全風險管理計劃利用美國國家標準與技術研究院(「NIH」)網絡安全框架制定的標準,該框架爲組織提供有關如何識別、預防、檢測、響應和恢復網絡安全威脅的指導。
此外,網絡安全風險已融入我們的企業風險管理(「ERM」)方法,並且是受董事會通過審計委員會監督的核心企業風險之一,如下所述。 我們使用多種旨在管理IT風險的工具和控制措施,包括但不限於特權訪問管理的控制措施、反惡意軟體工具、模擬電子郵件網絡釣魚攻擊以及其他旨在檢測和防止入侵以及監控風險的電子郵件安全工具。Cabot員工可以訪問正式的IT政策,這些政策定義和澄清了各個領域IT資源的預期行爲。我們制定了網絡事件響應計劃,該計劃制定了準備和響應各種網絡事件的程序,並參與響應規劃、模擬、培訓、桌面練習和其他工作,爲發生的任何事件做好準備。
我們定期聘請評估員、顧問、核數師和其他第三方來評估我們的網絡安全計劃,包括信息安全成熟度評估、審計和對我們的信息安全控制環境和運營有效性的獨立審查。這些評估爲風險緩解和進一步計劃開發的未來改進領域提供了見解。此外,我們依靠第三方履行各種業務職能,並通過入職後進行供應商調查以及持續監控來監督此類第三方服務提供商。
治理和監督
網絡安全治理中的管理監督
CABOT的網絡風險指導委員會負責審查和監督公司的網絡安全計劃和風險評估,以及應對不斷變化的風險的計劃的戰略方向。巴特·卡爾斯坦,卡博特執行副總裁總裁和卡博特管理執行委員會成員,是指導委員會成員,負責數字事務的執行責任。他由我們的首席數碼信息總監(「CDIO」)和我們的數字安全高級董事(「特殊標準」)提供支持。SDDS是公司管理層的成員,主要負責與整個公司的業務和職能領導人合作,監督公司的網絡安全風險管理計劃,以及提供威脅情報、全球基礎設施監控、威脅檢測和應對網絡事件的受管安全服務提供商。SDDS在卡博特的IT部門擔任過多個職位,她在公司任職約30年,具有信息系統方面的教育背景,併爲公司的管理團隊提供技術專長。
24
我們已經建立了評估網絡事件的性質、範圍和時間的流程,並酌情向管理層和董事會以及投資者傳達事件事實。如果發生網絡安全事件,事件響應團隊負責及時通知高級管理層,前提是特定事件的事實和情況需要通知。如果確定該事件對公司具有重大意義,則該事宜將升級至董事會。對於重大事件,公司將按照SEC法規向投資者提供有關事件性質和範圍的信息。
董事會對網絡安全治理的監督
Cabot董事會主要通過由獨立董事組成的審計委員會來監督公司的網絡安全計劃。公司高管以及外部和內部網絡安全人員至少每季度向審計委員會通報與網絡安全相關的風險以及爲監控和控制風險敞口而採取的措施。此外,上述公司網絡安全計劃的定期評估結果將在完成後傳達給審計委員會。相關事宜也至少每年與董事會全體成員一起審查一次。
截至本報告日期,我們尚未經歷過對我們的業務戰略、運營結果或財務狀況產生實質性影響的網絡安全事件。儘管我們做出了努力,但我們不能保證我們的網絡安全保障措施將防止我們或我們的第三方服務提供商的信息技術系統被破壞或崩潰,特別是在面對不斷髮展的網絡安全威脅和日益複雜的威脅行爲者的情況下。網絡安全事件可能會對我們的業務、運營結果或財務狀況造成實質性影響,包括此類事件導致聲譽、競爭或業務損害或損害我們的品牌、銷售損失、設施實物損壞、對個人的人身傷害、需求減少、知識產權損失、重大成本或公司受到政府調查、訴訟、罰款或損害。有關更多信息,請參閱第一部分第1A項,「風險因素--業務風險--信息技術系統故障、數據安全漏洞、網絡安全攻擊或網絡中斷過去曾傷害我們,可能危及我們的信息、擾亂我們的業務並使我們承擔責任,這可能對我們的業務產生不利影響。」
25
項目2. PR歌劇
Cabot的公司總部位於馬薩諸塞州波士頓的租賃辦公空間內。我們還在美國和外國擁有或租賃辦公室、製造、儲存、分銷、營銷和研發設施。我們的主要製造和/或行政設施的地點如下表所示。除非另有說明,否則所有房產均爲所有。
按地區劃分的位置 |
|
加固 |
|
性能 |
美洲地區 |
|
|
|
|
佐治亞州阿爾法雷塔 * |
|
X |
|
X |
伊利諾伊州圖斯科拉 |
|
|
|
X |
肯塔基州卡羅爾頓 ** |
|
|
|
X |
路易斯安那州富蘭克林 |
|
X |
|
X |
路易斯安那州維爾普拉特 |
|
X |
|
|
馬薩諸塞州比勒利卡 |
|
X |
|
X |
馬薩諸塞州哈弗希爾 |
|
|
|
X |
密歇根州米德蘭 |
|
|
|
X |
德克薩斯州潘帕 |
|
X |
|
X |
阿根廷坎帕納 |
|
X |
|
|
巴西毛阿 |
|
X |
|
X |
巴西聖保羅 *(1) |
|
X |
|
X |
加拿大魁北克省黎塞留河畔聖讓 |
|
|
|
X |
加拿大安大略省薩尼亞 |
|
X |
|
X |
哥倫比亞卡塔赫納 |
|
X |
|
|
墨西哥阿爾塔米拉 |
|
X |
|
|
歐洲、中東和非洲地區 |
|
|
|
|
比利時隆辛 |
|
|
|
X |
比利時佩平斯特 |
|
|
|
X |
捷克共和國瓦拉斯克·梅拉里奇(Valmez)** |
|
X |
|
|
法國傑羅姆港 ** |
|
X |
|
|
德國法蘭克福 * |
|
|
|
X |
德國明斯特 * |
|
|
|
X |
德國萊茵費爾登 |
|
|
|
X |
意大利拉文納 |
|
X |
|
|
拉脫維亞里加 *(1) |
|
X |
|
X |
瑞士沙夫豪森 * |
|
X |
|
X |
荷蘭博特萊克 ** |
|
X |
|
X |
阿拉伯聯合酋長國迪拜 * |
|
|
|
X |
英國巴里(威爾士)** |
|
|
|
X |
26
按地區劃分的位置 |
|
加固 |
|
性能 |
亞太地區 |
|
|
|
|
中國江蘇省 ** |
|
|
|
X |
中國江西省 ** |
|
|
|
X |
中國天津 **(2家工廠) |
|
X |
|
X |
中國上海 *(1) |
|
X |
|
X |
中國上海 **(工廠) |
|
X |
|
|
中國河北省興泰市 ** |
|
X |
|
|
中國威海 ** |
|
|
|
X |
中國深圳 ** |
|
|
|
X |
中國珠海 ** |
|
|
|
X |
印度孟買 * |
|
X |
|
X |
印度尼西亞西勒貢 ** |
|
X |
|
X |
印度尼西亞雅加達 *(1) |
|
X |
|
X |
日本千葉 |
|
X |
|
|
日本下關 ** |
|
X |
|
|
日本東京 *(1) |
|
X |
|
X |
馬來西亞迪克森港 ** |
|
X |
|
|
* 租賃場地
** Cabot在租賃土地上擁有的建築物
我們主要在馬薩諸塞州比勒裏卡、德克薩斯州潘帕、比利時佩平斯特、德國明斯特、日本千葉、馬來西亞迪克森港以及中國上海的工廠爲各種業務進行研究和開發。
憑藉我們現有的製造工廠和計劃的擴張,我們通常擁有足夠的產能來滿足當前的要求和預期的近期增長。這些工廠通常維護良好,運行狀況良好,適合且足以滿足其預期用途。我們的行政辦公室和其他設施適合且足以滿足其預期用途。
項目3. 法律 訴訟
卡博特是各種訴訟和環境訴訟的當事人,其中索賠金額很大。有關涉及Cabot的法律訴訟的其他信息在下文第8項「意外情況」標題下的註釋T中披露,該披露內容通過引用併入本文。
第四項。我薩披露
不適用。
關於我們的執行官員的信息
以下列出了截至2024年11月13日有關Cabot高管的某些信息。
Sean D. Keohane現年57歲,自2016年3月起擔任Cabot總裁兼首席執行官兼董事會成員。Keohane先生於2002年加入Cabot。2014年11月至2016年3月,他擔任執行副總裁兼加固材料總裁。2012年3月至2014年11月,他擔任高性能化學品高級副總裁兼總裁,2008年5月至2012年3月,他擔任高性能化學品總經理。他於2005年3月被任命爲副總裁,2012年3月被任命爲高級副總裁,2014年11月被任命爲執行副總裁。他是首席執行官臨時辦公室的成員,該辦公室於2015年12月至2016年3月設立。
Erica McLaughlin,48歲,執行副總裁、財務長兼企業戰略主管。麥克勞克林女士於2002年加入卡伯特。她於2022年12月當選爲執行副總裁,並於2018年5月當選爲高級副總裁兼財務長,並於2018年10月開始負責企業戰略和發展。2016年6月至2018年5月,她擔任增強材料業務運營副總裁兼輪胎業務總經理,2011年7月至2016年6月,她擔任投資者關係和企業傳播副總裁。2011年7月之前,她曾在財務和企業規劃領域擔任多個領導職位。
27
凱倫·A Kalita,45歲,高級副總裁兼總法律顧問。Kalita女士於2008年加入Cabot。在2019年6月擔任現任職位之前,她在卡伯特法律部門擔任多個關鍵職位,包括2015年11月至2019年6月擔任公司加固材料部門首席法律顧問,2013年6月至2019年6月擔任淨化解決方案部門首席法律顧問,以及公司之前先進技術部門的高級法律顧問。在加入公司之前,Kalita女士在馬薩諸塞州波士頓的WilmerHale LLP私人執業。
霍巴特·C·卡爾斯坦,現年54歲,現任加固材料事業部執行副總裁總裁和總裁,以及美洲地區的總裁。Kalkstein先生還負責Cabot的數字功能。卡爾斯坦於2005年加入卡博特。他於2022年12月當選爲執行副總裁總裁,2016年4月當選爲加固材料部門的高級副總裁和總裁,以及美洲地區的總裁。在此之前,他於2015年12月至2016年4月擔任企業戰略與發展部副總裁。2013年10月至2015年12月,擔任淨化解決方案全球業務運營副總裁總裁;2012年11月至2015年12月,擔任淨化解決方案全球排放控制解決方案總經理;2012年1月至2012年11月,擔任高效化學品全球業務運營副總裁總裁兼董事營銷與業務戰略主管。在此之前,他於2007年10月至2010年2月擔任氣凝膠業務總經理。
Jeff·朱,56歲,現任卡博特高性能化學品事業部執行副總裁總裁和總裁,負責碳和二氧化硅技術以及電池材料業務,並負責亞太地區的總裁。Mr.Zhu於2012年加入卡博特。自2022年12月起,他當選爲執行副總裁總裁,並於2019年10月當選爲性能添加劑業務部門的高級副總裁和總裁以及亞太地區的總裁。在此之前,自加入卡博特以來,他一直擔任總裁亞太區總裁。在加入卡博特之前,Mr.Zhu於1994年至2010年在羅地亞擔任過各種地區和全球業務領導職務,其中包括:1994年至2002年在董事擔任亞太區商務主管;2002年至2008年在羅地亞新華醫療亞太區擔任區域副總裁總裁兼總經理;2008年至2010年在羅地亞電子與催化事業部擔任總裁副總裁兼全球董事主管。此外,Mr.Zhu在2010年至2012年期間擔任亞太資源國際控股有限公司全球紙漿和造紙銷售主管。
部分 II
項目5. 註冊人普通股權市場,相關企業股票持有人事項和發行人購買股票證券
Cabot的普通股在紐約證券交易所上市交易(代碼CBT)。截至2024年11月13日,有530名卡博特普通股記錄持有者。
發行人購買股票證券
下表列出了有關Cabot在截至2024年9月30日的季度購買其股權證券的信息:
期間 |
|
總數 |
|
|
平均 |
|
|
總數 |
|
|
最大數量(或 |
|
||||
2024年7月1日至2024年7月31日 |
|
|
— |
|
|
$ |
— |
|
|
|
— |
|
|
1,938,177 |
|
|
2024年8月1日至2024年8月31日 |
|
|
440,000 |
|
|
$ |
102.62 |
|
|
|
440,000 |
|
|
|
1,498,177 |
|
2024年9月1日至2024年9月30日 |
|
|
197,206 |
|
|
$ |
100.70 |
|
|
|
197,206 |
|
|
|
1,300,971 |
|
總 |
|
|
637,206 |
|
|
|
|
|
|
637,206 |
|
|
|
|
28
比較股票表現
該圖表將截至2024年9月30日的五年期內Cabot普通股的累計總股東回報率與標準普爾400化學指數和標準普爾中型股400指數進行了比較。比較假設2019年10月1日對Cabot普通股和每個指數投資100美元,並對所有股息進行再投資。
下圖中的股價表現不一定表明未來的價格表現。
第5項中比較股票表現標題下包含的信息不應被視爲「徵集材料」或受第14 A條的約束,不應被視爲根據《交易法》第18條「提交」,或以其他方式承擔該條的責任,也不應被視爲通過引用納入根據1933年證券法(經修訂)的任何文件中,或《交易法》。
29
項目7. 管理層的討論與分析 財務狀況及經營業績
關鍵會計估計
我們的合併財務報表是按照美國公認會計准則編制的。我們財務報表的編制要求管理層作出估計和判斷,以影響資產、負債、收入和費用的報告金額以及或有資產和負債的相關披露。在下列情況下,我們認爲會計估計對財務報表至關重要:(I)估計性質複雜或需要高度判斷,以及(Ii)使用不同的估計和假設,其結果可能對綜合財務報表產生重大影響。在持續的基礎上,我們評估我們的估計和我們政策的應用。我們根據過往經驗、當前狀況及我們認爲在當時情況下屬合理的各種其他假設作出估計,而這些假設的結果構成對資產及負債的賬面價值作出判斷的基礎,而該等資產及負債的賬面價值並非從其他來源輕易可見。實際結果可能與這些估計不同。我們相信以下關鍵的會計估計對於理解我們的合併財務報表是最重要的。
遞延稅項資產
我們已針對各種遞延所得稅資產制定了估值撥備,包括淨營業虧損結轉、資本虧損結轉、外國稅收抵免和其他所得稅抵免。我們每季度評估遞延所得稅資產的可變現性,並在部分或全部遞延所得稅資產更有可能無法變現時確認估值備抵。這項評估是根據各個司法管轄區完成的,並依賴於所有可用積極和消極證據的權重。三年期的累計稅前虧損被視爲我們的部分或全部遞延所得稅資產可能無法變現的重要客觀負面證據。累計報告的稅前收入被認爲是我們未來產生正稅前收入能力的客觀可驗證的積極證據。
根據美國公認會計原則,當最近有稅前虧損的歷史時,爲了評估我們遞延稅項資產的可回收性,幾乎不重視預測。在考慮正面和負面證據的相對影響時,需要做出判斷。對積極和消極證據潛在影響的重視程度與其能夠被客觀核實的程度是相稱的。存在的負面證據越多,就越需要更多的正面證據來支持不需要估值津貼的結論。在確定我們利用遞延稅項資產的能力時,我們會考慮客觀可核實的證據的可用性,例如經非經常性項目調整後的近期核心經營業績。我們使用系統和邏輯的方法來估計遞延稅項負債何時沖銷併產生應稅收入,以及遞延稅項資產何時沖銷併產生扣稅。在估計未來收入和安排遞延稅項資產和負債的沖銷時,需要假設、判斷和估計,而且這項工作本質上是複雜和主觀的。
有關我們與所得稅相關的政策的描述,請參閱合併財務報表附註的註釋A和註釋R。
或有事件
我們已爲呼吸器責任索賠記錄了大量準備金。我們目前對未決和未來呼吸器責任索賠份額的成本估計是基於目前存在的事實和情況,包括剩餘索賠的數量和性質。可能影響我們估計的事態發展包括但不限於:(I)未來索賠數量的重大變化,(Ii)未支付未決索賠的駁回比率的變化,(Iii)解決索賠的平均費用的重大變化,包括可能的索賠群體的和解,(Iv)爲這些索賠辯護的法律費用的重大變化,(V)收到的索賠的性質的變化或我們對這些索賠的可行性的評估的變化,(Vi)審判和上訴結果,(Vii)適用於這些索賠的法律和程序的變化,(8)支付口罩索賠的各方的財務可行性;(9)有助於解決口罩索賠的某些當事人所維持的保險範圍耗盡或可收回程度的變化,或企業前所有人提供的賠償的可得性的變化;(10)支付法律和和解費用的各方之間費用分配的變化;以及(11)用來估計我們的責任份額的假設不再合理。我們無法確定這些潛在事態發展對我們目前估計的現有和未來索賠責任份額的影響。由於準備金限於於相關計量日期可能及可評估的金額,而預測潛在發展對我們對現有及未來索賠的負債份額的影響存在內在困難,因此,現有及未來索賠的負債有可能在短期內發生變化,這種變化可能是重大的。請參閱本公司合併財務報表附註A和附註T,以了解本公司有關或有事項的政策。
30
商譽減值
善意包括業務收購的購買價格超過所收購有形和可識別無形資產淨值的公允價值。善意不會攤銷,並每年接受一次減損測試,或者當業務環境的事件或變化表明報告單位的公允價值可能超過其公允價值時。
評估聲譽是否存在減損涉及應用重大假設,包括適用報告單位的貼現率和預測結果,包括息稅前利潤(「EBIT」)、市場倍數和增長率。這些假設是前瞻性的,可能會受到未來經濟和市場狀況的影響。我們根據需要聘請第三方估值專家來制定計算和評估善意餘額時使用的假設。有關我們與善意相關的政策的描述,請參閱合併財務報表附註的註釋A和註釋G。
近期發佈的會計公告
請參閱合併財務報表附註B中的討論。
經營成果
Cabot分爲兩個可報告部門:增強材料和性能化學品。 在2022財年第二季度剝離之前,該公司的前淨化解決方案業務是一個單獨的可報告部門。出於運營目的,Cabot還分爲三個地理區域:美洲;歐洲、中東和非洲;和亞太地區。對我們在所示期間運營結果的討論反映了這些結構。
我們對財務狀況和經營業績的分析應與我們的合併財務報表和隨附註釋一起閱讀。除非指定日歷年,否則本討論中所有提及的年份均指截至9月30日的財年。
本節討論我們2024財年和2023財年的運營業績以及2024財年和2023財年的同比比較。有關我們2022財年業績以及2023財年與2022財年之間的同比比較的討論,請參閱公司截至2023年9月30日財年的10-K表格年度報告第7項「經營業績」和「現金流和流動性」標題下的討論,該文件於2023年11月22日提交給美國證券交易委員會。
術語和非GAAP財務指標的定義
當討論我們的運營結果時,我們使用了以下幾個術語。
「產品組合」一詞是指銷售產品的類型和等級的組合或銷售產品的地理區域的組合,以及這對業務和/或分部的收入或盈利能力產生的積極或消極影響。
我們在「所得稅(撥備)福利和有效稅率與營業稅率的調整」標題下的討論包括討論和核對我們在所述期間的「實際稅率」和「營業稅率」,以及管理層對下一會計年度營業稅率範圍的預測。我們的營業稅率是非GAAP財務指標,不應被視爲我們的有效稅率的替代方案,有效稅率是GAAP財務指標中最具可比性的。營業稅率不包括某些稅目和離散稅目的所得稅(費用)福利。某些項目的所得稅(支出)利益是使用發生某些項目的課稅管轄區的適用稅率確定的,幷包括基於某些項目的性質的當期和遞延所得稅(支出)利益。離散稅項包括但不限於估值津貼的變化、不確定的稅務狀況和其他稅項,例如法律變化的稅收影響以及由於不確定再投資主張的變化而對歷史收益的應計稅額。我們對營業稅率的定義可能與其他公司使用的定義不同。管理層認爲,這一非公認會計准則財務指標是有用的補充信息,因爲它有助於我們的投資者在一致的基礎上每年比較我們的稅率,並了解如果沒有這些項目的影響,我們當前業務的稅率是多少。
31
我們在「2024財年與2023財年--按業務部門分類」的標題下的討論包括對總部門息稅前利潤的討論,這是一種非GAAP財務衡量標準,定義爲關聯公司減去某些項目和其他未分配項目前的運營收入(虧損)和權益。我們的首席運營決策者,也就是我們的首席執行官總裁,利用部門息稅前利潤來評估每個部門的經營業績,併爲部門分配資源。我們相信,反映我們可報告部門息稅前利潤總額的總部門息稅前利潤,爲我們的投資者提供了有用的補充信息,因爲它是我們運營實力和業績的重要指標,允許投資者從管理層的角度看到我們的業績,併爲我們討論個別業務部門的業績提供了背景。總部門息稅前利潤不應被視爲關聯公司所得稅和權益前運營收入(虧損)的替代方案,這是美國公認會計准則財務衡量標準中最直接的可比性指標。分部息稅前利潤總額與關聯公司所得稅和權益前營業收入(虧損)的對賬列在「2024財年與2023財年--按業務分部分列」的標題下。投資者應考慮與這一非GAAP衡量標準相關的侷限性,包括這一衡量標準在一家公司與另一家公司之間可能缺乏可比性。
在計算分部息稅前利潤總額時,我們從關聯公司的營業收入(虧損)中剔除了(I)管理層認爲不能代表我們正在進行的分部業績的費用和收入項目,我們稱之爲「某些項目」,以及(Ii)沒有分配給我們的業務部門的項目,例如利息支出和其他公司成本,包括未分配的公司管理費用,如某些公司工資和總部費用,以及與特殊項目和計劃相關的成本。我們稱之爲「其他未分配物品」。管理層認爲,剔除被確認爲某些項目的項目,通過消除在GAAP基礎上不明顯的差異,促進不同時期的經營業績比較,並有助於在不受這些成本或收益影響的情況下評估我們的經營業績。下文描述了我們已從總分部息稅前利潤中剔除但包括在我們的GAAP營業收入(虧損)中的收入和費用項目,這些收入和費用包括在關聯公司的所得稅和權益前收益(虧損)中。
32
需求驅動因素和影響盈利能力的關鍵因素
需求驅動因素和影響我們盈利能力的關鍵因素因細分市場而異。在加固材料方面,長期需求主要由以下因素推動:i)全球行駛的車輛里程數;ii)生產的原始設備和更換輪胎的數量;iii)汽車製造的數量;以及iv)供應鏈庫存水平的變化,以適應終端市場需求和其他市場動態。在過去的幾年中,經營業績受到多個因素的推動,包括:i)輪胎或工業橡膠產品的產量水平和滿足需求的水平的變化導致我們銷售量的增加或減少;ii)原材料成本的變化以及我們根據原材料成本的變化調整產品銷售價格的能力;iii)定價和產品組合的變化,其中包括客戶定價以及所售產品的組合或銷售地區;iv)全球和地區的炭黑產能利用率;v)通過重組和其他成本節約活動實現的固定成本節約;Vi)我們在新興經濟體的產量和市場地位的增長;vii)產能管理和技術投資,包括我們製造設施的能源利用和產量提高技術的影響;viii)與我們在輪胎應用中使用的專利彈性體複合材料技術相關的特許權使用費和技術支付;ix)與我們能源中心銷售和公用事業成本相關的能源價格變化。
在高性能化學品方面,長期需求主要由建築和基礎設施、汽車行業推動,包括電動汽車、電子產品、噴墨打印和消費品行業的電池銷售。近年來,高性能化學品的經營業績受到以下因素的推動:i)對先前提到的行業銷售量的增加或減少;ii)價格和產品組合的變化,其中包括客戶定價以及所售產品的組合或銷售地區;iii)我們提供差異化產品以提高客戶應用性能的能力;iv)我們爲這種差異化產品獲得價值定價的能力;v)新產能的成本;vi)銷售價格相對於原材料成本的變化;vii)採用新產品用於客戶應用的能力;和viii)供應鏈庫存水平的變化,以適應終端市場需求和其他市場動態。
2024財年業績概覽
與2023財年相比,2024財年,所得稅前運營收入(虧損)和附屬公司利潤中的權益有所增加,主要是由於我們的增強材料和高性能化學品部門的盈利增加。
2024財年與2023財年相比-合併
淨銷售額和其他營業收入和毛利潤
|
|
截至9月30日的年份 |
|
|||||
|
|
2024 |
|
|
2023 |
|
||
|
|
(In數百萬) |
|
|||||
淨銷售額和其他營業收入 |
|
$ |
3,994 |
|
|
$ |
3,931 |
|
毛利 |
|
$ |
960 |
|
|
$ |
839 |
|
與2023財年相比,2024財年淨銷售額和其他營業收入增加了6300萬美元。淨銷售額和其他營業收入的增長是由增強材料和高性能化學品部門銷量的增加推動的(總計14800萬美元),部分被兩個部門不利的定價和產品組合所抵消(總計4800萬美元)、兩個部門的外幣兌換(總計2200萬美元)以及兩個部門副產品收入下降(總計500萬美元)的不利影響。銷量增加的原因是亞太地區和歐洲、中東和非洲加強材料銷量增加,以及由於銷量重新與關鍵終端市場的潛在需求驅動因素聯繫起來,性能化學品銷量增加。這兩個部門的不利定價主要是由於通常轉嫁給我們客戶的原材料成本較低。
與2023財年相比,2024財年毛利潤增加了12100萬美元。這一增長主要是由於我們的增強材料和高性能化學品部門的盈利增加,因爲這兩個部門的銷量和單位利潤率(扣除成本)都有所改善。
銷售及行政開支
|
|
截至9月30日的年份 |
|
|||||
|
|
2024 |
|
|
2023 |
|
||
|
|
(In數百萬) |
|
|||||
銷售及行政開支 |
|
$ |
283 |
|
|
$ |
253 |
|
33
與2023財年相比,2024財年的銷售和管理費用增加了3000萬美元。增加主要是由於激勵薪酬費用增加。
研究和技術費用
|
|
截至9月30日的年份 |
|
|||||
|
|
2024 |
|
|
2023 |
|
||
|
|
(In數百萬) |
|
|||||
研究和技術費用 |
|
$ |
63 |
|
|
$ |
57 |
|
與2023財年相比,2024財年的研究和技術費用增加了600萬美元。增加主要是由於激勵薪酬費用增加。
出售業務損失
|
|
截至9月30日的年份 |
|
|||||
|
|
2024 |
|
|
2023 |
|
||
|
|
(In數百萬) |
|
|||||
出售業務損失 |
|
$ |
— |
|
|
$ |
3 |
|
出售業務的損失 與淨化解決方案業務出售相關的事項在合併財務報表附註D中進行了描述。
利息和股息收入
|
|
截至9月30日的年份 |
|
|||||
|
|
2024 |
|
|
2023 |
|
||
|
|
(In數百萬) |
|
|||||
利息及股息收入 |
|
$ |
32 |
|
|
$ |
31 |
|
2024財年的利息和股息收入比2023財年增加了100萬美元,主要是由於利率上升和存款餘額的貨幣組合。
利息支出
|
|
截至9月30日的年份 |
|
|||||
|
|
2024 |
|
|
2023 |
|
||
|
|
(In數百萬) |
|
|||||
利息開支 |
|
$ |
81 |
|
|
$ |
90 |
|
與2023財年相比,2024財年的利息支出減少了900萬美元,主要是由於平均短期借款下降,部分被利率上升所抵消。
其他收入(費用)
|
|
截至9月30日的年份 |
|
|||||
|
|
2024 |
|
|
2023 |
|
||
|
|
(In數百萬) |
|
|||||
其他收入(費用) |
|
$ |
(36 |
) |
|
$ |
(16 |
) |
與2023財年相比,2024財年的其他費用增加了2000萬美元。這一增長主要是由於阿根廷外匯損失增加,包括2024財年第一季度政府貨幣貶值的影響。
34
(規定)所得稅福利以及有效稅率與營業稅率的對賬
|
|
截至9月30日的年份 |
|
|||||||||||
|
|
2024 |
|
|
2023 |
|
||||||||
|
|
(規定)/所得稅福利 |
|
費率 |
|
|
(規定)/所得稅福利 |
|
費率 |
|
||||
(百萬美元) |
|
|
|
|
|
|
|
|
|
|
||||
實際稅率(1) |
|
$ |
(111 |
) |
|
21 |
% |
|
$ |
28 |
|
|
-6 |
% |
減:非GAAP稅收調整(2) |
|
|
40 |
|
|
|
|
|
161 |
|
|
|
||
營業稅率的 |
|
$ |
(151 |
) |
|
26 |
% |
|
$ |
(133 |
) |
|
28 |
% |
截至2024年9月30日的年度,所得稅(撥備)福利爲11100萬美元,而2023財年的福利爲2800萬美元。截至2024年9月30日和2023年9月30日止年度的所得稅(準備金)福利中分別包括2400萬美元和15200萬美元的稅收福利,與公司美國淨遞延所得稅資產的部分估值津貼釋放有關。 我們的所得稅受到我們經營所在稅務司法管轄區的收入組合以及某些稅務司法管轄區的估值津貼的影響。
對於2025財年,我們預計我們的營業稅率將在27%至29%之間。我們不會提供營業稅率範圍與有效稅率範圍的前瞻性對賬,因爲如果不做出不合理的努力,我們無法合理確定地預測我們將分配給「某些項目」的事項,包括異常損益、與未來重組相關的成本、收購相關的費用和訴訟結果。這些項目不確定,取決於各種因素,並可能對未來期間的實際稅率產生重大影響。
附屬公司收益中的權益和歸屬於非控制性權益的凈利潤(虧損),扣除稅
|
|
截至9月30日的年份 |
|
|||||
|
|
2024 |
|
|
2023 |
|
||
|
|
(In數百萬) |
|
|||||
附屬公司盈利權益,扣除稅款 |
|
$ |
6 |
|
|
$ |
5 |
|
歸屬於非控股權益的凈利潤(虧損), |
|
$ |
44 |
|
|
$ |
39 |
|
與2023財年相比,2024財年附屬公司的淨稅後權益利潤增加了100萬美元,主要原因是我們在委內瑞拉的股權附屬公司的盈利能力更高。
與2023財年相比,2024財年歸屬於非控股權益的凈利潤(虧損)增加了500萬美元,主要是由於我們在中國和捷克共和國的合資企業的盈利增加。
歸屬於Cabot Corporation的凈利潤(損失)
2024財年和2023財年,我們報告歸屬於Cabot Corporation的凈利潤分別爲38000萬美元(每股稀釋普通股收益6.72美元)和44500萬美元(每股稀釋普通股收益7.73美元)。2024財年的減少主要是由於我們美國遞延所得稅資產的估值津貼部分釋放減少(12800萬美元)以及阿根廷政府控制的貨幣貶值造成的損失增加(2600萬美元),部分被我們增強材料和高性能化學品部門的盈利增加所抵消(總計9400萬美元)。
35
2024財年與2023財年相比-按業務部門
下表列出了2024財年和2023財年的所得稅前運營收入(損失)和附屬公司盈利權益、稅前某些項目、其他未分配項目以及分部EBIT總額。某些項目和其他未分配項目的詳細信息載於下文和綜合財務報表附註的附註五。
|
|
截至9月30日的年份 |
|
|||||
|
|
2024 |
|
|
2023 |
|
||
|
|
(In數百萬) |
|
|||||
收入前的經營收入(損失) |
|
$ |
529 |
|
|
$ |
451 |
|
減:某些項目,稅前 |
|
|
(59 |
) |
|
|
(29 |
) |
減:其他未分配項目 |
|
|
(113 |
) |
|
|
(127 |
) |
分部EBIT總額 |
|
$ |
701 |
|
|
$ |
607 |
|
2024財年,所得稅前運營收入(損失)和附屬公司權益收益增加了7800萬美元。這一增長主要是由於強化材料和高性能化學品部門的盈利增加(總計94美元)以及一般未分配收入增加(2000萬美元),部分被阿根廷控制貨幣貶值和其他損失(3600萬美元)的增加所抵消。
某些物品:
2024財年和2023財年的某些項目詳情如下:
|
|
截至9月30日的年份 |
|
|||||
|
|
2024 |
|
|
2023 |
|
||
|
|
(In數百萬) |
|
|||||
阿根廷控制了貨幣貶值和其他損失 |
|
$ |
(43 |
) |
|
$ |
(7 |
) |
全球重組活動(注O) |
|
|
(13 |
) |
|
|
(4 |
) |
法律和環境事務及儲備(注T) |
|
|
(2 |
) |
|
|
(10 |
) |
土地出售收益 |
|
|
— |
|
|
|
1 |
|
收購和整合相關費用 |
|
|
— |
|
|
|
(4 |
) |
出售業務損失(注D) |
|
|
— |
|
|
|
(3 |
) |
其他某些物品 |
|
|
(1 |
) |
|
|
(2 |
) |
某些項目總計 |
|
$ |
(59 |
) |
|
$ |
(29 |
) |
對這些費用和收入項目的解釋包含在我們「術語的定義和非GAAP財務指標」標題下的討論中。
其他未分配物品:
|
|
截至9月30日的年份 |
|
|||||
|
|
2024 |
|
|
2023 |
|
||
|
|
(In數百萬) |
|
|||||
利息開支 |
|
$ |
(81 |
) |
|
$ |
(90 |
) |
未分配的企業成本 |
|
|
(68 |
) |
|
|
(54 |
) |
一般未分配收入(費用) |
|
|
42 |
|
|
|
22 |
|
減:附屬公司盈利權益,扣除稅款 |
|
|
6 |
|
|
|
5 |
|
其他未分配項目總計 |
|
$ |
(113 |
) |
|
$ |
(127 |
) |
對我們稱爲「其他未分配項目」的項目的討論可以在「術語定義和非GAAP財務措施」標題下找到。未分配企業成本餘額主要包括與管理上市公司相關但未分配到分部的支出以及與正在進行的企業項目相關的企業業務開發成本。一般未分配收入(費用)的餘額包括外幣交易產生的收益(損失),扣除其他外幣風險管理活動、利息和股息收入,以及與未賺取收入和未實現持股的企業調整相關的損益投資收益(損失)。這不包括單獨視爲某些項目的項目的收入或費用項目。
36
2024財年,其他未分配項目總支出比2023財年減少了1400萬美元,主要是由於一般未分配收入增加,部分被未分配企業成本增加所抵消。一般未分配收入(費用)增加了2000萬美元,主要是由於2024財年阿根廷的外幣經營損失比2023財年減少。阿根廷政府貶值造成的外幣損失被視爲特定項目,不計入一般未分配收入(費用)。未分配企業成本增加了14億美元,主要是由於激勵薪酬費用增加。
增強材料
2024財年和2023財年加固材料的銷售額和EBIT如下:
|
|
截至9月30日的年份 |
|
|||||
|
|
2024 |
|
|
2023 |
|
||
|
|
(In數百萬) |
|
|||||
加固材料銷售 |
|
$ |
2,610 |
|
|
$ |
2,563 |
|
增強材料EBIT |
|
$ |
537 |
|
|
$ |
482 |
|
2024財年,加固材料的銷售額比2023財年增加了4700萬美元。這一增長主要是由於銷量增加(7900萬美元),部分被外幣兌換(1700萬美元)以及不利的定價和產品組合(1300萬美元)的不利影響所抵消。較高的交易量主要集中在亞太地區和歐洲、中東和非洲地區。不利的定價主要是由於原材料成本較低,而原材料成本通常會轉嫁給我們的客戶。與2023財年相比,加固材料的EBIT增加了5500萬美元。這一增長是由銷量增加(2800萬美元)和單位利潤率增加(扣除成本增加(2500萬美元)推動的。較高的交易量主要集中在亞太地區和歐洲、中東和非洲地區。扣除成本上升後,單位利潤率上升主要是由2023年和2024年曆年客戶協議中有利的定價和產品組合推動的,而成本上升主要是由銷售和管理成本上升推動的。
Performance Chemicals
Performance Chemical 2024財年和2023財年的銷售額和EBIT如下:
|
|
截至9月30日的年份 |
|
|||||
|
|
2024 |
|
|
2023 |
|
||
|
|
(In數百萬) |
|
|||||
性能化學品銷售 |
|
$ |
1,250 |
|
|
$ |
1,225 |
|
績效化學品息稅前利潤 |
|
$ |
164 |
|
|
$ |
125 |
|
2024財年,Performance Chemical的銷售額比2023財年同期增加了2500萬美元。這一增長是由銷量增加(6900萬美元)推動的,部分被不利的定價和產品組合(3600萬美元)以及外幣兌換的不利影響(500萬美元)所抵消。銷量增加主要是由於關鍵終端市場的需求復甦,因爲2023財年發生的客戶去庫存在2024財年沒有再次發生。定價不太有利主要是由於原材料成本較低,而原材料成本通常會轉嫁給我們的客戶。
由於銷量增加(3500萬美元)和單位利潤率增加(扣除成本增加(1100萬美元),與2023財年相比,Performance Chemical的EBIT增加了3900萬美元,部分被外幣兌換的不利影響(600萬美元)所抵消。 銷量增加主要是由於關鍵終端市場的需求復甦,因爲2023財年發生的客戶去庫存在2024財年沒有再次發生。扣除成本上升後,單位利潤率上升主要是由於更有利的產品組合以及汽車和電子終端市場的銷量增加,單位利潤率上升。成本上升主要是由於維護和週轉成本上升所致。
2025財年展望
展望2025財年,我們仍然專注於「爲明天創造」的戰略,推進多項戰略舉措,產生強勁的現金流,繼續嚴格的資本配置方法,並繼續致力於我們的投資級信用評級。我們預計增強材料和高性能化學品的息稅前利潤將持續增長,這兩個部門的銷量將增加,增強材料的利潤率將增加。
流動性與資本資源
概述
按現金和現金等值物加上借款可用性衡量,我們的流動性狀況在2024財年增加了13700萬美元,主要是由於期末未償還循環信貸和商業票據餘額減少。截至2024年9月30日,我們的現金和現金等值物爲22300萬美元,循環信貸協議下的借款可用性爲12億美元。
37
我們可以根據以下兩項信貸協議獲得借款:
截至2024年9月30日,我們遵守了信貸協議項下的債務契約,除有限的例外情況外,該契約要求我們每季度遵守槓桿測試,要求合併淨債務與合併EBITDA的比率不得超過3.50至1.00。合併淨債務定義爲合併債務被(i)不受限制現金及現金等值物與(ii)15000萬美元中較低者抵消。
我們很大一部分業務發生在美國以外,我們產生的現金並不總是與我們的現金需求保持一致。我們持有的絕大多數現金和現金等價物往往是在美國境外持有的。我們通常結合美國的收益、某些外國收益的匯回、商業票據發行和我們的美國信貸協議下的借款來滿足我們在美國的現金需求。除了阿根廷有阻止現金分配的貨幣管制外,我們通常能夠根據需要通過我們的現金池結構、公司間賬戶和/或分配在公司內部轉移現金。雖然我們將某些海外收益匯回國內,但外國子公司持有的現金通常被認爲是永久性的再投資,並用於爲子公司的運營活動和未來投資提供資金。我們通常在季度末使用來自客戶託收的現金來減少我們的商業票據餘額,如果適用,還會根據我們的信貸協議減少借款,包括利用客戶供應鏈融資計劃、結算公司間餘額和短期公司間貸款。如果在美國需要更多資金,我們預計能夠匯回現金,包括中國的現金,同時支付任何預扣或其他稅款。美國或外國法規和稅法的變化可能會限制我們轉移資金或對此類轉移收取物質成本的能力。
截至2024年9月30日和2023年9月30日,我們在歐元信貸協議下分別有11300萬美元和12000萬美元的未償借款,在這兩天均沒有美國信貸協議下的未償借款。截至2024年9月30日和2023年9月30日,未償商業票據分別爲4500萬美元和17200萬美元。
我們預計(i)手頭現金;(ii)經營活動的現金流;(iii)信貸協議和商業票據計劃中可用的現金提供充足的流動性,以滿足我們未來十二個月和可預見的未來的運營和資本投資需求以及財務義務。我們從運營現金流中獲得的流動性在很大程度上取決於我們及時收取應收賬款的能力、原材料成本以及我們管理庫存水平的能力。
以下對現金餘額變化的討論涉及我們合併現金流量表的各個部分。
經營活動產生的現金流量
2024財年,經營活動提供的現金包括根據收入中的各種非現金項目進行調整的凈利潤、流動資金變化和某些其他資產負債表賬戶的變化,總計69200萬美元。2023財年運營活動提供了59500萬美元現金。
2024財年運營活動提供的現金由業務盈利推動,不包括折舊和攤銷的非現金影響15100萬美元,加上淨運營資本減少5700萬美元。淨營運資金減少主要是由於原材料成本下降導致庫存減少以及應付賬款和應計負債增加,但部分被銷量增加導致應收賬款增加所抵消。
2023財年運營活動提供的現金由業務盈利推動,不包括折舊和攤銷的非現金影響14400萬美元,加上淨運營資本減少9700萬美元。淨營運資金減少主要是由於原材料成本下降導致客戶價格下降、銷量下降和庫存減少導致應收賬款減少,部分被原材料成本下降導致的應付賬款和應計費用減少所抵消。
38
投資活動產生的現金流量
2024財年投資活動消耗了23500萬美元現金,而2023財年爲21400萬美元。2024財年,投資活動使用的現金主要包括24100萬美元的資本支出,用於維持運營設施的合規資本項目,以及與增長相關的資本,包括產能擴張項目。
2023財年,投資活動使用的現金主要包括24400萬美元的資本支出,用於維持運營設施的合規資本項目以及與增長相關的資本,包括Performance Chemical的產能擴張項目,部分被保險和解收益1200萬美元、出售土地收益700萬美元、以及出售淨化解決方案業務的收益600萬美元。
2025財年的資本支出預計在25000萬美元至30000萬美元之間。我們計劃的2025財年資本支出計劃主要用於維持、合規和改進我們運營設施的資本項目以及產能擴張資本支出。
融資活動現金流量
2024財年融資活動消耗了41500萬美元現金,而2023財年消耗了40300萬美元。2024財年融資活動消耗的現金主要包括普通股回購17200萬美元、商業票據淨償還12700萬美元、向股東支付股息9300萬美元、向非控股權益支付股息2700萬美元以及歐元信貸協議下長期債務淨償還1200萬美元,其中包括2600萬美元的還款額,部分被1400萬美元的收益抵消。這些付款被股票期權行使中出售普通股2000萬美元的收益部分抵消。
2023財年融資活動消耗的現金主要包括長期債務淨償還600萬美元,其中9000萬美元的還款被8400萬美元收益部分抵消,商業票據淨償還14900萬美元,信貸融資借款淨償還2400萬美元,向股東支付股息8800萬美元,回購普通股9800萬美元,向非控股權益支付股息4200萬美元。
我們的長期總債務(其中800萬美元爲流動債務)在不同時間到期,如合併財務報表附註附註I所示。截至2024年9月30日,我們固定利率長期債務的加權平均利率爲4.29%。
股票回購
2018財年,我們的董事會授權我們額外回購最多一千萬股普通股。2024財年,我們在公開市場上以15900萬美元回購了約1.7億股普通股。2023財年,我們在公開市場上以91億美元回購了約130萬股普通股。此外,在2024財年和2023財年,我們分別以1300萬美元和700萬美元回購了2000萬美元和1000萬美元與基於股票的薪酬獎勵的員工稅務義務相關的普通股。截至2024年9月30日,根據董事會的股份回購授權,我們有約1.3億股可供回購。
股息支付
2024財年和2023財年,我們分別向普通股支付了每股1.66美元和1.54美元的現金股息。2024財年和2023財年,這些現金股息支付總額分別爲9300萬美元和8800萬美元。
員工福利計劃
截至2024年9月30日,我們的合併養老金義務(扣除計劃資產的公允價值)爲2600萬美元,主要與退休後福利計劃負債相關。
2024財年,我們向固定福利養老金計劃提供了總計400萬美元的現金繳款。在2025財年,我們預計將向我們的固定福利養老金計劃提供500萬美元的現金繳款。
2500萬美元的無資金退休後福利計劃負債包括美國的1300萬美元和外國退休後福利計劃的1200萬美元。這些退休後福利計劃爲退休員工提供某些醫療保健和人壽保險福利。在此類計劃中,我們的退休後計劃沒有資金支持,因此沒有計劃資產。我們在索賠或保險費到期時爲這些計劃提供資金。2024財年,我們支付了400萬美元的退休後福利。2025財年,我們退休後計劃的福利付款預計爲300萬美元。
2023財年,我們開始了Cabot Carbon Limited養老金計劃和Carbon Plastics養老金計劃的計劃終止程序,並預計在2025財年完成該程序。
39
合同義務
下表列出了我們的長期合同義務。
|
|
按財年劃分的應付款項 |
|
|||||||||||||||||||||||||
|
|
2025 |
|
|
2026 |
|
|
2027 |
|
|
2028 |
|
|
2029 |
|
|
此後 |
|
|
總 |
|
|||||||
|
|
(In數百萬) |
|
|||||||||||||||||||||||||
購買承諾 |
|
$ |
251 |
|
|
$ |
210 |
|
|
$ |
184 |
|
|
$ |
132 |
|
|
$ |
116 |
|
|
$ |
1,349 |
|
|
$ |
2,242 |
|
長期債務 |
|
|
4 |
|
|
|
250 |
|
|
|
113 |
|
|
|
8 |
|
|
|
300 |
|
|
|
400 |
|
|
|
1,075 |
|
長期債務固定利息 |
|
|
41 |
|
|
|
41 |
|
|
|
33 |
|
|
|
32 |
|
|
|
32 |
|
|
|
60 |
|
|
|
239 |
|
長期債務的可變利息 |
|
|
5 |
|
|
|
5 |
|
|
|
4 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
14 |
|
融資租賃(1) |
|
|
5 |
|
|
|
5 |
|
|
|
3 |
|
|
|
3 |
|
|
|
3 |
|
|
|
13 |
|
|
|
32 |
|
經營租約(1) |
|
|
17 |
|
|
|
14 |
|
|
|
12 |
|
|
|
10 |
|
|
|
10 |
|
|
|
69 |
|
|
|
132 |
|
總 |
|
$ |
323 |
|
|
$ |
525 |
|
|
$ |
349 |
|
|
$ |
185 |
|
|
$ |
461 |
|
|
$ |
1,891 |
|
|
$ |
3,734 |
|
購買承諾
我們已與所有業務部門的各個主要供應商簽訂了長期、批量採購協議,主要用於購買原材料和天然氣。根據某些協議,購買的材料數量是固定的,但我們支付的價格會隨着市場價格的變化而變化。出於上表的目的,當前購買價格已用於量化總承諾。我們還簽署了主要針對與信息技術相關的服務(未包含在上表中)的長期採購協議,截至2024年9月30日,總價值3100萬美元,其中大部分預計將在未來5年內支付。
租賃
我們作爲承租人簽訂了多項租賃,主要與某些交通車輛、倉庫設施、辦公空間以及機械設備有關。這些租賃的剩餘租期爲一年至十五年,其中一些可能包括將租賃延長最多十五年的選擇權或終止租賃的選擇權。我們的土地租約的剩餘租期最長爲78年。
項目7A. 定量和質量市場風險披露
我們面臨利率和外幣匯率變化的風險,因爲我們通過長期和短期借款爲某些業務提供資金,並以多種外幣計價。這些利率的變化可能會對未來的現金流和盈利產生影響。我們通過正常的運營和融資活動以及在認爲合適的情況下使用衍生金融工具來管理這些風險。
我們制定了管理衍生工具使用的政策,並且我們不會出於交易或投機目的而進入金融工具。
通過使用衍生工具,我們面臨信用和市場風險。衍生工具以公允價值計入我們的資產負債表,並反映截至2024年9月30日的資產或負債狀況。如果交易對手未能履行衍生品合同項下的履行義務,我們的風險敞口將等於衍生品的公允價值。通常,當衍生品合同的公允價值爲正值時,交易對手欠卡博特,從而給卡博特帶來付款風險。我們通過與具有投資級信用評級的主要金融機構進行這些交易,最大限度地降低交易對手信用或還款風險。我們面臨的市場風險並未以完全消除市場狀況變化對盈利或現金流的影響的方式對沖。
外幣風險
我們的國際業務面臨一定的風險,包括貨幣匯率波動和政府行爲。我們有跨貨幣掉期被指定爲對沖我們對某些歐元計價子公司的淨投資。下表總結了我們跨貨幣掉期的主要條款,包括掉期的名義總金額、我們從掉期交易對手方收到和支付給掉期交易對手方的利率付款、期限和2024年9月30日和2023年的公允價值。
描述 |
|
名義金額 |
|
收到的利率 |
|
已付利率 |
|
進入的財年 |
|
成熟年份 |
|
2024年9月30日的公允價值 |
|
2023年9月30日的公允價值 |
交叉貨幣掉期 |
|
25000萬美元兌換爲22300萬歐元 |
|
3.40% |
|
1.94% |
|
2016 |
|
2026 |
|
$100萬 |
|
1200萬美元 |
40
我們還面臨因以特定子公司功能貨幣以外的外幣計價貨幣資產和負債而產生的外幣風險,以及貨幣波動可能影響外幣產生的未來現金流的美元價值的風險。因此,我們使用短期遠期合同來最大限度地減少外匯風險。截至2024年9月30日和2023年9月30日,我們的名義外幣合約分別爲13800萬美元和8200萬美元,以印度尼西亞盾、捷克克朗和哥倫比亞披索計價。截至2024年9月30日和2023年9月30日,這些遠期的公允價值均低於100萬美元。
在某些情況下,如果我們預測以外幣計價的長期承諾購買或預測銷售,我們可能會根據我們的風險管理政策簽訂適當的金融工具以對沖未來現金流風險。
2024財年和2023財年,由於大多數外幣兌美元走弱,外幣兌換總額使我們的業務部門EBIT分別減少了500萬美元和1600萬美元,這影響了增強材料和高性能材料部門的業績。2024財年和2023財年,我們在貨幣資產和負債從交易性貨幣重新估值至功能貨幣的其他收入(費用)中分別確認了4600萬美元和3500萬美元的淨外匯損失,主要歸因於這兩個時期阿根廷披索價值的變化。
41
項目8. 財務狀況nts和補充數據
財務報表索引
描述 |
頁面 |
|
(1) |
43 |
|
(2) |
44 |
|
(3) |
45 |
|
(4) |
47 |
|
(5) |
48 |
|
(6) |
49 |
|
(7) |
獨立註冊會計師事務所報告 (PCAOB ID |
84 |
42
Cabot Corporation
合併聲明行動結束
|
|
截至9月30日的年份 |
|
|||||||||
|
|
2024 |
|
|
2023 |
|
|
2022 |
|
|||
|
|
(In百萬美元,每股金額除外) |
|
|||||||||
淨銷售額和其他營業收入 |
|
$ |
|
|
$ |
|
|
$ |
|
|||
銷售成本 |
|
|
|
|
|
|
|
|
|
|||
毛利 |
|
|
|
|
|
|
|
|
|
|||
銷售及行政開支 |
|
|
|
|
|
|
|
|
|
|||
研究和技術費用 |
|
|
|
|
|
|
|
|
|
|||
出售業務損失和資產減損費用(注D) |
|
|
— |
|
|
|
|
|
|
|
||
廉價收購企業的收益(注C) |
|
|
— |
|
|
|
— |
|
|
|
( |
) |
營業收入(虧損) |
|
|
|
|
|
|
|
|
|
|||
利息及股息收入 |
|
|
|
|
|
|
|
|
|
|||
利息開支 |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
其他收入(費用) |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
所得稅前的經營收入(損失)和 |
|
|
|
|
|
|
|
|
|
|||
(規定)所得稅福利 |
|
|
( |
) |
|
|
|
|
|
( |
) |
|
附屬公司盈利權益,扣除稅款 |
|
|
|
|
|
|
|
|
|
|||
淨收益(虧損) |
|
|
|
|
|
|
|
|
|
|||
歸屬於非控股權益的淨收入(虧損),扣除稅後 |
|
|
|
|
|
|
|
|
|
|||
歸屬於Cabot Corporation的凈利潤(虧損) |
|
$ |
|
|
$ |
|
|
$ |
|
|||
|
|
|
|
|
|
|
|
|
|
|||
加權平均已發行普通股: |
|
|
|
|
|
|
|
|
|
|||
基本 |
|
|
|
|
|
|
|
|
|
|||
稀釋 |
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|||
每股普通股收益(虧損): |
|
|
|
|
|
|
|
|
|
|||
基本 |
|
$ |
|
|
$ |
|
|
$ |
|
|||
稀釋 |
|
$ |
|
|
$ |
|
|
$ |
|
隨附的附註是該等綜合財務報表的組成部分。
43
CABOT CORPORATION
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
|
|
Years Ended September 30 |
|
|||||||||
|
|
2024 |
|
|
2023 |
|
|
2022 |
|
|||
|
|
(In millions) |
|
|||||||||
Net income (loss) |
|
$ |
|
|
$ |
|
|
$ |
|
|||
Other comprehensive income (loss), net of tax |
|
|
|
|
|
|
|
|
|
|||
Foreign currency translation adjustment, net of tax |
|
|
|
|
|
|
|
|
( |
) |
||
Derivatives: net investment hedges |
|
|
|
|
|
|
|
|
|
|||
(Gains) losses reclassified to interest expense, net of tax |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
(Gains) losses excluded from effectiveness testing and amortized to |
|
|
|
|
|
|
|
|
|
|||
Pension and other postretirement benefit liability adjustments, |
|
|
( |
) |
|
|
|
|
|
|
||
Other comprehensive income (loss), net of tax of $ |
|
|
|
|
|
|
|
|
( |
) |
||
Comprehensive income (loss) |
|
|
|
|
|
|
|
|
|
|||
Net income (loss) attributable to noncontrolling interests, net of tax |
|
|
|
|
|
|
|
|
|
|||
Foreign currency translation adjustment attributable to noncontrolling |
|
|
|
|
|
— |
|
|
|
( |
) |
|
Comprehensive income (loss) attributable to noncontrolling interests |
|
|
|
|
|
|
|
|
|
|||
Comprehensive income (loss) attributable to Cabot Corporation |
|
$ |
|
|
$ |
|
|
$ |
|
The accompanying notes are an integral part of these consolidated financial statements.
44
CABOT CORPORATION
CONSOLIDATED BALANCE SHEETS
ASSETS
|
|
September 30 |
|
|||||
|
|
2024 |
|
|
2023 |
|
||
|
|
(In millions, except |
|
|||||
Current assets: |
|
|
|
|
|
|
||
Cash and cash equivalents |
|
$ |
|
|
$ |
|
||
Accounts and notes receivable, net of reserve for doubtful accounts of $ |
|
|
|
|
|
|
||
Inventories |
|
|
|
|
|
|
||
Prepaid expenses and other current assets |
|
|
|
|
|
|
||
Total current assets |
|
|
|
|
|
|
||
Property, plant and equipment |
|
|
|
|
|
|
||
Accumulated depreciation |
|
|
( |
) |
|
|
( |
) |
Net property, plant and equipment |
|
|
|
|
|
|
||
Goodwill |
|
|
|
|
|
|
||
Equity affiliates |
|
|
|
|
|
|
||
Intangible assets, net |
|
|
|
|
|
|
||
Deferred income taxes |
|
|
|
|
|
|
||
Other assets |
|
|
|
|
|
|
||
Total assets |
|
$ |
|
|
$ |
|
The accompanying notes are an integral part of these consolidated financial statements.
45
CABOT CORPORATION
CONSOLIDATED BALANCE SHEETS
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
|
September 30 |
|
|||||
|
|
2024 |
|
|
2023 |
|
||
|
|
(In millions, except |
|
|||||
Current liabilities: |
|
|
|
|
|
|
||
Short-term borrowings |
|
$ |
|
|
$ |
|
||
Accounts payable and accrued liabilities |
|
|
|
|
|
|
||
Income taxes payable |
|
|
|
|
|
|
||
Current portion of long-term debt |
|
|
|
|
|
|
||
Total current liabilities |
|
|
|
|
|
|
||
Long-term debt |
|
|
|
|
|
|
||
Deferred income taxes |
|
|
|
|
|
|
||
Other liabilities |
|
|
|
|
|
|
||
|
|
|
|
|
|
|||
Stockholders’ equity: |
|
|
|
|
|
|
||
Preferred stock: |
|
|
|
|
|
|
||
Authorized: |
|
|
— |
|
|
|
— |
|
Common stock: |
|
|
|
|
|
|
||
Authorized: |
|
|
|
|
|
|
||
Less cost of |
|
|
( |
) |
|
|
( |
) |
Additional paid-in capital |
|
|
— |
|
|
|
— |
|
Retained earnings |
|
|
|
|
|
|
||
Accumulated other comprehensive income (loss) |
|
|
( |
) |
|
|
( |
) |
Total Cabot Corporation stockholders’ equity |
|
|
|
|
|
|
||
Noncontrolling interests |
|
|
|
|
|
|
||
Total stockholders’ equity |
|
|
|
|
|
|
||
Total liabilities and stockholders’ equity |
|
$ |
|
|
$ |
|
The accompanying notes are an integral part of these consolidated financial statements.
46
CABOT CORPORATION
CONSOLIDATED STATEMENTS OF CASH FLOWS
|
|
Years Ended September 30 |
|
|||||||||
|
|
2024 |
|
|
2023 |
|
|
2022 |
|
|||
|
|
(In millions) |
|
|||||||||
Cash Flows from Operating Activities: |
|
|
|
|
|
|
|
|
|
|||
Net income (loss) |
|
$ |
|
|
$ |
|
|
$ |
|
|||
Adjustments to reconcile net income (loss) to cash provided by operating activities: |
|
|
|
|
|
|
|
|
|
|||
Depreciation and amortization |
|
|
|
|
|
|
|
|
|
|||
Loss on sale of a business and asset impairment charge |
|
|
— |
|
|
|
|
|
|
|
||
Gain on bargain purchase of a business |
|
|
— |
|
|
|
— |
|
|
|
( |
) |
Gain on sale of land |
|
|
— |
|
|
|
( |
) |
|
|
( |
) |
Deferred tax provision (benefit) |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
Employee benefit plan settlement |
|
|
— |
|
|
|
— |
|
|
|
( |
) |
Equity in net income of affiliated companies |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
Share-based compensation |
|
|
|
|
|
|
|
|
|
|||
Other non-cash (income) expense |
|
|
|
|
|
|
|
|
|
|||
Cash dividends received from equity affiliates |
|
|
|
|
|
|
|
|
|
|||
Changes in assets and liabilities: |
|
|
|
|
|
|
|
|
|
|||
Accounts and notes receivable |
|
|
( |
) |
|
|
|
|
|
( |
) |
|
Inventories |
|
|
|
|
|
|
|
|
( |
) |
||
Prepaid expenses and other assets |
|
|
|
|
|
|
|
|
( |
) |
||
Accounts payable and accrued liabilities |
|
|
|
|
|
( |
) |
|
|
|
||
Income taxes payable |
|
|
|
|
|
( |
) |
|
|
|
||
Other liabilities |
|
|
|
|
|
|
|
|
( |
) |
||
Cash provided by operating activities |
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|||
Cash Flows from Investing Activities: |
|
|
|
|
|
|
|
|
|
|||
Additions to property, plant and equipment |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
Proceeds from sale of a business |
|
|
— |
|
|
|
|
|
|
|
||
Cash paid for acquisition of business, net of cash acquired of $—, $— and $ |
|
|
— |
|
|
|
— |
|
|
|
( |
) |
Proceeds from sale of land |
|
|
— |
|
|
|
|
|
|
|
||
Proceeds from insurance settlements |
|
|
— |
|
|
|
|
|
|
|
||
Other |
|
|
|
|
|
|
|
|
|
|||
Cash used in investing activities |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
|
|
|
|
|
|
|
|
|
|
|||
Cash Flows from Financing Activities: |
|
|
|
|
|
|
|
|
|
|||
Proceeds from short-term borrowings |
|
|
— |
|
|
|
|
|
|
|
||
Repayments of short-term borrowings |
|
|
( |
) |
|
|
( |
) |
|
|
— |
|
Proceeds from issuance of (repayments of) commercial paper, net |
|
|
( |
) |
|
|
( |
) |
|
|
|
|
Proceeds from long-term debt, net of issuance costs |
|
|
|
|
|
|
|
|
|
|||
Repayments of long-term debt |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
Purchases of common stock |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
Proceeds from sales of common stock |
|
|
|
|
|
|
|
|
|
|||
Cash dividends paid to noncontrolling interests |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
Cash dividends paid to common stockholders |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
Cash provided by (used in) financing activities |
|
|
( |
) |
|
|
( |
) |
|
|
|
|
Effects of exchange rate changes on cash |
|
|
( |
) |
|
|
|
|
|
( |
) |
|
Increase (decrease) in cash, cash equivalents |
|
|
( |
) |
|
|
|
|
|
|
||
Cash, cash equivalents at beginning of year |
|
|
|
|
|
|
|
|
|
|||
Cash, cash equivalents at end of year |
|
$ |
|
|
$ |
|
|
$ |
|
|||
|
|
|
|
|
|
|
|
|
|
|||
Non-cash investing activities and supplemental cash flow information: |
|
|
|
|
|
|
|
|
|
|||
Additions to property, plant and equipment included in Accounts payable and |
|
$ |
|
|
$ |
|
|
$ |
|
|||
Income taxes paid |
|
$ |
|
|
$ |
|
|
$ |
|
|||
Interest paid |
|
$ |
|
|
$ |
|
|
$ |
|
The accompanying notes are an integral part of these consolidated financial statements.
47
CABOT CORPORATION
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY
(In millions, except shares in thousands and per share amounts)
|
|
Common Stock, Net of Treasury Stock |
|
|
Additional |
|
|
Retained |
|
|
Accumulated Other Comprehensive |
|
|
Total Cabot Corporation Stockholders’ |
|
|
Noncontrolling |
|
|
Total Stockholders’ |
|
|||||||||||
|
|
Shares |
|
|
Cost |
|
|
Capital |
|
|
Earnings |
|
|
Income (Loss) |
|
|
Equity |
|
|
Interests |
|
|
Equity |
|
||||||||
Balance at September 30, 2021 |
|
|
|
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
( |
) |
|
$ |
|
|
$ |
|
|
$ |
|
|||||||
Net income (loss) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Total other comprehensive income (loss) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
||||
Cash dividends declared to noncontrolling interests |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
— |
|
|
|
( |
) |
|
|
( |
) |
|||||
Cash dividends declared to common stockholders, $ |
|
|
|
|
|
|
|
|
|
|
|
( |
) |
|
|
|
|
|
( |
) |
|
|
|
|
|
( |
) |
|||||
Issuance of stock under equity compensation plans |
|
|
|
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
Share-based compensation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Purchase and retirement of common stock |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
|
|
— |
|
|
|
|
|
|
( |
) |
|
|
|
|
|
( |
) |
||
Balance at September 30, 2022 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
( |
) |
|
|
|
|
|
|
|
|
|
|||||||
Net income (loss) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Total other comprehensive income (loss) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
— |
|
|
|
|
|||||||
Cash dividends declared to noncontrolling interests |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
— |
|
|
|
( |
) |
|
|
( |
) |
|||||
Cash dividends declared to common stockholders, $ |
|
|
|
|
|
|
|
|
|
|
|
( |
) |
|
|
|
|
|
( |
) |
|
|
|
|
|
( |
) |
|||||
Issuance of stock under equity compensation plans |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Share-based compensation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Purchase and retirement of common stock |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
|
|
|
|
|
( |
) |
|
|
|
|
|
( |
) |
||
Balance at September 30, 2023 |
|
|
|
|
|
|
|
|
— |
|
|
|
|
|
|
( |
) |
|
|
|
|
|
|
|
|
|
||||||
Net income (loss) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Total other comprehensive income (loss) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Cash dividends declared to noncontrolling interests |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
— |
|
|
|
( |
) |
|
|
( |
) |
|||||
Cash dividends declared to common stockholders, $ |
|
|
|
|
|
|
|
|
|
|
|
( |
) |
|
|
|
|
|
( |
) |
|
|
|
|
|
( |
) |
|||||
Issuance of stock under equity compensation plans |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Share-based compensation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Purchase and retirement of common stock |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
|
|
|
|
|
( |
) |
|
|
|
|
|
( |
) |
||
Balance at September 30, 2024 |
|
|
|
|
$ |
|
|
$ |
— |
|
|
$ |
|
|
$ |
( |
) |
|
$ |
|
|
$ |
|
|
$ |
|
The accompanying notes are an integral part of these consolidated financial statements.
48
Notes to the Consolidated Financial Statements
Note A. Significant Accounting Policies
The consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States (“U.S. GAAP”). The significant accounting policies of Cabot Corporation (“Cabot” or “the Company”) are described below.
Unless otherwise indicated, all disclosures and amounts in the Notes to the Consolidated Financial Statements relate to the Company’s operations.
Principles of Consolidation
The consolidated financial statements include the accounts of Cabot and its wholly-owned subsidiaries and majority-owned and controlled subsidiaries. Additionally, Cabot considers consolidation of entities over which control is achieved through means other than voting rights, of which there were none in the periods presented. Intercompany transactions have been eliminated in consolidation.
Cash and Cash Equivalents
Cash equivalents include all highly liquid investments with a maturity of three months or less at date of acquisition. Cabot continually assesses the liquidity of cash equivalents and, as of September 30, 2024, has determined that they are readily convertible to cash.
Inventories
Inventories are stated at the lower of cost or net realizable value. The cost of inventories is determined using the first-in, first-out method.
Cabot periodically reviews inventory for both potential obsolescence and potential declines in anticipated selling prices. In this review, the Company makes assumptions about the future demand for and market value of the inventory, and based on these assumptions estimates the amount of any obsolete, unmarketable, slow moving, or overvalued inventory. Cabot writes down the value of these inventories by an amount equal to the difference between the cost of the inventory and its estimated net realizable value.
Investments
The Company has investments in equity affiliates and marketable securities. As circumstances warrant, all investments are subject to periodic impairment reviews. Unless consolidation is required, investments in equity affiliates, where Cabot generally owns between
Intangible Assets and Goodwill Impairment
The Company records tangible and intangible assets acquired and liabilities assumed in business combinations under the acquisition method of accounting. Amounts paid for an acquisition are allocated to the assets acquired and liabilities assumed based on their fair values at the date of acquisition. The Company uses assumptions and estimates in determining the fair value of assets acquired and liabilities assumed in a business combination. The determination of the fair value of intangible assets requires the use of significant judgment with regard to assumptions used in the valuation model. The Company estimates the fair value of identifiable acquisition-related intangible assets principally based on projections of cash flows that will arise from these assets. The projected cash flows are discounted to determine the fair value of the assets at the dates of acquisition.
Definite-lived intangible assets, which are comprised of trademarks, customer relationships and developed technologies, are amortized over their estimated useful lives and are reviewed for impairment when indication of potential impairment exists, such as a significant reduction in cash flows associated with the assets.
Goodwill is comprised of the purchase price of business acquisitions in excess of the fair value assigned to the net tangible and identifiable intangible assets acquired. Goodwill is not amortized and is subject to impairment testing annually, or when events or changes in the business environment indicate that the carrying value of the reporting unit may exceed its fair value.
49
A reporting unit, for the purpose of the impairment test, is at or below the operating segment level, and constitutes a business for which discrete financial information is available and regularly reviewed by segment management. Reinforcement Materials, and the fumed metal oxides, specialty compounds, specialty carbons and battery materials product lines within Performance Chemicals, which are considered separate reporting units, carry the Company’s goodwill balances as of September 30, 2024.
For the purpose of the goodwill impairment test, the Company first assesses qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If an initial qualitative assessment identifies that it is more likely than not that the carrying value of a reporting unit exceeds its estimated fair value, an additional quantitative evaluation is performed. Alternatively, the Company may elect to proceed directly to the quantitative goodwill impairment test. If based on the quantitative evaluation the fair value of the reporting unit is less than its carrying amount, a goodwill impairment loss would result. The goodwill impairment loss would be the amount by which the carrying value of the reporting unit, including goodwill, exceeds its fair value, limited to the total amount of goodwill allocated to that reporting unit. The fair value of a reporting unit is based on discounted estimated future cash flows. The assumptions used to estimate fair value include management’s best estimates of future growth rates, operating cash flows, capital expenditures and discount rates over an estimate of the remaining operating period at the reporting unit level. The fair value is also benchmarked against the value calculated from a market approach using the guideline public company method. Based on the Company's most recent annual goodwill impairment test performed as of August 31, 2024, the fair values of the Reinforcement Materials, fumed metal oxides, specialty compounds, specialty carbons and battery materials reporting units were substantially in excess of their carrying values.
Long-lived Assets Impairment
Long-lived assets are grouped with other assets and liabilities at the lowest level for which independent identifiable cash flows are determinable. The carrying values of long-lived assets are reviewed for impairment whenever events or changes in business circumstances indicate that the carrying amount of an asset may not be recoverable. To test for impairment of assets, the Company generally uses a probability-weighted estimate of the future undiscounted net cash flows of the assets over their remaining lives to determine if the value of the asset is recoverable.
An asset impairment is recognized when the carrying value of the asset is not recoverable based on the analysis described above, in which case the asset is written down to its fair value. If the asset does not have a readily determinable market value, a discounted cash flow model may be used to determine the fair value of the asset.
Property, Plant and Equipment
Property, plant and equipment are recorded at cost. Depreciation of property, plant and equipment is calculated using the straight-line method over the estimated useful lives of the related assets. The depreciable lives for buildings, machinery and equipment, and other fixed assets are generally between and
Cabot capitalizes interest costs when they are part of the cost of acquiring and constructing certain assets that require a period of time to prepare for their intended use. During fiscal 2024, 2023 and 2022, Cabot capitalized $
Asset Retirement Obligations
Cabot estimates incremental costs for special handling, removal and disposal of materials that may or will give rise to conditional asset retirement obligations (“ARO”) and then discounts the expected costs back to the current year using a credit adjusted risk-free rate. Cabot recognizes ARO liabilities and costs when they are probable and can be reasonably estimated. In certain instances, Cabot has not recorded a reserve for AROs because the timing of disposal of the underlying asset is unknown. The ARO reserves were $
50
Foreign Currency Translation
The functional currency of the majority of Cabot’s foreign subsidiaries is the local currency in which the subsidiary operates. Assets and liabilities of foreign subsidiaries are translated into U.S. dollars at exchange rates in effect at the balance sheet dates. Income and expense items are translated at average monthly exchange rates during the year. The functional currency of Cabot’s foreign subsidiaries that operate in a highly inflationary economy is the U.S. dollar. Refer below to Argentinian Government Actions for detail regarding foreign currency exchange losses recorded by Cabot’s wholly-owned Argentinian subsidiary which operates in a highly inflationary economy. Cabot’s operations in other highly inflationary economies are not material.
Unrealized currency translation adjustments (“CTA”) are included as a separate component of Accumulated other comprehensive income (loss) (“AOCI”) within stockholders’ equity. Realized and unrealized foreign currency gains and losses arising from transactions denominated in currencies other than the subsidiary’s functional currency are reflected in earnings with the exception of (i) intercompany transactions considered to be of a long-term investment nature; (ii) income taxes upon future repatriation of unremitted earnings from non-U.S. subsidiaries that are not indefinitely reinvested; and (iii) foreign currency borrowings designated as net investment hedges. Gains or losses arising from these transactions are included within the CTA component of Other comprehensive income (loss). In fiscal 2024, 2023 and 2022, net foreign currency transaction loss of $
Argentinian Government Actions
The Company’s wholly-owned Argentinian subsidiary operates in a highly inflationary economy and, as a result, the functional currency of the subsidiary is Cabot’s reporting currency, the U.S. dollar. During fiscal 2024, 2023 and 2022, the Company recorded foreign exchange losses of $
During the second quarter of fiscal 2024, the Company purchased $
Share Repurchases
Periodically, Cabot repurchases shares of the Company’s common stock under the authorization provided by the Board of Directors. The Company retires the repurchased shares and records the excess of the purchase price over par value to additional paid-in capital (“APIC”) until such amount is reduced to zero and then charges the remainder against retained earnings.
Financial Instruments
Cabot’s financial instruments consist primarily of cash and cash equivalents, accounts and notes receivable, investments, accounts payable and accrued liabilities, short-term and long-term debt, and derivative instruments. The carrying values of Cabot’s financial instruments approximate fair value with the exception of fixed rate long-term debt, which is recorded at amortized cost. The fair values of the Company’s financial instruments are based on quoted market prices, if such prices are available. In situations where quoted market prices are not available, the Company relies on valuation models to derive fair value. Such valuations take into account the ability of the financial counterparty to perform and the Company’s own credit risk.
51
Cabot uses derivative financial instruments primarily for purposes of hedging the exposures to fluctuations in foreign currency exchange rates, which exist as part of its on-going business operations. Cabot does not enter into derivative contracts for speculative purposes, nor does it hold or issue any derivative contracts for trading purposes. All derivatives are recognized on the Consolidated Balance Sheets at fair value. Where Cabot has a legal right to offset derivative settlements under a master netting agreement with a counterparty, derivatives with that counterparty are presented on a net basis. The changes in the fair value of derivatives are recorded in either earnings or AOCI, depending on whether or not the instrument is designated as part of a hedge transaction and, if designated as part of a hedge transaction, the type of hedge transaction. The gains or losses on derivative instruments reported in AOCI are reclassified to earnings in the period in which earnings are affected by the underlying hedged item. The ineffective portion of all hedges is recognized in earnings during the period in which the ineffectiveness occurs.
In accordance with Cabot’s risk management strategy, the Company may enter into certain derivative instruments that may not be designated as hedges for hedge accounting purposes. Although these derivatives are not designated as hedges, the Company believes that such instruments are closely correlated with the underlying exposure, thus managing the associated risk. The Company records in earnings the gains or losses from changes in the fair value of derivative instruments that are not designated as hedges. Cash movements associated with these instruments are presented in the Consolidated Statements of Cash Flows as Cash Flows from Operating Activities because the derivatives are designed to mitigate risk to the Company’s cash flow from operations.
Revenue Recognition
Cabot recognizes revenue when its customers obtain control of promised goods or services. The revenue recognized is the amount of consideration which the Company expects to receive in exchange for those goods or services. The Company’s contracts with customers are generally for products only and do not include other performance obligations. Generally, Cabot considers purchase orders, which in some cases are governed by master supply agreements, to be contracts with customers. The transaction price as specified on the purchase order or sales contract is considered the standalone selling price for each distinct product. To determine the transaction price at the time when revenue is recognized, the Company evaluates whether the price is subject to adjustments, such as for returns, discounts or volume rebates, which are stated in the customer contract, to determine the net consideration to which the Company expects to be entitled. Substantially all revenue from product sales is based on a point in time model and is recognized when control of the product is transferred to the customer, which typically occurs upon shipment or delivery of the product to the customer and title, risk and rewards of ownership have passed to the customer. For contracts where Cabot completes its performance obligation prior to its right to consideration or contracts where consideration is received prior to completing the Company’s performance obligation, the Company records a contract asset or a contract liability, respectively, on the Consolidated Balance Sheets.
Shipping and handling activities that occur after the transfer of control to the customer are billed to customers and are recorded as sales revenue, as the Company considers these to be fulfillment costs. These shipping and handling costs are expensed in the period incurred and included in Cost of sales within the Consolidated Statement of Operations. Taxes collected on sales to customers are excluded from the transaction price.
The Company generally provides a warranty that its products will substantially conform to the identified specifications. The Company’s liability typically is limited to either a credit equal to the purchase price or replacement of the non-conforming product. Returns under warranty have historically been immaterial.
Payment terms typically range from to
Cost of Sales
Cost of sales consists of the cost of raw and packaging materials, direct manufacturing costs, depreciation, internal transfer costs, inspection costs, inbound and outbound freight and shipping and handling costs, plant purchasing and receiving costs and other overhead expenses necessary to manufacture the products.
Accounts and Notes Receivable
Trade receivables are recorded at the invoiced amount and generally do not bear interest.
Cabot maintains allowances for doubtful accounts based on an assessment of the collectability of specific customer accounts, the aging of accounts receivable and other economic information on both a historical and prospective basis. Customer account balances are charged against the allowance when it is probable the receivable will not be recovered. There were
52
Share-based Compensation
Cabot recognizes compensation expense for share-based awards granted to employees using the fair value method. Under the fair value recognition provisions, share-based compensation cost is measured at the grant date based on the fair value of the award, and is recognized as expense over the service period, which generally represents the vesting period, and includes an estimate of what level of performance the Company will achieve for Cabot’s performance-based stock awards. Cabot calculates the fair value of its stock options using the Black-Scholes option pricing model. The fair value of restricted stock units is determined using the closing price of Cabot stock on the day of the grant. The Company recognizes forfeitures as they occur.
Selling and Administrative Expenses
Selling and administrative expenses consist of salaries and fringe benefits of sales and office personnel, general office expenses and other expenses not directly related to manufacturing operations.
Research and Technical Expenses
Research and technical expenses include salaries, equipment and material expenditures, and contractor fees and are expensed as incurred.
Pensions and Other Postretirement Benefits
The Company recognizes the funded status of defined benefit pension and other postretirement benefit plans as an asset or liability. This amount is defined as the difference between the fair value of plan assets and the benefit obligation. Pension and post-retirement benefit costs other than service cost are included in Other income (expense) in the Consolidated Statement of Operations. Service cost is included with other employee compensation costs within Cost of sales, Selling and administrative expenses, or Research and technical expenses. The Company recognizes actuarial gains and losses and prior service costs and credits as a component of Other comprehensive income (loss), net of tax, which are subsequently amortized into earnings as a component of net periodic benefit cost.
Accumulated Other Comprehensive Income (Loss)
AOCI, which is included as a component of stockholders’ equity, includes unrealized gains or losses on derivative instruments, currency translation adjustments in foreign subsidiaries and pension and post-retirement related adjustments.
Income Taxes
Deferred income taxes are determined based on the estimated future tax effects of differences between financial statement carrying amounts and the tax bases of existing assets and liabilities. Deferred tax assets are recognized to the extent that realization of those assets is considered to be more likely than not. A valuation allowance is established for deferred taxes when it is more likely than not that all or a portion of the deferred tax assets will not be realized. Provisions are made for the U.S. income tax liability and additional non-U.S. taxes on the undistributed earnings of non-U.S. subsidiaries, except for amounts Cabot has designated to be indefinitely reinvested.
Cabot records benefits for uncertain tax positions based on an assessment of whether the position is more likely than not to be sustained by the taxing authorities. If this threshold is not met, no tax benefit of the uncertain tax position is recognized. If the threshold is met, the tax benefit that is recognized is the largest amount that is greater than
Contingencies
Cabot accrues costs related to contingencies when it is probable that a liability has been incurred and the amount can be reasonably estimated. Contingencies could arise from litigation, environmental remediation or contractual arrangements. When a single liability amount cannot be reasonably estimated, but a range can be reasonably estimated, Cabot accrues the amount that reflects the best estimate within that range or the low end of the range if no estimate within the range would be considered more likely than any other estimate. The amount accrued is determined through the evaluation of various information, which could include claims, settlement offers, demands by government agencies, estimates performed by independent third parties, identification of other responsible parties and an assessment of their ability to contribute, and the Company’s prior experience. Cabot does not reduce its estimated liability for possible recoveries from insurance carriers. Proceeds from insurance carriers are recorded when realized by either the receipt of cash or a contractual agreement.
53
Use of Estimates
The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make certain estimates and assumptions that affect the reported amount of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reported period. Actual results could differ from those estimates.
Note B. Recent Accounting Pronouncements
Recently Adopted Accounting Standards
In November 2022, the Financial Accounting Standards Board (“FASB”) issued a new standard on the disclosure of supplier financing programs. The new standard requires qualitative and quantitative disclosures as to the nature and potential magnitude of such programs in addition to program activity and changes for the periods presented. The Company adopted this standard on October 1, 2023. See Note U for disclosures related to the Company's supplier financing programs. The adoption of this standard did not have a material impact on the Company's Consolidated Financial Statements.
Recent Accounting Pronouncements
In March 2024, the Securities and Exchange Commission (“SEC”) issued its final rule, The Enhancement and Standardization of Climate-Related Disclosures for Investors that requires the Company to provide certain climate-related information. The rule provided a phased-in compliance period and was effective for fiscal years beginning after December 15, 2024, with early adoption permitted. In April 2024, the SEC voluntarily stayed its rule pending completion of judicial review by the U.S. Court of Appeals for the Eighth Circuit and, therefore, the timing of the effectiveness of these disclosure requirements is uncertain. The Company is currently monitoring the timing of adoption and evaluating the impact of the potential adoption of this standard on the Company’s Consolidated Financial Statements.
In December 2023, the FASB issued a new standard, Improvements to Income Tax Disclosures. The new guidance requires additional disclosures primarily related to the income tax rate reconciliation and income taxes paid. The new standard is effective for the Company’s fiscal years and interim periods beginning October 1, 2025. The Company is currently evaluating the impact of the adoption of this standard on the Company’s Consolidated Financial Statements.
In November 2023, the FASB issued a new standard, Improvement to Reportable Segment Disclosures. The new guidance enhances the disclosure of significant reportable segment expenses. The new standard is effective for the Company’s fiscal years beginning October 1, 2024, and for interim periods beginning October 1, 2025. The Company is currently evaluating the impact of the adoption of this standard on the Company’s Consolidated Financial Statements.
In October 2021, the Organization for Economic Co-operation and Development (“OECD”) published its model rules “Global Anti-Base Erosion Model Rules (Pillar Two)” which established a global minimum corporate tax rate of
Note C. Acquisitions
Tokai Carbon (Tianjin) Co.
In February 2022, the Company purchased
The excess of the fair value of the net assets over the purchase price was recorded as a gain of $
Note D. Divestitures
Sale of Purification Solutions Business
In March 2022, the Company completed the sale of its Purification Solutions business, a reporting segment of the Company, to an affiliate of funds advised by One Equity Partners for total cash proceeds of $
54
$
Note E. Inventories
Inventories, net of obsolete, unmarketable and slow-moving reserves, are as follows:
|
|
September 30 |
|
|||||
|
|
2024 |
|
|
2023 |
|
||
|
|
(In millions) |
|
|||||
Raw materials |
|
$ |
|
|
$ |
|
||
Finished goods |
|
|
|
|
|
|
||
Other(1) |
|
|
|
|
|
|
||
Total |
|
$ |
|
|
$ |
|
At both September 30, 2024 and 2023, total inventory reserves were $
Note F. Property, Plant and Equipment
Property, plant and equipment consists of the following:
|
|
September 30 |
|
|||||
|
|
2024 |
|
|
2023 |
|
||
|
|
(In millions) |
|
|||||
Land and land improvements |
|
$ |
|
|
$ |
|
||
Buildings |
|
|
|
|
|
|
||
Machinery and equipment |
|
|
|
|
|
|
||
Other |
|
|
|
|
|
|
||
Construction in progress |
|
|
|
|
|
|
||
Total property, plant and equipment |
|
|
|
|
|
|
||
Less: Accumulated depreciation |
|
|
( |
) |
|
|
( |
) |
Net property, plant and equipment |
|
$ |
|
|
$ |
|
Note G. Goodwill and Intangible Assets
|
|
Reinforcement |
|
|
Performance |
|
|
Total |
|
|||
|
|
(In millions) |
|
|||||||||
Balance at September 30, 2022 |
|
$ |
|
|
$ |
|
|
$ |
|
|||
Foreign currency impact |
|
|
|
|
|
- |
|
|
|
|
||
Balance at September 30, 2023 |
|
|
|
|
|
|
|
|
|
|||
Foreign currency impact |
|
|
( |
) |
|
|
|
|
|
( |
) |
|
Balance at September 30, 2024 |
|
$ |
|
|
$ |
|
|
$ |
|
|||
|
|
|
|
|
|
|
|
|
|
The following table provides information regarding the Company’s intangible assets with finite lives:
|
|
September 30, 2024 |
|
|
September 30, 2023 |
|
||||||||||||||||||
|
|
Gross |
|
|
Accumulated |
|
|
Net |
|
|
Gross |
|
|
Accumulated |
|
|
Net |
|
||||||
|
|
(In millions) |
|
|||||||||||||||||||||
Developed technologies |
|
$ |
|
|
$ |
( |
) |
|
$ |
|
|
$ |
|
|
$ |
( |
) |
|
$ |
|
||||
Trademarks |
|
|
|
|
|
( |
) |
|
|
|
|
|
|
|
|
( |
) |
|
|
|
||||
Customer relationships |
|
|
|
|
|
( |
) |
|
|
|
|
|
|
|
|
( |
) |
|
|
|
||||
Total intangible assets |
|
$ |
|
|
$ |
( |
) |
|
$ |
|
|
$ |
|
|
$ |
( |
) |
|
$ |
|
55
Intangible assets are amortized over their estimated useful lives, which range between and
Note H. Accounts Payable, Accrued Liabilities and Other Liabilities
Accounts payable and accrued liabilities included in current liabilities consist of the following:
|
|
September 30 |
|
|||||
|
|
2024 |
|
|
2023 |
|
||
|
|
(In millions) |
|
|||||
Accounts payable |
|
$ |
|
|
$ |
|
||
Accrued employee compensation |
|
|
|
|
|
|
||
Other accrued liabilities |
|
|
|
|
|
|
||
Total |
|
$ |
|
|
$ |
|
Other long-term liabilities consist of the following:
|
|
September 30 |
|
|||||
|
|
2024 |
|
|
2023 |
|
||
|
|
(In millions) |
|
|||||
Employee benefit plan liabilities |
|
$ |
|
|
$ |
|
||
Operating lease liabilities |
|
|
|
|
|
|
||
Other accrued liabilities |
|
|
|
|
|
|
||
Total |
|
$ |
|
|
$ |
|
Note I. Debt and Other Obligations
Short-term Borrowings
Commercial Paper— The Company has a commercial paper program and the maximum aggregate balance of commercial paper notes outstanding and the amounts borrowed under the revolving credit facility may not exceed the borrowing capacity of $
There was an outstanding balance of commercial paper of $
56
Long-term Obligations
The Company’s long-term obligations, the fiscal year in which they mature and their respective interest rates are summarized below:
|
|
September 30 |
|
|||||
|
|
2024 |
|
|
2023 |
|
||
|
|
(In millions) |
|
|||||
Variable Rate Debt: |
|
|
|
|
|
|
||
Revolving Credit Facility, expires fiscal |
|
$ |
— |
|
|
$ |
— |
|
Revolving Credit Facility - Euro, expires fiscal |
|
|
|
|
|
|
||
Total variable rate debt |
|
|
|
|
|
|
||
Fixed Rate Debt: |
|
|
|
|
|
|
||
|
|
|
|
|
|
|||
|
|
|
|
|
|
|||
|
|
400 |
|
|
|
|
||
Medium-Term Notes due fiscal |
|
|
|
|
|
|
||
Chinese Renminbi Debt, due fiscal |
|
|
|
|
|
|
||
Total fixed rate debt |
|
|
|
|
|
|
||
Finance lease obligations (Note S) |
|
|
|
|
|
|
||
Unamortized debt issuance costs and debt discount |
|
|
( |
) |
|
|
( |
) |
Total debt |
|
|
|
|
|
|
||
Less current portion of long-term debt |
|
|
( |
) |
|
|
( |
) |
Total long-term debt |
|
$ |
|
|
$ |
|
Revolving Credit Facility, expiring fiscal 2027—In August 2021, the Company entered into a revolving credit agreement (the “U.S. Credit Agreement”) with a loan commitment not to exceed $
Revolving Credit Facility-Euro, expiring fiscal 2027—In May 2023, several subsidiaries entered into a revolving credit agreement (the “Euro Credit Agreement”, and together with the U.S. Credit Agreement, the "Credit Agreements") with a loan commitment not to exceed
Debt Covenants—As of September 30, 2024, Cabot was in compliance with the financial debt covenants under the Credit Agreements, which, with limited exceptions, require us to comply on a quarterly basis with a leverage test requiring the ratio of consolidated net debt to consolidated EBITDA not to exceed
Chinese Renminbi Debt—The Company’s consolidated Chinese subsidiaries had $
57
3.4% Notes due fiscal 2026—In September 2016, Cabot issued $
4.0% Notes due fiscal 2029—In June 2019, Cabot issued $
5.0% Notes due fiscal 2032—In June 2022, Cabot issued $
Medium-Term Notes—At both September 30, 2024 and 2023, there were $
Finance Lease obligations—See Note S for a discussion of the Company’s leases.
Future Years Payment Schedule
The aggregate principal amounts of long-term debt, excluding finance lease liabilities presented separately in Note S, due in each of the five years from fiscal 2025 through 2029 and thereafter are as follows:
Years Ending September 30 |
|
Principal Payments |
|
|
|
|
(In millions) |
|
|
2025 |
|
$ |
|
|
2026 |
|
|
|
|
2027 |
|
|
|
|
2028 |
|
|
|
|
2029 |
|
|
|
|
Thereafter |
|
|
|
|
Total |
|
$ |
|
Standby letters of credit—At September 30, 2024, the Company had provided standby letters of credit that were outstanding and not drawn totaling $
Note J. Financial Instruments and Fair Value Measurements
The FASB authoritative guidance on fair value measurements defines fair value, provides a framework for measuring fair value, and requires certain disclosures about fair value measurements. The required disclosures focus on the inputs used to measure fair value. The guidance establishes the following hierarchy for categorizing these inputs:
Level 1 |
— |
Quoted market prices in active markets for identical assets or liabilities |
|
|
|
Level 2 |
— |
Significant other observable inputs (e.g., quoted prices for similar items in active markets, quoted prices for identical or similar items in markets that are not active, inputs other than quoted prices that are observable such as interest rate and yield curves, and market-corroborated inputs) |
|
|
|
Level 3 |
— |
Significant unobservable inputs |
There were
At both September 30, 2024 and 2023, the fair values of cash and cash equivalents, accounts and notes receivable, accounts payable and accrued liabilities, and short term borrowings and variable rate debt approximated their carrying values due to the short-term nature of these instruments. Cash and cash equivalents are classified as Level 1 within the fair value hierarchy.
58
At both September 30, 2024 and 2023, Cabot had derivatives relating to foreign currency risks carried at fair value. The Company uses standard models with market-based inputs, which take into account the present value of estimated future cash flows and the ability of Cabot or the financial counterparty to perform. For interest rate and cross-currency swaps, the significant inputs to these models are interest rate curves for discounting future cash flows and are adjusted for credit risk. For forward foreign currency contracts, the significant inputs are interest rate curves for discounting future cash flows, and exchange rate curves of the foreign currency for translating future cash flows. These derivatives are classified as Level 2 instruments within the fair value hierarchy as the fair value determination was based on observable inputs.
At both September 30, 2024 and 2023, the fair value of Guaranteed investment contracts, included in Other assets on the Consolidated Balance Sheets was $
The carrying value and fair value of the long-term fixed rate debt were each $
Note K. Derivatives
The Company has foreign currency exposure arising from its net investments in foreign operations. The Company uses cross-currency swaps to partially mitigate the impact of the Euro currency rate changes on the Company’s Euro denominated net investments. The Company’s cross-currency swaps are designated as net investment hedges.
The Company also has foreign currency exposure arising from the denomination of monetary assets and liabilities in foreign currencies other than the functional currency of a given subsidiary as well as the risk that currency fluctuations could affect the dollar value of future cash flows generated in foreign currencies. The Company uses short-term forward contracts to minimize the exposure to foreign currency risk.
The Company had
The following table provides details of the derivatives held as of September 30, 2024 and 2023 to manage foreign currency risk.
|
|
|
|
Notional Amount |
|
|
||
Description |
|
Borrowing |
|
September 30, 2024 |
|
September 30, 2023 |
|
Hedge |
Cross Currency Swaps |
|
|
USD |
|
USD |
|
Net investment |
|
Forward Foreign Currency Contracts(1) |
|
N/A |
|
USD |
|
USD |
|
No designation |
Accounting for Derivative Instruments and Hedging Activities
Net Investment Hedge
For net investment hedges, changes in the fair value of the effective portion of the derivatives’ gains or losses are reported as CTA in AOCI while changes in the ineffective portion are reported in earnings. Effectiveness is assessed based on the hypothetical derivative method. The gains or losses on derivative instruments reported in AOCI are reclassified to earnings in the period in which earnings are affected by the underlying item, such as a disposal or substantial liquidations of the entities being hedged.
59
Cash settlements related to the net investment hedge occur
The following table summarizes the impact of the cross-currency swaps, net of tax, to AOCI and the Consolidated Statements of Operations:
|
|
Years Ended September 30 |
|
|||||||||
|
|
2024 |
|
|
2023 |
|
|
2022 |
|
|||
|
|
(In millions) |
|
|||||||||
Gain/(loss) recognized in AOCI |
|
$ |
( |
) |
|
$ |
( |
) |
|
$ |
|
|
(Gain)/loss reclassified from AOCI into |
|
$ |
( |
) |
|
$ |
( |
) |
|
$ |
( |
) |
(Gain)/loss recognized in Interest expense (amount excluded |
|
$ |
|
|
$ |
|
|
$ |
|
Forward Foreign Currency Contracts
At both September 30, 2024 and 2023, the Company had foreign currency forward contracts that were not designated as hedges for accounting purposes. Although these derivatives do not qualify for hedge accounting, Cabot believes that such instruments are closely correlated with the underlying exposure, thus managing the associated risk. The gains or losses from changes in the fair value of derivative instruments that are not accounted for as hedges are recognized in current period earnings.
At both September 30, 2024 and 2023, the fair value of derivative instruments not designated as hedges was less than $
Note L. Insurance Recoveries
Pepinster, Belgium
In July 2021, the Company’s Specialty Compounds manufacturing and research and development facility in Pepinster, Belgium experienced significant flooding. Full production, which was temporarily halted, resumed in the second quarter of fiscal 2022. The Company agreed to a final insurance settlement in fiscal 2023 for total proceeds of $
During fiscal 2022, the Company recorded expenses of $
During fiscal 2023 and 2022, the Company received insurance proceeds of $
In August 2021, the Company’s specialty carbons and reinforcing carbons manufacturing facility in Franklin, Louisiana experienced an unplanned plant outage due to equipment failure. During fiscal 2022, the Company received insurance proceeds of $
Note M. Employee Benefit Plans
The information below provides detail concerning the Company’s benefit obligations under the defined benefit and postretirement benefit plans it sponsors.
Defined benefit plans provide pre-determined benefits to employees that are distributed upon retirement. Cabot is making all sponsor required contributions to these plans. The accumulated benefit obligation was $
60
$
The following provides information about projected benefit obligations, plan assets, the funded status and weighted-average assumptions of the defined benefit pension and postretirement benefit plans:
|
|
Years Ended September 30 |
|
|||||||||||||||||||||||||||||
|
|
2024 |
|
|
2023 |
|
|
2024 |
|
|
2023 |
|
||||||||||||||||||||
|
|
Pension Benefits |
|
|
Postretirement Benefits |
|
||||||||||||||||||||||||||
|
|
U.S. |
|
|
Foreign |
|
|
U.S. |
|
|
Foreign |
|
|
U.S. |
|
|
Foreign |
|
|
U.S. |
|
|
Foreign |
|
||||||||
|
|
(In millions) |
|
|||||||||||||||||||||||||||||
Change in Benefit Obligations: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Benefit obligation at beginning of |
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||||
Service cost |
|
|
— |
|
|
|
|
|
|
— |
|
|
|
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
||
|
|
— |
|
|
|
|
|
|
— |
|
|
|
|
|
|
— |
|
|
|
|
|
|
|
|
|
|
||||||
Plan participants’ contribution |
|
|
— |
|
|
|
|
|
|
— |
|
|
|
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
||
Foreign currency exchange rate |
|
|
— |
|
|
|
|
|
|
— |
|
|
|
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
|
|||
(Gain) loss from changes in actuarial |
|
|
— |
|
|
|
|
|
|
— |
|
|
|
( |
) |
|
|
|
|
|
|
|
|
( |
) |
|
|
( |
) |
|||
Benefits paid |
|
|
— |
|
|
|
( |
) |
|
|
— |
|
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
ents or |
|
|
— |
|
|
|
( |
) |
|
|
— |
|
|
|
( |
) |
|
|
— |
|
|
|
( |
) |
|
|
— |
|
|
|
— |
|
Benefit obligation at end of year |
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
|
|
Years Ended September 30 |
|
|||||||||||||||||||||||||||||
|
|
2024 |
|
|
2023 |
|
|
2024 |
|
|
2023 |
|
||||||||||||||||||||
|
|
Pension Benefits |
|
|
Postretirement Benefits |
|
||||||||||||||||||||||||||
|
|
U.S. |
|
|
Foreign |
|
|
U.S. |
|
|
Foreign |
|
|
U.S. |
|
|
Foreign |
|
|
U.S. |
|
|
Foreign |
|
||||||||
|
|
(In millions) |
|
|||||||||||||||||||||||||||||
Change in Plan Assets: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Fair value of plan assets at beginning |
|
$ |
— |
|
|
$ |
|
|
$ |
— |
|
|
$ |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
||
Actual return on plan assets |
|
|
— |
|
|
|
|
|
|
— |
|
|
|
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
||
Employer contribution |
|
|
— |
|
|
|
|
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Plan participants’ contribution |
|
|
— |
|
|
|
|
|
|
— |
|
|
|
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
||
Foreign currency exchange rate |
|
|
— |
|
|
|
|
|
|
— |
|
|
|
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
||
Benefits paid |
|
|
— |
|
|
|
( |
) |
|
|
— |
|
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
Settlements or curtailments |
|
|
— |
|
|
|
( |
) |
|
|
— |
|
|
|
( |
) |
|
|
— |
|
|
|
( |
) |
|
|
— |
|
|
|
— |
|
Fair value of plan assets at end |
|
$ |
— |
|
|
$ |
|
|
$ |
— |
|
|
$ |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
||
Funded status |
|
$ |
( |
) |
|
$ |
|
|
$ |
( |
) |
|
$ |
|
|
$ |
( |
) |
|
$ |
( |
) |
|
$ |
( |
) |
|
$ |
( |
) |
||
Recognized asset (liability) |
|
$ |
( |
) |
|
$ |
|
|
$ |
( |
) |
|
$ |
|
|
$ |
( |
) |
|
$ |
( |
) |
|
$ |
( |
) |
|
$ |
( |
) |
61
Pension Assumptions and Strategy
The following assumptions were used to determine the pension benefit obligations and periodic benefit costs as of and for the years ended September 30:
|
|
2024 |
|
|
2023 |
|
|
2022 |
|
|||||||||||||||
|
|
Pension Benefits |
|
|||||||||||||||||||||
|
|
U.S. |
|
|
Foreign |
|
|
U.S. |
|
|
Foreign |
|
|
U.S. |
|
|
Foreign |
|
||||||
Actuarial assumptions as of the year-end |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Discount rate |
|
|
% |
|
|
% |
|
|
% |
|
|
% |
|
|
% |
|
|
% |
||||||
Rate of increase in compensation |
|
N/A |
|
|
|
% |
|
N/A |
|
|
|
% |
|
|
% |
|
|
% |
||||||
Cash balance interest credit rate |
|
|
% |
|
|
% |
|
|
% |
|
|
% |
|
|
% |
|
|
% |
||||||
Actuarial assumptions used to determine net |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Discount rate - benefit obligation |
|
|
% |
|
|
% |
|
|
% |
|
|
% |
|
|
% |
|
|
% |
||||||
Discount rate - service cost |
|
N/A |
|
|
|
% |
|
N/A |
|
|
|
% |
|
N/A |
|
|
|
% |
||||||
Discount rate - interest cost |
|
|
% |
|
|
% |
|
|
% |
|
|
% |
|
|
% |
|
|
% |
||||||
Expected long-term rate of return on |
|
N/A |
|
|
|
% |
|
N/A |
|
|
|
% |
|
N/A |
|
|
|
% |
||||||
Rate of increase in compensation |
|
N/A |
|
|
|
% |
|
N/A |
|
|
|
% |
|
N/A |
|
|
|
% |
||||||
Cash balance interest credit rate |
|
|
% |
|
|
% |
|
|
% |
|
|
% |
|
|
% |
|
|
% |
Postretirement Assumptions and Strategy
The following assumptions were used to determine the postretirement benefit obligations and net costs as of and for the years ended September 30:
|
|
2024 |
|
|
2023 |
|
|
2022 |
|
|||||||||||||||
|
|
Postretirement Benefits |
|
|||||||||||||||||||||
|
|
U.S. |
|
|
Foreign |
|
|
U.S. |
|
|
Foreign |
|
|
U.S. |
|
|
Foreign |
|
||||||
Actuarial assumptions as of the year-end |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Discount rate |
|
|
% |
|
|
% |
|
|
% |
|
|
% |
|
|
% |
|
|
% |
||||||
Initial health care cost trend rate |
|
|
% |
|
|
% |
|
|
% |
|
|
% |
|
|
— |
% |
|
|
% |
|||||
Actuarial assumptions used to determine |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Discount rate - benefit obligation |
|
|
% |
|
|
% |
|
|
% |
|
|
% |
|
|
% |
|
|
% |
||||||
Discount rate - service cost |
|
|
% |
|
|
% |
|
|
% |
|
|
% |
|
|
% |
|
|
% |
||||||
Discount rate - interest cost |
|
|
% |
|
|
% |
|
|
% |
|
|
% |
|
|
% |
|
|
% |
||||||
Initial health care cost trend rate |
|
|
% |
|
|
% |
|
|
— |
% |
|
|
% |
|
|
% |
|
|
% |
Cabot uses discount rates as of September 30, the plans’ measurement date, to determine future benefit obligations under its U.S. and foreign defined benefit plans. The discount rates for the defined benefit plans in Canada, the Eurozone, Japan, Switzerland, the United Arab Emirates, the United Kingdom and the U.S. are derived from yield curves that reflect high quality corporate bond yield or swap rate information in each region and reflect the characteristics of Cabot’s employee benefit plans. The discount rates for the defined benefit plans in Mexico, the Czech Republic and Indonesia are based on government bond indices that best reflect the durations of the plans, adjusted for credit spreads presented in selected AA corporate bond indices. The rates utilized are selected because they represent long-term, high quality, fixed income benchmarks that approximate the long-term nature of Cabot’s pension obligations and related payouts.
62
Amounts recognized in the Consolidated Balance Sheets at September 30, 2024 and 2023 related to the Company's defined benefit pension and postretirement benefit plans were as follows:
|
|
September 30 |
|
|||||||||||||||||||||||||||||
|
|
2024 |
|
|
2023 |
|
|
2024 |
|
|
2023 |
|
||||||||||||||||||||
|
|
Pension Benefits |
|
|
Postretirement Benefits |
|
||||||||||||||||||||||||||
|
|
U.S. |
|
|
Foreign |
|
|
U.S. |
|
|
Foreign |
|
|
U.S. |
|
|
Foreign |
|
|
U.S. |
|
|
Foreign |
|
||||||||
|
|
(In millions) |
|
|||||||||||||||||||||||||||||
Other assets |
|
$ |
— |
|
|
$ |
|
|
$ |
— |
|
|
$ |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
||
Accounts payable and accrued liabilities |
|
$ |
— |
|
|
$ |
( |
) |
|
$ |
— |
|
|
$ |
( |
) |
|
$ |
( |
) |
|
$ |
( |
) |
|
$ |
( |
) |
|
$ |
( |
) |
Other liabilities |
|
$ |
( |
) |
|
$ |
( |
) |
|
$ |
( |
) |
|
$ |
( |
) |
|
$ |
( |
) |
|
$ |
( |
) |
|
$ |
( |
) |
|
$ |
( |
) |
Amounts recognized in AOCI at September 30, 2024 and 2023 related to the Company's defined benefit pension and postretirement benefit plans were as follows:
|
|
September 30 |
|
|||||||||||||||||||||||||||||
|
|
2024 |
|
|
2023 |
|
|
2024 |
|
|
2023 |
|
||||||||||||||||||||
|
|
Pension Benefits |
|
|
Postretirement Benefits |
|
||||||||||||||||||||||||||
|
|
U.S. |
|
|
Foreign |
|
|
U.S. |
|
|
Foreign |
|
|
U.S. |
|
|
Foreign |
|
|
U.S. |
|
|
Foreign |
|
||||||||
|
|
(In millions) |
|
|||||||||||||||||||||||||||||
Net actuarial (gain) loss |
|
$ |
— |
|
|
$ |
|
|
$ |
— |
|
|
$ |
|
|
$ |
( |
) |
|
$ |
( |
) |
|
$ |
( |
) |
|
$ |
( |
) |
||
Net prior service credit |
|
|
— |
|
|
|
( |
) |
|
|
— |
|
|
|
( |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Balance in accumulated other |
|
$ |
— |
|
|
$ |
|
|
$ |
— |
|
|
$ |
|
|
$ |
( |
) |
|
$ |
( |
) |
|
$ |
( |
) |
|
$ |
( |
) |
Estimated Future Benefit Payments
The Company expects that the following benefit payments will be made to plan participants in the years from 2025 to 2034:
|
|
Pension Benefits |
|
|
Postretirement Benefits |
|
||||||||||
Years Ending September 30 |
|
U.S. |
|
|
Foreign |
|
|
U.S. |
|
|
Foreign |
|
||||
|
|
(In millions) |
|
|||||||||||||
2025 |
|
$ |
— |
|
|
$ |
|
|
$ |
|
|
$ |
|
|||
2026 |
|
$ |
— |
|
|
$ |
|
|
$ |
|
|
$ |
|
|||
2027 |
|
$ |
— |
|
|
$ |
|
|
$ |
|
|
$ |
|
|||
2028 |
|
$ |
— |
|
|
$ |
|
|
$ |
|
|
$ |
|
|||
2029 |
|
$ |
— |
|
|
$ |
|
|
$ |
|
|
$ |
|
|||
2030 - 2034 |
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
Postretirement benefits are unfunded and impact Cabot’s cash flows as benefits become due, which is expected to be $
Net periodic defined benefit pension and other postretirement benefit costs include the following components:
|
|
Years Ended September 30 |
|
|||||||||||||||||||||||||||||||||||||||||||||
|
|
2024 |
|
|
2023 |
|
|
2022 |
|
|
2024 |
|
|
2023 |
|
|
2022 |
|
||||||||||||||||||||||||||||||
|
|
Pension Benefits |
|
|
Postretirement Benefits |
|
||||||||||||||||||||||||||||||||||||||||||
|
|
U.S. |
|
|
Foreign |
|
|
U.S. |
|
|
Foreign |
|
|
U.S. |
|
|
Foreign |
|
|
U.S. |
|
|
Foreign |
|
|
U.S. |
|
|
Foreign |
|
|
U.S. |
|
|
Foreign |
|
||||||||||||
|
|
(In millions) |
|
|||||||||||||||||||||||||||||||||||||||||||||
Service cost |
|
$ |
— |
|
|
$ |
|
|
$ |
— |
|
|
$ |
|
|
$ |
— |
|
|
$ |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|||
Interest cost |
|
|
— |
|
|
|
|
|
|
— |
|
|
|
|
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
— |
|
|
|
|
||||||||
E on plan |
|
|
— |
|
|
|
( |
) |
|
|
— |
|
|
|
( |
) |
|
|
— |
|
|
|
( |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
of ) losses |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
( |
) |
|
|
— |
|
|
|
|
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
Settlements or |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
( |
) |
|
|
— |
|
Net periodic (benefit) cost |
|
$ |
— |
|
|
$ |
|
|
$ |
— |
|
|
$ |
|
|
$ |
— |
|
|
$ |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
|
|
$ |
( |
) |
|
$ |
|
63
Other changes in plan assets and benefit obligations recognized in Other comprehensive income (loss) are as follows:
|
|
Years Ended September 30 |
|
|||||||||||||||||||||||||||||||||||||||||||||
|
|
2024 |
|
|
2023 |
|
|
2022 |
|
|
2024 |
|
|
2023 |
|
|
2022 |
|
||||||||||||||||||||||||||||||
|
|
Pension Benefits |
|
|
Postretirement Benefits |
|
||||||||||||||||||||||||||||||||||||||||||
|
|
U.S. |
|
|
Foreign |
|
|
U.S. |
|
|
Foreign |
|
|
U.S. |
|
|
Foreign |
|
|
U.S. |
|
|
Foreign |
|
|
U.S. |
|
|
Foreign |
|
|
U.S. |
|
|
Foreign |
|
||||||||||||
|
|
(In millions) |
|
|||||||||||||||||||||||||||||||||||||||||||||
Net (gains) losses |
|
$ |
— |
|
|
$ |
|
|
$ |
— |
|
|
$ |
|
|
$ |
— |
|
|
$ |
( |
) |
|
$ |
— |
|
|
$ |
|
|
$ |
( |
) |
|
$ |
( |
) |
|
$ |
( |
) |
|
$ |
( |
) |
|||
Prior service (credit) cost |
|
|
— |
|
|
|
( |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Amortization of prior |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
|
|
|
— |
|
|
|
( |
) |
|
|
|
|
|
— |
|
|
|
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|||
Loss on divestiture |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
( |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
ain on ements |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
|
|
|
— |
|
|
Net changes recognized in |
|
$ |
— |
|
|
$ |
|
|
$ |
— |
|
|
$ |
|
|
$ |
— |
|
|
$ |
( |
) |
|
$ |
|
|
$ |
|
|
$ |
— |
|
|
$ |
( |
) |
|
$ |
( |
) |
|
$ |
( |
) |
U.K. Plans Termination
In fiscal 2023, the Company commenced the plan termination process for the Cabot Carbon Limited Pension Plan and Carbon Plastics Pension Plan and expects to complete the transaction in fiscal 2025.
Plan Assets
The Company’s foreign defined benefit pension plans weighted-average asset allocations at September 30, 2024 and 2023 by asset category, are as follows:
|
|
September 30 |
|
|||||
|
|
2024 |
|
|
2023 |
|
||
Equity securities |
|
|
% |
|
|
% |
||
Debt securities |
|
|
% |
|
|
% |
||
Real estate |
|
|
% |
|
|
% |
||
Cash and other securities |
|
|
% |
|
|
% |
||
Total |
|
|
% |
|
|
% |
To develop the expected long-term rate of return on plan assets assumption, the Company used a capital asset pricing model. The model considers the current level of expected returns on risk-free investments comprised of government bonds, the historical level of the risk premium associated with the other asset classes in which the portfolio is invested and the expectations for future returns for each asset class. The expected return for each asset class was then weighted based on the target asset allocation to develop the expected long-term rate of return for each plan.
Cabot’s investment strategy for each of its foreign defined benefit plans is generally based on a set of investment objectives and policies that cover time horizons and risk tolerance levels consistent with plan liabilities. Periodic studies are performed to determine the asset mix that will meet pension obligations at a reasonable cost to the Company. The assets of the defined benefit plans are comprised principally of investments in equity and high-quality fixed income securities, which are broadly diversified across the capitalization and style spectrum and are managed using both active and passive strategies. The weighted average target asset allocation for the foreign plans is
For pension plan assets classified as Level 1 measurements (measured using quoted prices in active markets), total fair value is either the price of the most recent trade at the time of the market close or the official close price, as defined by the exchange on which the asset is most actively traded on the last trading day of the period, multiplied by the number of units held without consideration of transaction costs.
For pension plan assets classified as Level 2 measurements, where the security is frequently traded in less active markets, fair value is based on the closing price at the end of the period; where the security is less frequently traded, fair value is based on the price a dealer would pay for the security or similar securities, adjusted for any terms specific to that asset or liability. Market inputs are obtained from third-party vendors of market data and subjected to tolerance/quality checks.
64
The fair value of the Company’s pension plan assets at September 30, 2024 and 2023 by asset category is as follows:
|
|
September 30 |
|
|||||||||||||||||||||
|
|
2024 |
|
|
2023 |
|
||||||||||||||||||
|
|
Quoted Prices in |
|
|
Significant |
|
|
Total |
|
|
Quoted Prices in |
|
|
Significant |
|
|
Total |
|
||||||
|
|
(In millions) |
|
|||||||||||||||||||||
Cash |
|
$ |
|
|
$ |
— |
|
|
$ |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
||
Direct investments: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
U.S government bonds |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
U.S. corporate bonds |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Non-U.S. equities |
|
|
|
|
|
— |
|
|
|
|
|
|
|
|
|
— |
|
|
|
|
||||
Non-U.S. government bonds |
|
|
|
|
|
— |
|
|
|
|
|
|
|
|
|
— |
|
|
|
|
||||
Non-U.S. corporate bonds |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
— |
|
|
|
|
|||||
Mortgage-backed securities |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
|
|
|
|
||
Other fixed income |
|
|
|
|
|
— |
|
|
|
|
|
|
|
|
|
— |
|
|
|
|
||||
Total direct investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Investment funds: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Equity funds(1) |
|
|
— |
|
|
|
|
|
|
|
|
|
— |
|
|
|
|
|
|
|
||||
Fixed income funds(2) |
|
|
— |
|
|
|
|
|
|
|
|
|
— |
|
|
|
|
|
|
|
||||
Real estate funds(3) |
|
|
— |
|
|
|
|
|
|
|
|
|
— |
|
|
|
|
|
|
|
||||
Cash equivalent funds |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
|
|
|
— |
|
|
|
|
||
Other investment funds |
|
|
— |
|
|
|
|
|
|
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
||
Total investment funds |
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Alternative investments: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Insurance contracts(4) |
|
|
— |
|
|
|
|
|
|
|
|
|
— |
|
|
|
|
|
|
|
||||
Other alternative investments |
|
|
— |
|
|
|
|
|
|
|
|
|
— |
|
|
|
|
|
|
|
||||
Total alternative investments |
|
|
— |
|
|
|
|
|
|
|
|
|
— |
|
|
|
|
|
|
|
||||
Total pension plan assets |
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
Defined Contribution Plans
In addition to benefits provided under the defined benefit and postretirement benefit plans, the Company provides benefits under defined contribution plans. Cabot recognized expenses related to these plans of $
Note N. Share-Based Compensation
The Cabot Corporation Amended and Restated 2017 Long-Term Incentive Plan (the “Amended Plan”) was established by the Company to provide stock-based compensation to eligible employees. The Amended Plan was approved by Cabot’s stockholders on March 11, 2021 and authorizes the issuance of up to
65
The terms of awards made under Cabot’s equity compensation plans are generally determined by the Compensation Committee of Cabot’s Board of Directors. The awards made in fiscal 2024, 2023 and 2022 consist of grants of stock options, time-based restricted stock units and performance-based restricted stock units. The options were issued with an exercise price equal to
Share-based employee compensation expense was $
The following table presents share-based compensation expenses included in the Company’s Consolidated Statements of Operations:
|
|
Years Ended September 30 |
|
|||||||||
|
|
2024 |
|
|
2023 |
|
|
2022 |
|
|||
|
|
(In millions) |
|
|||||||||
Cost of sales |
|
$ |
|
|
$ |
|
|
$ |
|
|||
Selling and administrative expenses |
|
|
|
|
|
|
|
|
|
|||
Research and technical expenses |
|
|
|
|
|
|
|
|
|
|||
Share-based compensation expense |
|
|
|
|
|
|
|
|
|
|||
Income tax benefit |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
Net share-based compensation expense |
|
$ |
|
|
$ |
|
|
$ |
|
As of September 30, 2024, Cabot had $
Equity Incentive Plan Activity
The following table summarizes the total stock option and restricted stock unit activity in the equity incentive plans for fiscal 2024:
|
|
Stock Options |
|
|
Restricted Stock Units |
|
||||||||||
|
|
Total |
|
|
Weighted |
|
|
Restricted |
|
|
Weighted |
|
||||
|
|
(Shares in thousands) |
|
|||||||||||||
Outstanding at September 30, 2023 |
|
|
|
|
$ |
|
|
|
|
|
$ |
|
||||
Granted |
|
|
|
|
$ |
|
|
|
|
|
$ |
|
||||
Performance-based adjustment(2) |
|
|
— |
|
|
$ |
— |
|
|
|
|
|
$ |
|
||
Exercised / Vested |
|
|
( |
) |
|
$ |
|
|
|
( |
) |
|
$ |
|
||
Cancelled / Forfeited |
|
|
( |
) |
|
$ |
|
|
|
( |
) |
|
$ |
|
||
Outstanding at September 30, 2024(3) |
|
|
|
|
$ |
|
|
|
|
|
$ |
|
||||
Exercisable at September 30, 2024 |
|
|
|
|
$ |
|
|
|
|
|
|
|
66
Stock Options
As of September 30, 2024, the aggregate intrinsic value for all options outstanding and options exercisable was $
The Company uses the Black-Scholes option-pricing model to estimate the fair value of the options at the grant date. The weighted average grant date fair values of options granted during fiscal 2024, 2023 and 2022 was $
|
|
Years Ended September 30 |
|
|||||||||
|
|
2024 |
|
|
2023 |
|
|
2022 |
|
|||
Expected stock price volatility |
|
|
% |
|
|
% |
|
|
% |
|||
Risk free interest rate |
|
|
% |
|
|
% |
|
|
% |
|||
Expected life of options (years) |
|
|
|
|
|
|
|
|
|
|||
Expected annual dividends per year |
|
$ |
|
|
$ |
|
|
$ |
|
The expected stock price volatility assumption was determined using the historical volatility of the Company’s common stock over the expected life of the option. The expected term reflects the anticipated time period between the measurement date and the exercise date or post-vesting cancellation date.
Restricted Stock Units
The value of restricted stock unit awards is the closing stock price at the date of the grant. The weighted average grant date fair values of restricted stock unit awards granted during fiscal 2024, 2023 and 2022 was $
Supplemental 401(k) Plan
Cabot’s Deferred Compensation and Supplemental Retirement Plan (“SERP 401(k)”) provides benefits to highly compensated employees when the retirement plan limits established under the Internal Revenue Code prevent them from receiving all of the Company matching and retirement contributions that would otherwise be provided under the qualified 401(k) plan. The SERP 401(k) is non-qualified and unfunded. Contributions under the SERP 401(k) are treated as if invested in Cabot common stock. The majority of the distributions made under the SERP 401(k) are required to be paid with shares of Cabot common stock. The remaining distributions, which relate to certain grandfathered accounts, will be paid in cash based on the market price of Cabot common stock at the time of distribution. The aggregate value of the accounts that will be paid out in stock, which is equivalent to approximately
Note O. Restructuring
2024 Reorganizations
During the first quarter of fiscal 2024, the Company initiated restructuring activities in both its Reinforcement Materials segment (“RM Plan”) and its Performance Chemicals segment (“PC Plan”). Under the RM Plan, the Company closed its reinforcing carbons unit at the facility in Tianjin, China that the Company acquired from Tokai Carbon Group in February 2022, consolidating its reinforcing carbons operations and reducing ongoing operational costs. Under the PC Plan, the Company has temporarily idled its aerogel manufacturing plant in Frankfurt, Germany and reorganized certain positions within the Performance Chemicals segment to reduce operating costs. Although the Frankfurt facility is idled, the Company continues its efforts to commercialize aerogel for use in thermal insulation for electric vehicles. During fiscal 2024, the Company recorded charges of $
67
Details of the 2024 Reorganization restructuring activities and the related reserves for fiscal 2024 are as follows:
|
|
Severance |
|
|
Accelerated Depreciations on Assets |
|
|
Other |
|
|
Total |
|
||||
|
|
(In millions) |
|
|||||||||||||
Reserve at September 30, 2023 |
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
||||
Charges |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Costs charged against assets |
|
|
— |
|
|
|
( |
) |
|
|
— |
|
|
|
( |
) |
Cash paid |
|
|
( |
) |
|
|
— |
|
|
|
( |
) |
|
|
( |
) |
Reserve at September 30, 2024 |
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
Cabot’s restructuring reserves are reflected in Accounts payable and accrued liabilities on the Company’s Consolidated Balance Sheets.
Cabot’s restructuring activities were recorded in the Consolidated Statements of Operations as follows:
|
|
Years Ended September 30 |
|
|||||||||
|
|
2024 |
|
|
2023 |
|
|
2022 |
|
|||
|
|
(In millions) |
|
|||||||||
Cost of sales |
|
$ |
|
|
$ |
|
|
$ |
|
|||
Selling and administrative expenses |
|
|
|
|
|
— |
|
|
|
|
||
Total |
|
$ |
|
|
$ |
|
|
$ |
|
Note P. Accumulated Other Comprehensive Income (Loss)
Changes in each component of AOCI, net of tax, are as follows for fiscal 2024 and 2023:
|
|
Currency |
|
|
Pension and Other |
|
|
Total |
|
|||
|
|
(In millions) |
|
|||||||||
Balance at September 30, 2022 attributable to |
|
$ |
( |
) |
|
$ |
( |
) |
|
$ |
( |
) |
Other comprehensive income (loss) before reclassifications |
|
|
|
|
|
|
|
|
|
|||
Amounts reclassified from AOCI |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
Less: Other comprehensive income (loss) attributable to |
|
|
— |
|
|
|
— |
|
|
|
— |
|
Balance at September 30, 2023 attributable to |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
Other comprehensive income (loss) before reclassifications |
|
|
|
|
|
( |
) |
|
|
|
||
Amounts reclassified from AOCI |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
Less: Other comprehensive income (loss) attributable to |
|
|
|
|
|
— |
|
|
|
|
||
Balance at September 30, 2024 attributable to |
|
$ |
( |
) |
|
$ |
( |
) |
|
$ |
( |
) |
68
The amounts reclassified out of AOCI and into the Consolidated Statements of Operations for fiscal 2024, 2023 and 2022 are as follows:
|
|
Affected Line Item in the Consolidated |
|
Years Ended September 30 |
|
|||||||||
|
|
Statements of Operations |
|
2024 |
|
|
2023 |
|
|
2022 |
|
|||
|
|
|
|
(In Millions) |
|
|||||||||
Derivatives: net investment hedges |
|
|
|
|
|
|
|
|
|
|
|
|||
(Gains) losses reclassified to interest |
|
Interest expense |
|
$ |
( |
) |
|
$ |
( |
) |
|
$ |
( |
) |
(Gains) losses excluded from effectiveness |
|
Interest expense |
|
|
|
|
|
|
|
|
|
|||
Release of current translation adjustment |
|
Loss on sale of business and asset impairment charge |
|
|
— |
|
|
|
— |
|
|
|
|
|
Pension and other postretirement benefit |
|
|
|
|
|
|
|
|
|
|
|
|||
Release of actuarial losses and prior service cost |
|
Loss on sale of business and asset impairment charge |
|
|
— |
|
|
|
— |
|
|
|
|
|
Amortization of actuarial losses and prior service |
|
Other income (expense) |
|
|
( |
) |
|
|
( |
) |
|
|
|
|
Settlement and curtailment loss (gain) |
|
Other income (expense) |
|
|
— |
|
|
|
— |
|
|
|
( |
) |
Total before tax |
|
|
|
$ |
( |
) |
|
$ |
( |
) |
|
$ |
|
69
Note Q. Earnings Per Share
The following tables summarize the components of the basic and diluted earnings per common share (“EPS”) computations:
|
|
Years Ended September 30 |
|
|||||||||
|
|
2024 |
|
|
2023 |
|
|
2022 |
|
|||
|
|
(In millions, except per share amounts) |
|
|||||||||
Basic EPS: |
|
|
|
|
|
|
|
|
|
|||
Net income (loss) attributable to Cabot Corporation |
|
$ |
|
|
$ |
|
|
$ |
|
|||
Less: Dividends and dividend equivalents to participating |
|
|
|
|
|
|
|
|
|
|||
Less: Undistributed earnings allocated to participating |
|
|
|
|
|
|
|
|
|
|||
Earnings (loss) allocated to common shareholders (numerator) |
|
$ |
|
|
$ |
|
|
$ |
|
|||
|
|
|
|
|
|
|
|
|
|
|||
Weighted average common shares and participating |
|
|
|
|
|
|
|
|
|
|||
Less: Participating securities(1) |
|
|
|
|
|
|
|
|
|
|||
Adjusted weighted average common shares |
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|||
Per share amounts—basic: |
|
|
|
|
|
|
|
|
|
|||
Net income (loss) attributable to Cabot Corporation |
|
$ |
|
|
$ |
|
|
$ |
|
|||
|
|
|
|
|
|
|
|
|
|
|||
Diluted EPS: |
|
|
|
|
|
|
|
|
|
|||
Earnings (loss) allocated to common shareholders |
|
$ |
|
|
$ |
|
|
$ |
|
|||
Plus: Earnings allocated to participating securities |
|
|
|
|
|
|
|
|
|
|||
Less: Adjusted earnings allocated to participating |
|
|
|
|
|
|
|
|
|
|||
Earnings (loss) available to common shares (numerator) |
|
$ |
|
|
$ |
|
|
$ |
|
|||
|
|
|
|
|
|
|
|
|
|
|||
Adjusted weighted average common shares outstanding |
|
|
|
|
|
|
|
|
|
|||
Effect of dilutive securities: |
|
|
|
|
|
|
|
|
|
|||
Common shares issuable(3) |
|
|
|
|
|
|
|
|
|
|||
Adjusted weighted average common shares |
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|||
Per share amounts—diluted: |
|
|
|
|
|
|
|
|
|
|||
Net income (loss) attributable to Cabot Corporation |
|
$ |
|
|
$ |
|
|
$ |
|
70
Undistributed earnings are the earnings which remain after dividends declared during the period are assumed to be distributed to the common and participating shareholders. Undistributed earnings are allocated to common and participating shareholders on the same basis as dividend distributions. The calculation of undistributed earnings is as follows:
|
|
Years Ended September 30 |
|
|||||||||
|
|
2024 |
|
|
2023 |
|
|
2022 |
|
|||
|
|
(In millions) |
|
|||||||||
Calculation of undistributed earnings: |
|
|
|
|
|
|
|
|
|
|||
Net income (loss) attributable to Cabot Corporation |
|
$ |
|
|
$ |
|
|
$ |
|
|||
Less: Dividends declared on common stock |
|
|
|
|
|
|
|
|
|
|||
Less: Dividends and dividend equivalents to participating |
|
|
|
|
|
|
|
|
|
|||
Undistributed earnings (loss) |
|
$ |
287 |
|
|
$ |
|
|
$ |
|
||
Allocation of undistributed earnings: |
|
|
|
|
|
|
|
|
|
|||
Undistributed earnings (loss) allocated to common |
|
$ |
|
|
$ |
|
|
$ |
|
|||
Undistributed earnings allocated to participating |
|
|
|
|
|
|
|
|
|
|||
Undistributed earnings (loss) |
|
$ |
|
|
$ |
|
|
$ |
|
Note R. Income Taxes
Income from operations before income taxes and equity in net earnings of affiliated companies was as follows:
|
|
Years Ended September 30 |
|
|||||||||
|
|
2024 |
|
|
2023 |
|
|
2022 |
|
|||
|
|
(In millions) |
|
|||||||||
Domestic |
|
$ |
|
|
$ |
|
|
$ |
( |
) |
||
Foreign |
|
|
|
|
|
|
|
|
|
|||
Income from operations before income taxes and |
|
$ |
|
|
$ |
|
|
$ |
|
Tax provision (benefit) for income taxes consisted of the following:
|
|
Years Ended September 30 |
|
|||||||||
|
|
2024 |
|
|
2023 |
|
|
2022 |
|
|||
|
|
(In millions) |
|
|||||||||
U.S. federal and state: |
|
|
|
|
|
|
|
|
|
|||
Current |
|
$ |
|
|
$ |
|
|
$ |
|
|||
Deferred |
|
|
( |
) |
|
|
( |
) |
|
|
|
|
Total |
|
|
( |
) |
|
|
( |
) |
|
|
|
|
Foreign: |
|
|
|
|
|
|
|
|
|
|||
Current |
|
|
|
|
|
|
|
|
|
|||
Deferred |
|
|
( |
) |
|
|
— |
|
|
|
( |
) |
Total |
|
|
|
|
|
|
|
|
|
|||
Provision (benefit) for income taxes |
|
$ |
|
|
$ |
( |
) |
|
$ |
|
71
The provision (benefit) for income taxes differed from the provision for income taxes as calculated using the U.S. statutory rate as follows:
|
|
Years Ended September 30 |
|
|||||||||
|
|
2024 |
|
|
2023 |
|
|
2022 |
|
|||
|
|
(In millions) |
|
|||||||||
Computed tax expense at the federal statutory rate |
|
$ |
|
|
$ |
|
|
$ |
|
|||
Foreign impact of taxation at different rates, repatriation, |
|
|
|
|
|
|
|
|
|
|||
Global Intangible Low Taxed Income (GILTI) |
|
|
( |
) |
|
|
|
|
|
|
||
Purification Solutions business divestiture |
|
|
— |
|
|
|
— |
|
|
|
( |
) |
Impact of increase (decrease) in valuation allowance on |
|
|
( |
) |
|
|
( |
) |
|
|
|
|
U.S. and state benefits from research and experimentation |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
Provision (settlement) of unrecognized tax benefits |
|
|
|
|
|
|
|
|
|
|||
Permanent differences, net |
|
|
( |
) |
|
|
( |
) |
|
|
|
|
State taxes, net of federal effect |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
Provision (benefit) for income taxes |
|
$ |
|
|
$ |
( |
) |
|
$ |
|
Significant components of deferred income taxes were as follows:
|
|
September 30 |
|
|||||
|
|
2024 |
|
|
2023 |
|
||
|
|
(In millions) |
|
|||||
Deferred tax assets: |
|
|
|
|
|
|
||
Deferred expenses |
|
$ |
|
|
$ |
|
||
Intangible assets |
|
|
|
|
|
|
||
Inventory |
|
|
|
|
|
|
||
Operating lease liability |
|
|
|
|
|
|
||
Other |
|
|
|
|
|
|
||
U.S. federal interest expense carryforward |
|
|
|
|
|
|
||
Pension and other benefits |
|
|
|
|
|
|
||
Net operating loss carryforwards ("NOLs") |
|
|
|
|
|
|
||
Capital loss carryforwards |
|
|
|
|
|
|
||
Foreign tax credit carryforwards |
|
|
|
|
|
|
||
R&D credit carryforwards |
|
|
|
|
|
|
||
Other business credit carryforwards |
|
|
|
|
|
|
||
Subtotal |
|
|
|
|
|
|
||
Valuation allowance |
|
|
( |
) |
|
|
( |
) |
Total deferred tax assets |
|
$ |
|
|
$ |
|
|
|
September 30 |
|
|||||
|
|
2024 |
|
|
2023 |
|
||
|
|
(In millions) |
|
|||||
Deferred tax liabilities: |
|
|
|
|
|
|
||
Property, plant and equipment |
|
$ |
( |
) |
|
$ |
( |
) |
Right of use asset |
|
|
( |
) |
|
|
( |
) |
Unremitted earnings of non-U.S. subsidiaries |
|
|
( |
) |
|
|
( |
) |
Total deferred tax liabilities |
|
$ |
( |
) |
|
$ |
( |
) |
The Company assesses the available positive and negative evidence to estimate whether sufficient future taxable income will be generated to permit utilization of the existing deferred tax assets. When performing this assessment, the Company looks to the potential future reversal of existing taxable temporary differences, taxable income in carryback years and the feasibility of tax planning strategies and estimated future taxable income. Failure to achieve operating income targets resulting in a cumulative loss may change the Company’s assessment regarding the realization of Cabot’s deferred tax assets, resulting in valuation allowances being recorded against some or all of the Company’s deferred tax assets. The need for a valuation allowance can also be affected by changes to tax laws, changes to statutory tax rates and changes to future taxable income estimates. A valuation allowance
72
represents management’s best estimate of the non-realizable portion of the deferred tax assets. Any adjustments in a valuation allowance would result in an adjustment to Provision (benefit) for income taxes in the Consolidated Statement of Operations.
Since 2020, the Company has maintained a valuation allowance against its net U.S. deferred tax assets. On a quarterly basis, the Company evaluates all positive and negative evidence to determine if a valuation allowance is required. In analyzing all available evidence as of September 30, 2024 and 2023, the Company determined that there is sufficient positive evidence outweighing the negative evidence to conclude that it is more likely than not that a portion of the U.S. deferred tax assets are realizable. As a result, the Company reversed a portion of the valuation allowance that was recorded against U.S. net deferred tax assets. This reversal resulted in a non-cash income tax benefit of $
The valuation allowance decreased by $
After the valuation allowance, approximately $
The following table provides detail surrounding the expiration dates of NOLs, capital loss and other tax credit carryforwards before valuation allowances:
Years Ending September 30 |
|
NOLs/Capital Losses |
|
|
Credits |
|
||
|
|
(In millions) |
|
|||||
|
$ |
|
|
$ |
|
|||
|
|
|
|
|
|
|||
Indefinite carryforwards |
|
|
|
|
|
|
||
Total |
|
$ |
|
|
$ |
|
As of September 30, 2024, provisions have not been made for non-U.S. withholding taxes or other applicable taxes on $
|
|
Years Ended September 30 |
|
|||||||||
|
|
2024 |
|
|
2023 |
|
|
2022 |
|
|||
|
|
(In millions) |
|
|||||||||
Balance at beginning of the year |
|
$ |
|
|
$ |
|
|
$ |
|
|||
Additions based on tax positions related to the current |
|
|
|
|
|
|
|
|
|
|||
Additions for tax positions of prior years |
|
|
|
|
|
— |
|
|
|
|
||
Reductions of tax positions of prior years |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
Reductions related to settlements |
|
|
( |
) |
|
|
( |
) |
|
|
— |
|
Reductions from lapse of statute of limitations |
|
|
— |
|
|
|
( |
) |
|
|
( |
) |
Balance at end of the year |
|
$ |
|
|
$ |
|
|
$ |
|
Cabot has filed its tax returns in accordance with the tax laws in each jurisdiction and recognizes tax benefits for uncertain tax positions when the position would more likely than not be sustained based on its technical merits and recognizes measurement adjustments when needed. As of September 30, 2024, the total amount of unrecognized tax benefits was $
73
As of September 30, 2023, the total amount of unrecognized tax benefits was $
Cabot and certain subsidiaries are under audit in a number of jurisdictions. In addition, certain statutes of limitations are scheduled to expire in the near future. It is reasonably possible that a further change in the unrecognized tax benefits may occur within the next twelve months related to the settlement of one or more of these audits or the lapse of applicable statutes of limitations; however, an estimated range of the impact on the unrecognized tax benefits cannot be quantified at this time.
Cabot is subject to taxation in the United States and various states and foreign jurisdictions. The
Note S. Leases
The Company determines if an arrangement is a lease at inception. The Company considers a contract to be or to contain a lease if the contract conveys the right to control the use of identified property, plant or equipment (an identified asset) for a period of time in exchange for consideration.
A lease liability is recorded at commencement for the net present value of future lease payments over the lease term. The discount rate used is generally the Company’s estimated incremental borrowing rate based on credit-adjusted and term-specific discount rates, using a third-party yield curve. A right of use (“ROU”) asset is recorded and recognized at commencement at the lease liability amount, adjusted for lease prepayments, initial direct costs incurred and lease incentives received. The Company’s lease terms include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option.
In the normal course of its business, the Company enters into various leases as the lessee, primarily related to certain transportation vehicles, warehouse facilities, office space, and machinery and equipment. These leases have remaining lease terms between and
The Company has elected not to recognize short-term leases on the balance sheet for all underlying asset classes. Short-term leases are leases that, at the commencement date, have a lease term of twelve months or less and do not include a purchase option that the Company is reasonably certain to exercise. Short-term leases are expensed on a straight-line basis over the lease term.
The components of the Company’s lease costs were as follows:
|
|
Years Ended September 30 |
|
|||||||||
|
|
2024 |
|
|
2023 |
|
|
2022 |
|
|||
|
|
(In millions) |
|
|||||||||
Operating lease cost |
|
$ |
|
|
$ |
|
|
$ |
|
|||
Finance lease cost |
|
|
|
|
|
|
|
|
|
|||
Total lease cost |
|
$ |
|
|
$ |
|
|
$ |
|
Included within operating lease costs are short-term lease costs, which were $
74
Supplemental cash flow information related to the Company’s leases was as follows:
|
|
Years Ended September 30 |
|
|||||||||
|
|
2024 |
|
|
2023 |
|
|
2022 |
|
|||
|
|
(In millions) |
|
|||||||||
Cash paid for amounts included in the measurement of lease liabilities: |
|
|
|
|
|
|
|
|
|
|||
Operating cash flows from operating leases |
|
$ |
|
|
$ |
|
|
$ |
|
|||
Operating cash flows from finance leases |
|
|
|
|
|
|
|
|
|
|||
Financing cash flows from finance leases |
|
|
|
|
|
|
|
|
|
|||
Right-of-use assets obtained in exchange for new operating lease |
|
$ |
|
|
$ |
|
|
$ |
|
|||
Right-of-use assets obtained in exchange for new finance lease |
|
$ |
|
|
$ |
|
|
$ |
|
Supplemental balance sheet information related to the Company’s leases was as follows:
Description |
|
Balance Sheet Classification |
|
September 30, 2024 |
|
|
September 30, 2023 |
|
||
|
|
|
|
(In millions) |
|
|||||
Lease ROU assets: |
|
|
|
|
|
|
|
|
||
Operating |
|
|
$ |
|
|
$ |
|
|||
Finance |
|
|
|
|
|
|
|
|||
Total lease ROU assets |
|
|
|
$ |
|
|
$ |
|
||
|
|
|
|
|
|
|
|
|
||
Lease liabilities: |
|
|
|
|
|
|
|
|
||
Current: |
|
|
|
|
|
|
|
|
||
Operating |
|
|
$ |
|
|
$ |
|
|||
Finance |
|
|
|
|
|
|
|
|||
Long-term: |
|
|
|
|
|
|
|
|
||
Operating |
|
|
|
|
|
|
|
|||
Finance |
|
|
|
|
|
|
|
|||
Total lease liabilities |
|
|
|
$ |
|
|
$ |
|
The following table presents the weighted-average remaining lease term and discount rates for the Company’s leases:
Description |
|
September 30, 2024 |
|
|
September 30, 2023 |
|
||
Weighted-average remaining lease term (years): |
|
|
|
|
|
|
||
Operating leases |
|
|
|
|
|
|
||
Finance leases |
|
|
|
|
|
|
||
Weighted-average discount rate: |
|
|
|
|
|
|
||
Operating leases |
|
|
% |
|
|
% |
||
Finance leases |
|
|
% |
|
|
% |
Future minimum lease payments under non-cancelable operating and finance leases as of September 30, 2024 were as follows:
Years Ending September 30 |
|
Operating leases |
|
|
Finance leases |
|
||
|
|
(In millions) |
|
|||||
2025 |
|
$ |
|
|
$ |
|
||
2026 |
|
|
|
|
|
|
||
2027 |
|
|
|
|
|
|
||
2028 |
|
|
|
|
|
|
||
2029 |
|
|
|
|
|
|
||
2030 and thereafter |
|
|
|
|
|
|
||
Total lease payments |
|
|
|
|
|
|
||
Less: imputed interest |
|
|
|
|
|
|
||
|
$ |
|
|
$ |
|
75
Note T. Commitments and Contingencies
Other Long-Term Commitments
Cabot has entered into long-term purchase agreements primarily for the purchase of raw materials. Under certain of these agreements, the quantity of material being purchased is fixed, but the price paid changes as market prices change. Raw materials purchased under these agreements were $
For these purchase commitments, the amounts included in the table below are based on market prices as of September 30, 2024 which may differ from actual market prices at the time of purchase.
|
|
Payments Due by Fiscal Year |
|
|||||||||||||||||||||||||
|
|
2025 |
|
|
2026 |
|
|
2027 |
|
|
2028 |
|
|
2029 |
|
|
Thereafter |
|
|
Total |
|
|||||||
|
|
(In millions) |
|
|||||||||||||||||||||||||
Reinforcement Materials |
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
|||||||
Performance Chemicals |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
|
|||||||
Total |
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
The Company has also entered into long-term purchase agreements primarily for services related to information technology, which are not included in the table above, that totaled $
Guarantee Agreements
Cabot has provided certain indemnities pursuant to which it may be required to make payments to an indemnified party in connection with certain transactions and agreements. In connection with certain acquisitions and divestitures, Cabot has provided routine indemnities with respect to such matters as environmental, tax, insurance, product and employee liabilities. In connection with various other agreements, including service and supply agreements with customers, Cabot has provided indemnities for certain contingencies and routine warranties. Cabot is unable to estimate the maximum potential liability for these types of indemnities as a maximum obligation is not explicitly stated in most cases and the amounts, if any, are dependent upon the outcome of future contingent events, the nature and likelihood of which cannot be reasonably estimated. The duration of the indemnities vary, and in many cases are indefinite. Cabot has not recorded any liability for these indemnities in the consolidated financial statements, except as otherwise disclosed.
Self-Insurance and Retention for Certain Contingencies
The Company is partially self-insured for certain third-party liabilities globally, as well as workers’ compensation and employee medical benefits in the United States. The third-party and workers’ compensation liabilities are managed through a wholly-owned insurance captive and the related liabilities are included in the consolidated financial statements. The employee medical obligations are managed by a third-party provider and the related liabilities are included in the consolidated financial statements. To limit Cabot’s potential liabilities for these risks, however, the Company purchases insurance from third parties that provides stop-loss protection. The self-insured liability in fiscal 2024 for third-party liabilities was $
Contingencies
Cabot is a defendant, or potentially responsible party, in various lawsuits and environmental proceedings wherein substantial amounts are claimed or at issue.
Environmental Matters
As of both September 30, 2024 and 2023, Cabot had $
76
conditions, and other factors, it is reasonably possible that the Company could incur additional costs in excess of environmental reserves currently recorded. Management estimates, based on the latest available information, that any such future environmental remediation costs that are reasonably possible to be in excess of amounts already recorded would be immaterial to the Company’s consolidated financial statements.
Charges for environmental expense were $
The operation and maintenance component of the reserve for environmental matters was $
In November 2013, Cabot entered into a Consent Decree with the EPA and the Louisiana Department of Environmental Quality (“LDEQ”) regarding Cabot’s three carbon black manufacturing facilities in the U.S. This settlement is related to EPA’s national enforcement initiative focused on the U.S. carbon black manufacturing sector alleging non-compliance with certain regulatory and permitting requirements under The Clean Air Act, including the New Source Review (“NSR”) construction permitting requirements. Pursuant to this settlement, Cabot has installed technology controls for the reduction of sulfur dioxide and nitrogen oxide emissions at two of its plants and is in the process of installing these controls at the third plant. Cabot is currently in discussions with the EPA and LDEQ to extend its compliance date at the third plant to mid-2025 based upon force majeure events primarily related to the COVID-19 pandemic.
Respirator Liabilities
Cabot has exposure in connection with a safety respiratory products business that a subsidiary acquired from American Optical Corporation (“AO”) in an April 1990 asset purchase transaction. The subsidiary manufactured respirators under the AO brand and disposed of that business in July 1995. In connection with its acquisition of the business, the subsidiary agreed, in certain circumstances, to assume a portion of AO’s liabilities, including costs of legal fees together with amounts paid in settlements and judgments, allocable to AO respiratory products used prior to the 1990 purchase by the Cabot subsidiary. In exchange for the subsidiary’s assumption of certain of AO’s respirator liabilities, AO agreed to provide to the subsidiary the benefits of: (i) AO’s insurance coverage for the period prior to the 1990 acquisition and (ii) a former owner’s indemnity of AO holding it harmless from any liability allocable to AO respiratory products used prior to May 1982.
Generally, these respirator liabilities involve claims for personal injury, including asbestosis, silicosis and coal worker’s pneumoconiosis (“CWP”), allegedly resulting from the use of respirators that are alleged to have been negligently designed and/or labeled. At no time did this respiratory product line represent a significant portion of the respirator market.
The subsidiary transferred the business to Aearo Technologies (“Aearo”) in July 1995. Cabot agreed to have the subsidiary retain certain liabilities associated with exposure to asbestos and silica while using respirators prior to the 1995 transaction so long as Aearo paid, and continues to pay, Cabot an annual fee of $400,000. Aearo can discontinue payment of the fee at any time, in which case it will assume the responsibility for and indemnify Cabot against those liabilities which Cabot’s subsidiary had agreed to retain. The Company anticipates that it will continue to receive payment of the $400,000 fee from Aearo and thereby retain these liabilities for the foreseeable future. Cabot has no liability in connection with any products manufactured by Aearo after 1995. Because of the difficulty in determining when a particular respirator was manufactured, Aearo and Cabot have applied the retention of liabilities under the 1995 agreement to claims arising out of the alleged use of respirators involving exposure to asbestos, silica or silica products prior to January 1, 1997. On July 26, 2022, Aearo voluntarily filed for Chapter 11 bankruptcy protection with the stated goal of establishing a trust, funded by Aearo and its parent 3M, to satisfy respirator and other unrelated claims related to earplug products determined to be entitled to compensation. On June 9, 2023, the court dismissed Aearo’s bankruptcy case based on motions filed by various creditors in the case. Aearo appealed the decision but did not seek to stay the dismissal, which made the dismissal effective immediately and ended the automatic bankruptcy stay. In August 2023, Aearo entered into a settlement agreement to resolve the unrelated earplug product claims. Upon joint motion of the parties, Aearo’s appeal was dismissed on July 11, 2024, thereby formally ending its bankruptcy case.
In addition to Cabot’s subsidiary and as described above, other parties are responsible for significant portions of the costs of respirator liabilities, leaving Cabot’s subsidiary with a portion of the liability in only some of the pending cases. These parties include Aearo, AO, AO’s insurers, another former owner and its insurers and a third-party manufacturer of respirators formerly sold under the AO brand and its insurers (collectively, with the Company’s subsidiary, the “Payor Group”).
Cabot has contributed to the Payor Group’s defense and settlement costs with respect to a percentage of pending claims depending on several factors, including the period of alleged product use. In order to quantify Cabot’s estimated share of liability for pending and future respirator liability claims, Cabot has periodically engaged, through counsel, the assistance of Gnarus Advisors, LLC (“Gnarus”), a consulting firm in the field of tort liability valuation. Cabot last engaged Gnarus during fiscal year 2023.
77
The methodology used to estimate the liability addresses the complexities surrounding Cabot’s potential liability by making assumptions about Cabot’s likely exposure based on various factors, including the Payor Group’s historical experience with these claims, the number of future claims and the cost to resolve pending and future claims. Using those and other assumptions, the Company estimates the costs that would be incurred in defending and resolving both currently pending and future claims.
As of September 30, 2024 and 2023, the Company had $
The Company made payments related to its respirator liability of $
The Company’s current estimate of the cost of its share of pending and future respirator liability claims is based on facts and circumstances existing at this time, including the number and nature of the remaining claims. Developments that could affect the Company’s estimate include, but are not limited to, (i) significant changes in the number of future claims, (ii) changes in the rate of dismissals without payment of pending claims, (iii) significant changes in the average cost of resolving claims, including potential settlements of groups of claims, (iv) significant changes in the legal costs of defending these claims, (v) changes in the nature of claims received or changes in the Company’s assessment of the viability of these claims, (vi) trial and appellate outcomes, (vii) changes in the law and procedure applicable to these claims, (viii) the financial viability of the parties that contribute to the payment of respirator claims , (ix) exhaustion or changes in the recoverability of the insurance coverage maintained by certain members of the Payor Group, or a change in the availability of the indemnity provided by a former owner of AO, (x) changes in the allocation of costs among the various parties paying legal and settlement costs, and (xi) a determination that the assumptions that were used to estimate Cabot’s share of liability are no longer reasonable. The Company cannot determine the impact of these potential developments on its current estimate of its share of liability for existing and future claims. Because reserves are limited to amounts that are probable and estimable as of a relevant measurement date, and there is inherent difficulty in projecting the impact of potential developments on Cabot’s share of liability for these existing and future claims, it is reasonably possible that the liabilities for existing and future claims could change in the near term and that change could be material.
Other Matters
The Company has various other lawsuits, claims and contingent liabilities arising in the ordinary course of its business and with respect to its divested businesses. The Company does not believe that any of these matters will have a material adverse effect on its financial position; however, litigation is inherently unpredictable. Cabot could incur judgments, enter into settlements or revise its expectations regarding the outcome of certain matters, and such developments could have a material impact on its results of operations in the period in which the amounts are accrued or its cash flows in the period in which the amounts are paid.
Note U. Supplier Financing Programs
The Company maintains supply chain finance agreements with third-party financial institutions. These agreements allow the Company’s participating suppliers to sell their receivables to such third-party financial institutions to receive payment earlier than the negotiated commercial terms between the supplier and the Company. Such sales are at the sole discretion of the supplier, and on terms and conditions that are negotiated between the supplier and the respective financial institution. The terms and conditions of the supplier invoice, including payment terms and amounts due, are not impacted by a supplier’s participation in the program. Pursuant to the supply chain finance agreements, the Company has agreed to pay financial institutions on the original due date of the applicable invoice. There are no guarantees associated with these programs. The Company's outstanding payment obligations to financial institutions related to supplier financing programs were $
78
Note V. Financial Information by Segment & Geographic Area
Segment Information
The Company identifies a business as an operating segment if: i) it engages in business activities from which it may earn revenues and incur expenses; ii) its operating results are regularly reviewed by the Chief Operating Decision Maker (“CODM”), who is Cabot’s President and Chief Executive Officer, to make decisions about resources to be allocated to the segment and assess its performance; and iii) it has available discrete financial information. The Company has determined that all of its businesses are operating segments. The CODM reviews financial information at the operating segment level to allocate resources and to assess the operating results and financial performance for each operating segment. Operating segments are aggregated into a reportable segment if the operating segments are determined to have similar economic characteristics and if the operating segments are similar in the following areas: i) nature of products and services; ii) nature of production processes; iii) type or class of customer for their products and services; iv) methods used to distribute the products or provide services; and v) if applicable, the nature of the regulatory environment.
The Company has
Income (loss) from operations before income taxes (“Segment EBIT”) is presented for each reportable segment in the financial information by the reportable segment table below on the line entitled Income (loss) from operations before taxes. Segment EBIT excludes certain items, meaning items management does not consider representative of on-going operating segment results. In addition, Segment EBIT includes Equity in earnings of affiliated companies, net of tax, royalties, Net income (loss) attributable to noncontrolling interests, net of tax, and discounting charges for certain Notes receivable, but excludes Interest expense, foreign currency transaction gains and losses, interest income, dividend income, unearned revenue, general unallocated expense and unallocated corporate costs. Segment assets exclude cash, short-term investments, cost investments, income taxes receivable, deferred taxes and headquarters’ assets, which are included in unallocated and other. Expenditures for additions to long-lived assets include total equity and other investments (including available-for-sale securities) and property, plant and equipment.
Reinforcement Materials
Carbon black is a form of elemental carbon that is manufactured in a highly controlled process to produce particles and aggregates of varied size, structure and surface chemistry, resulting in many different performance characteristics for a wide variety of applications. Reinforcing carbons (a class of carbon blacks manufactured by Cabot) are used to enhance the physical properties of the systems and applications in which they are incorporated.
The Company’s reinforcing carbons products are used in tires and industrial products. Reinforcing carbons have traditionally been used in the tire industry as a rubber reinforcing agent to increase tread durability and are also used as a performance additive to reduce rolling resistance and improve traction. In industrial products such as hoses, belts, extruded profiles and molded goods, reinforcing carbons are used to improve the physical performance of the product, including the product’s physical strength, fluid resistance, conductivity and resistivity.
In addition to its reinforcing carbons products, the Company manufactures engineered elastomer composites (“E2C®”) solutions that are composites of reinforcing carbons and rubber made using the Company’s patented elastomer composites manufacturing process. These composites improve abrasion/wear resistance, reduce fatigue of rubber parts and reduce rolling resistance compared to reinforcing carbons/rubber compounds made entirely by conventional rubber mix methods enabling rubber product manufacturers to reduce the need to make performance trade-offs.
Performance Chemicals
The Performance Chemicals segment aggregates the specialty carbons, specialty compounds, fumed metal oxides, battery materials, inkjet colorants and aerogel product lines. In Performance Chemicals, the Company designs, manufactures and sells materials that deliver performance in a broad range of customer applications across the automotive, construction, infrastructure, inkjet printing, electronics and consumer products sectors, and applications related to generation, transmission and storage of energy. The Company’s focus areas for growth include conductive additives and other materials for battery applications, and inkjet dispersions for post print corrugated packaging applications.
The Company’s specialty carbons are used to impart color, provide rheology control, enhance conductivity and static charge control, provide UV protection, enhance mechanical properties and provide formulation flexibility through surface treatment. These specialty carbon products are used in a wide variety of applications, such as inks, coatings, cables, plastics, adhesives, toners, batteries and displays.
79
Cabot’s masterbatch and conductive compound products, which Cabot refers to as “specialty compounds”, are formulations derived from specialty carbons mixed with polymers and other additives. These products are generally used by plastic resin producers and converters in applications for the automotive, industrial, packaging, infrastructure, agricultural, consumer products, and electronics industries. As an alternative to directly mixing specialty carbon blacks, these formulations offer greater ease of handling and help customers achieve their desired levels of dispersion and color and manage the addition of small doses of additives. In addition, Cabot’s electrically conductive compound products generally are used to help ensure uniform conductive performance and reduce risks associated with electrostatic discharge in plastics applications.
The Company’s battery materials products include its conductive additives and fumed alumina, which are used principally in advanced lead acid and lithium-ion batteries used in electric vehicles. The Company’s conductive additives consist of conductive carbons, carbon nanotubes and carbon nano structures, and blends of these materials, each of which offers different levels of conductivity and formulation flexibility for battery manufacturers to address performance (energy density, fast charging), cost and safety. In lithium-ion batteries, the Company’s conductive additives are used in both cathode and anode applications to increase energy density by providing a conductive network between active materials. Fumed alumina is used to reduce cathode material and electrolyte decomposition and improve capacity retention leading to longer cycle life.
Fumed silica is an ultra-fine, high-purity particle used as a reinforcing, thickening, abrasive, thixotropic, suspending or anti-caking agent in a wide variety of products for the automotive, construction, microelectronics, batteries, and consumer products industries. These products include adhesives, sealants, cosmetics, batteries, inks, toners, silicone elastomers, coatings, polishing slurries and pharmaceuticals. In addition to its battery application, fumed alumina, also an ultra-fine, high-purity particle, is used as an abrasive, absorbent or barrier agent in a variety of products, such as inkjet media, lighting, coatings, cosmetics and polishing slurries.
Aerogel is a hydrophobic, silica-based particle with a high surface area that is used in a variety of thermal insulation and specialty chemical applications. In the building and construction industry, the product is used in insulative sprayable plasters and composite building products, as well as translucent skylight, window, wall and roof systems for insulating eco-daylighting applications. In the specialty chemicals industry, the product is used to provide matte finishing, insulating and thickening properties for use in a variety of applications, including thermal management for lithium-ion batteries.
The Company’s inkjet colorants are high-quality pigment-based black and color dispersions and inks. The Company’s dispersions are based on patented pigment surface modification technology and polymer encapsulation technology. The dispersions are used in aqueous inkjet inks to impart color, sharp print characteristics and durability, while maintaining high printhead reliability. These products are used in various inkjet printing applications, including traditional work-from-home and corporate office settings, and, increasingly, in commercial and corrugated packaging printing, that all require a high level of dispersibility and colloidal stability. Inkjet inks, which utilize the Company’s pigment-based colorant dispersions, are used in the commercial printing segment for graphic arts.
Purification Solutions
Cabot divested its Purification Solutions business on March 1, 2022. Refer to Note D for the terms of this transaction.
80
Financial information by reportable segment is as follows:
Years Ended September 30 |
|
Reinforcement |
|
|
Performance |
|
|
Purification |
|
|
Segment |
|
|
Unallocated |
|
|
Consolidated |
|
||||||
|
|
(In millions) |
|
|||||||||||||||||||||
2024 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Revenues from external customers(3) |
|
$ |
|
|
$ |
|
|
$ |
— |
|
|
$ |
|
|
$ |
|
|
$ |
|
|||||
Depreciation and amortization |
|
$ |
|
|
$ |
|
|
$ |
— |
|
|
$ |
|
|
$ |
|
|
$ |
|
|||||
Equity in earnings of affiliated companies |
|
$ |
|
|
$ |
|
|
$ |
— |
|
|
$ |
|
|
$ |
— |
|
|
$ |
|
||||
Income (loss) from operations |
|
$ |
|
|
$ |
|
|
$ |
— |
|
|
$ |
|
|
$ |
( |
) |
|
$ |
|
||||
Assets(5) |
|
$ |
|
|
$ |
|
|
$ |
— |
|
|
$ |
|
|
$ |
|
|
$ |
|
|||||
Total expenditures for additions to long-lived |
|
$ |
|
|
$ |
|
|
$ |
— |
|
|
$ |
|
|
$ |
|
|
$ |
|
|||||
2023 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Revenues from external customers(3) |
|
$ |
|
|
$ |
|
|
$ |
— |
|
|
$ |
|
|
$ |
|
|
$ |
|
|||||
Depreciation and amortization |
|
$ |
|
|
$ |
|
|
$ |
— |
|
|
$ |
|
|
$ |
|
|
$ |
|
|||||
Equity in earnings of affiliated companies |
|
$ |
|
|
$ |
|
|
$ |
— |
|
|
$ |
|
|
$ |
— |
|
|
$ |
|
||||
Income (loss) from operations |
|
$ |
|
|
$ |
|
|
$ |
— |
|
|
$ |
|
|
$ |
( |
) |
|
$ |
|
||||
Assets(5) |
|
$ |
|
|
$ |
|
|
$ |
— |
|
|
$ |
|
|
$ |
|
|
$ |
|
|||||
Total expenditures for additions to long-lived |
|
$ |
|
|
$ |
|
|
$ |
— |
|
|
$ |
|
|
$ |
|
|
$ |
|
|||||
2022 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Revenues from external customers(3) |
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
Depreciation and amortization |
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
Equity in earnings of affiliated companies |
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
— |
|
|
$ |
|
|||||
Income (loss) from operations |
|
$ |
|
|
$ |
|
|
$ |
— |
|
|
$ |
|
|
$ |
( |
) |
|
$ |
|
||||
Assets(5) |
|
$ |
|
|
$ |
|
|
$ |
— |
|
|
$ |
|
|
$ |
|
|
$ |
|
|||||
Total expenditures for additions to long-lived |
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
|
|
Years Ended September 30 |
|
|||||||||
|
|
2024 |
|
|
2023 |
|
|
2022 |
|
|||
|
|
(In millions) |
|
|||||||||
Shipping and handling fees |
|
$ |
|
|
$ |
|
|
$ |
|
|||
By-product sales |
|
|
|
|
|
|
|
|
|
|||
Other |
|
|
|
|
|
|
|
|
( |
) |
||
Total |
|
$ |
|
|
$ |
|
|
$ |
|
81
|
|
Years Ended September 30 |
|
|||||||||
|
|
2024 |
|
|
2023 |
|
|
2022 |
|
|||
|
|
(In millions) |
|
|||||||||
Interest expense |
|
$ |
( |
) |
|
$ |
( |
) |
|
$ |
( |
) |
Certain items:(a) |
|
|
|
|
|
|
|
|
|
|||
Argentina controlled currency devaluation and other losses |
|
|
( |
) |
|
|
( |
) |
|
|
— |
|
Global restructuring activities (Note O) |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
Legal and environmental matters and reserves (Note T) |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
Gain on sale of land |
|
|
— |
|
|
|
|
|
|
|
||
Acquisition and integration-related charges |
|
|
— |
|
|
|
( |
) |
|
|
( |
) |
Loss on sale of business and asset impairment charge (Note D) |
|
|
— |
|
|
|
( |
) |
|
|
( |
) |
Gain on bargain purchase of a business (Note C) |
|
|
— |
|
|
|
— |
|
|
|
|
|
Specialty Fluids divestiture related benefit |
|
|
— |
|
|
|
— |
|
|
|
|
|
Employee benefit plan settlement and other charges |
|
|
— |
|
|
|
— |
|
|
|
|
|
Purification Solutions divestiture related charges |
|
|
— |
|
|
|
— |
|
|
|
( |
) |
Other certain items |
|
|
( |
) |
|
|
( |
) |
|
|
— |
|
Total certain items, pre-tax |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
Unallocated corporate costs(b) |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
General unallocated income (expense)(c) |
|
|
|
|
|
|
|
|
|
|||
Less: Equity in earnings of affiliated companies, net of tax(d) |
|
|
|
|
|
|
|
|
|
|||
Total |
|
$ |
( |
) |
|
$ |
( |
) |
|
$ |
( |
) |
Geographic Information
Revenues from external customers attributable to an individual country, other than the U.S. and China, were not material for disclosure. Revenues from external customers by individual country are summarized as follows:
|
|
Years Ended September 30 |
|
|||||||||
|
|
2024 |
|
|
2023 |
|
|
2022 |
|
|||
|
|
(In millions) |
|
|||||||||
United States |
|
$ |
|
|
$ |
|
|
$ |
|
|||
China |
|
|
|
|
|
|
|
|
|
|||
Other countries |
|
|
|
|
|
|
|
|
|
|||
Total |
|
$ |
|
|
$ |
|
|
$ |
|
82
Each of the Company’s segments operates globally. In addition to presenting Revenue from external customers by reportable segment, the following tables further disaggregate Revenue from external customers by geographic region.
|
|
Year Ended September 30, 2024 |
|
|||||||||
|
|
Reinforcement |
|
|
Performance |
|
|
Consolidated Total |
|
|||
|
|
(In millions) |
|
|||||||||
Americas |
|
$ |
|
|
$ |
|
|
$ |
|
|||
Asia Pacific |
|
|
|
|
|
|
|
|
|
|||
Europe, Middle East and Africa |
|
|
|
|
|
|
|
|
|
|||
Segment revenues from external customers |
|
|
|
|
|
|
|
|
|
|||
Unallocated and other |
|
|
|
|
|
|
|
|
|
|||
Net sales and other operating revenues |
|
|
|
|
|
|
|
$ |
|
|
|
Year Ended September 30, 2023 |
|
|||||||||
|
|
Reinforcement |
|
|
Performance |
|
|
Consolidated Total |
|
|||
|
|
(In millions) |
|
|||||||||
Americas |
|
$ |
|
|
$ |
|
|
$ |
|
|||
Asia Pacific |
|
|
|
|
|
|
|
|
|
|||
Europe, Middle East and Africa |
|
|
|
|
|
|
|
|
|
|||
Segment revenues from external customers |
|
|
|
|
|
|
|
|
|
|||
Unallocated and other |
|
|
|
|
|
|
|
|
|
|||
Net sales and other operating revenues |
|
|
|
|
|
|
|
$ |
|
|
|
Year Ended September 30, 2022 |
|
|||||||||||||
|
|
Reinforcement |
|
|
Performance |
|
|
Purification |
|
|
Consolidated Total |
|
||||
|
|
(In millions) |
|
|||||||||||||
Americas |
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
||||
Asia Pacific |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Europe, Middle East and Africa |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Segment revenues from external customers |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Unallocated and other |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Net sales and other operating revenues |
|
|
|
|
|
|
|
|
|
|
$ |
|
Property, plant and equipment attributable to an individual country, other than the U.S. and China, were not material for disclosure. Property, plant and equipment information by individual country is summarized as follows:
|
|
Years Ended September 30 |
|
|||||
|
|
2024 |
|
|
2023 |
|
||
|
|
(In millions) |
|
|||||
United States |
|
$ |
|
|
$ |
|
||
China |
|
|
|
|
|
|
||
Other countries |
|
|
|
|
|
|
||
Total |
|
$ |
|
|
$ |
|
Note W. Subsequent Event
On July 19, 2024, Cabot entered into agreements to purchase certain assets and to license the related technology, which the Company expects to use in its manufacturing of certain products for its Battery Materials product line. Under these agreements, the Company paid $
83
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Shareholders and the Board of Directors of Cabot Corporation
Opinion on the Financial Statements
We have audited the accompanying consolidated balance sheets of Cabot Corporation and subsidiaries (the "Company") as of September 30, 2024 and 2023, the related consolidated statements of operations, comprehensive income, stockholders' equity, and cash flows, for each of the three years in the period ended September 30, 2024, and the related notes (collectively referred to as the "financial statements"). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of September 30, 2024 and 2023, and the results of its operations and its cash flows for each of the three years in the period ended September 30, 2024, in conformity with accounting principles generally accepted in the United States of America.
We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company's internal control over financial reporting as of September 30, 2024, based on criteria established in Internal Control — Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission and our report dated November 20, 2024, expressed an unqualified opinion on the Company's internal control over financial reporting.
Basis for Opinion
These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company's financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.
Critical Audit Matter
The critical audit matter communicated below is a matter arising from the current-period audit of the financial statements that was communicated or required to be communicated to the audit committee and that (1) relates to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing a separate opinion on the critical audit matters or on the accounts or disclosures to which it relates.
Commitments and Contingencies — CWP Respirator Liabilities — Refer to Note T to the consolidated financial statements
Critical Audit Matter Description
The Company has exposure in connection with a safety respiratory products business previously owned by one of its subsidiaries. The respirator liabilities involve claims for personal injury, including asbestosis, silicosis and coal worker’s pneumoconiosis (“CWP”).
We identified CWP respirator liabilities, which are part of the total respirator liabilities, as a critical audit matter because there is significant uncertainty related to the number of future claims and the estimate of the cost to resolve pending and future claims. Audit procedures around CWP respirator liabilities required a high degree of auditor judgment and an increased extent of effort and specialized skill, including the need to involve our actuarial specialists.
How the Critical Audit Matter Was Addressed in the Audit
Our audit procedures related to respirator liabilities included the following, among others:
84
/s/
November 20, 2024
We have served as the Company's auditor since 2007.
85
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Shareholders and the Board of Directors of Cabot Corporation
Opinion on Internal Control over Financial Reporting
We have audited the internal control over financial reporting of Cabot Corporation and subsidiaries (the “Company”) as of September 30, 2024, based on criteria established in Internal Control — Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). In our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of September 30, 2024, based on criteria established in Internal Control — Integrated Framework (2013) issued by COSO.
We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated financial statements as of and for the year ended September 30, 2024, of the Company and our report dated November 20, 2024, expressed an unqualified opinion on those financial statements.
Basis for Opinion
The Company’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management’s Annual Report on Internal Control Over Financial Reporting. Our responsibility is to express an opinion on the Company’s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.
Definition and Limitations of Internal Control over Financial Reporting
A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
/s/ Deloitte & Touche LLP
Boston, Massachusetts
November 20, 2024
86
PART II
Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure
None.
Item 9A. Controls and Procedures
Disclosure Controls and Procedures
Cabot carried out an evaluation, under the supervision and with the participation of its management, including its principal executive officer and its principal financial officer, of the effectiveness of the Company’s disclosure controls and procedures pursuant to Rule 13a-15 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), as of September 30, 2024. Based on that evaluation, Cabot’s principal executive officer and its principal financial officer concluded that the Company’s disclosure controls and procedures are effective with respect to the recording, processing, summarizing and reporting, within the time periods specified in the Securities and Exchange Commission’s rules and forms, of information required to be disclosed by the Company in the reports that it files or submits under the Exchange Act and such information is accumulated and communicated to management to allow timely decisions regarding required disclosure.
Management’s Annual Report on Internal Control Over Financial Reporting
Cabot’s management is responsible for establishing and maintaining adequate internal control over financial reporting for Cabot. Internal control over financial reporting is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act as a process designed by, or under the supervision of, a company’s principal executive and principal financial officers, and effected by the company’s board of directors, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles and includes those policies and procedures that:
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of the effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with policies or procedures may deteriorate.
Cabot’s management assessed the effectiveness of Cabot’s internal control over financial reporting as of September 30, 2024 based on the framework established in Internal Control—Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). Based on this assessment, Cabot’s management concluded that Cabot’s internal control over financial reporting was effective as of September 30, 2024.
Cabot’s internal control over financial reporting as of September 30, 2024 has been audited by Deloitte & Touche LLP, an independent registered public accounting firm, as stated in their report above.
Changes in Internal Control Over Financial Reporting
There were no changes in the Company’s internal control over financial reporting that occurred during the Company’s fiscal quarter ending September 30, 2024 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.
Item 9B. Other Information
(b). During our fiscal quarter ended September 30, 2024, none of our directors or officers (as defined in Rule 16a-1(f) under the Securities Exchange Act of 1934, as amended)
Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections
None.
87
PART III
Item 10. Directors, Executive Officers and Corporate Governance
Certain information regarding our executive officers is included at the end of Part I of this annual report under the heading “Information about our Executive Officers.”
Cabot has adopted a Code of Business Ethics that applies to all of the Company’s employees and directors, including the Chief Executive Officer, the Chief Financial Officer, the Controller and other senior financial officers. The Code of Business Ethics is posted on our website, www.cabotcorp.com (under the “About Cabot” caption under “Company”). We intend to satisfy the disclosure requirement regarding any amendment to, or waiver of, a provision of the Code of Business Ethics applicable to the Chief Executive Officer, the Chief Financial Officer, the Controller or other senior financial officers by posting such information on our website.
The other information required by this item will be included in our Proxy Statement for the 2025 Annual Meeting of Stockholders (“Proxy Statement”) and is herein incorporated by reference.
Item 11. Executive Compensation
The information required by this item will be included in our Proxy Statement and is incorporated herein by reference.
Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
The information required by this item will be included in our Proxy Statement and is incorporated herein by reference.
The information required by this item will be included in our Proxy Statement and is incorporated herein by reference.
Item 14. Principal Accounting Fees and Services
The information required by this item will be included in our Proxy Statement and is incorporated herein by reference.
PART IV
Item 15. Exhibits, Financial Statement Schedules
See “Index to Financial Statements” under Item 8 of this Form 10-K.
The Schedules have been omitted since the required information is not applicable or is not present in amounts sufficient to require submission of the schedule, or because the information required is included in the consolidated financial statements and notes thereto included in this Form 10-K.
The exhibit numbers in the Exhibit Index correspond to the numbers assigned to such exhibits in the Exhibit Table of Item 601 of Regulation S-K. Cabot will furnish to any stockholder, upon written request, any exhibit listed in the Exhibit Index, upon payment by such stockholder of the Company’s reasonable expenses in furnishing such exhibit.
Exhibit Number |
|
Description |
|
|
|
3(a) |
|
|
|
|
|
3(b) |
|
|
|
|
|
4(a) |
|
|
|
|
|
88
Exhibit Number |
|
Description |
|
|
|
4(a)(i) |
|
|
|
|
|
4(a)(ii) |
|
|
|
|
|
4(a)(iii) |
|
|
|
|
|
4(a)(iv) |
|
|
|
|
|
4(a)(v) |
|
|
|
|
|
4(a)(vi) |
|
|
|
|
|
4(b) |
|
|
|
|
|
10(a) |
|
|
|
|
|
10(a)(i) |
|
|
|
|
|
10(a)(ii) |
|
|
|
|
|
10(a)(iii) |
|
|
|
|
|
10(b) |
|
89
Exhibit Number |
|
Description |
|
|
|
|
|
|
|
|
|
10(c)* |
|
|
|
|
|
10(c)(i)* |
|
|
|
|
|
10(c)(ii)* |
|
|
|
|
|
10(c)(iii)* |
|
|
|
|
|
10(c)(vi)* |
|
|
|
|
|
10(d)* |
|
|
|
|
|
10(e)* |
|
|
|
|
|
10(f)* |
|
|
|
|
|
10(g)* |
|
|
|
|
|
10(h)* |
|
|
|
|
|
10(i)* |
|
|
|
|
|
10(j)* |
|
|
|
|
|
90
Exhibit Number |
|
Description |
|
|
|
10(k)* |
|
|
|
|
|
10(l)* |
|
|
|
|
|
10(m)* |
|
|
|
|
|
10(n)* |
|
|
|
|
|
10(o)* |
|
|
|
|
|
19† |
|
|
|
|
|
21† |
|
|
|
|
|
23† |
|
|
|
|
|
31(i)† |
|
|
|
|
|
31(ii)† |
|
|
|
|
|
32†† |
|
|
|
|
|
97† |
|
Cabot Corporation Policy for Recoupment of Incentive Compensation. |
|
|
|
101.INS† |
|
Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document. |
|
|
|
101.SCH† |
|
Inline XBRL Taxonomy Extension Schema Document. |
|
|
|
101.CAL† |
|
Inline XBRL Taxonomy Extension Calculation Linkbase Document. |
|
|
|
101.DEF† |
|
Inline XBRL Taxonomy Extension Definition Linkbase Document. |
|
|
|
101.LAB† |
|
Inline XBRL Taxonomy Extension Label Linkbase Document. |
|
|
|
101.PRE† |
|
Inline XBRL Taxonomy Extension Presentation Linkbase Document. |
|
|
|
104† |
|
Cover Page Interactive Data File (embedded within the Inline XBRL document). |
|
|
|
* Management contract or compensatory plan or arrangement.
† Filed herewith.
†† Furnished herewith.
91
Item 16. Form 10-K Summary
None.
92
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
CABOT CORPORATION |
||
|
|
|
|
|
BY: |
|
/S/ SEAN D. KEOHANE |
|
|
|
Sean D. Keohane President and Chief Executive Officer |
Date: November 20, 2024
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.
Signatures |
|
Title |
|
Date |
|
|
|
|
|
/s/ SEAN D. KEOHANE |
|
Director, President and |
|
November 20, 2024 |
Sean D. Keohane |
|
Chief Executive Officer |
|
|
|
|
|
|
|
/s/ ERICA MCLAUGHLIN |
|
Executive Vice President and |
|
November 20, 2024 |
Erica McLaughlin |
|
Chief Financial Officer |
|
|
|
|
(principal financial officer) |
|
|
|
|
|
|
|
/s/ LISA M. DUMONT |
|
Vice President, Controller and Chief Accounting Officer |
|
November 20, 2024 |
Lisa M. Dumont |
|
(Chief Accounting Officer) |
|
|
|
|
|
|
|
/s/ MICHAEL M. MORROW |
|
Director, Non-Executive |
|
November 20, 2024 |
Michael M. Morrow |
|
Chair of the Board |
|
|
|
|
|
|
|
/s/ CYNTHIA A. ARNOLD |
|
Director |
|
November 20, 2024 |
Cynthia A. Arnold |
|
|
|
|
|
|
|
|
|
/s/ DOUGLAS DEL GROSSO |
|
Director |
|
November 20, 2024 |
Douglas Del Grosso |
|
|
|
|
|
|
|
|
|
/s/ JUAN ENRIQUEZ |
|
Director |
|
November 20, 2024 |
Juan Enriquez |
|
|
|
|
|
|
|
|
|
/s/ WILLIAM C. KIRBY |
|
Director |
|
November 20, 2024 |
William C. Kirby |
|
|
|
|
|
|
|
|
|
/s/ RAFFIQ NATHOO |
|
Director |
|
November 20, 2024 |
Raffiq Nathoo |
|
|
|
|
|
|
|
|
|
/s/ THIERRY VANLANCKER |
|
Director |
|
November 20, 2024 |
Thierry Vanlancker |
|
|
|
|
|
|
|
|
|
/s/ MICHELLE E. WILLIAMS |
|
Director |
|
November 20, 2024 |
Michelle E. Williams |
|
|
|
|
|
|
|
|
|
/s/ FRANK A. WILSON |
|
Director |
|
November 20, 2024 |
Frank A. Wilson |
|
|
|
|
|
|
|
|
|
/s/ MATTHIAS L. WOLFGRUBER |
|
Director |
|
November 20, 2024 |
Matthias L. Wolfgruber |
|
|
|
|
|
|
|
|
|
/s/ CHRISTINE Y. YAN |
|
Director |
|
November 20, 2024 |
Christine Y. Yan |
|
|
|
|
93